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Thesis Abstract 
 
Biomaterials for use in bone regeneration and healing range from metal and metal alloy 
implants to hydrogel-based solutions. These materials can be optimized to increase bone 
healing and integration by improving the mechanical and biological properties. 
Regardless of the material itself, the cell-substrate interaction is key to the success of the 
biomaterial once implanted. Substrate surface characteristics such as roughness, 
wettability and particle density are well-known contributors of a substrate’s overall 
osteogenic potential, and therefore the substrates overall success. Unfortunately, it is still 
unknown how these substrate surface characteristics are transduced into intracellular 
signals by cells, preventing specific tailoring of biomaterial characteristics to maximize 
osteogenesis. One theory that has been postulated is that substrate characteristics 
modulate cytoskeletal changes which in turn differentially regulate numerous cell 
pathways. Specifically, the canonical Wnt signaling pathway, relies on β-catenin 
translocation to the nucleus to regulate transcription factors, which in the case of 
osteoblastic cells, regulate pro-osteogenic genes. Another role of β-catenin is its 
contribution to the formation and stabilization of cell adhesions such as focal adhesions 
and cadherins. Furthermore, previous studies have suggested that the β-catenin pool that 
stabilizes adhesions and cadherins may also be the same β-catenin pool that functions 
to induce osteogenesis. Evaluating the link between substrate surface characteristics, 
focal adhesions, and β-catenin could reveal how cells transduce substrate surface 
characteristics into intracellular signals and enable greater optimization of biomaterials 
for bone regeneration.  
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SPECIFIC AIMS 
 
Numerous attempts at optimizing biomaterials for use in bone implants and bone tissue 
engineering have been made over the past decades. Three approaches have been 
utilized in an attempt to improve materials: optimization of current material properties, 
utilization of osteoinductive factors, or development of novel biomaterials with enhanced 
osteogenic properties1. The development of novel biomaterials provides an attractive 
avenue, as it provides the researcher with the greatest flexibility and affords them 
numerous options for producing a pro-osteogenic material. Combination polymers, 
incorporation of growth factors and small molecules, and advanced hydrogels have all 
yielded positive results and their successes have been reviewed in numerous studies1–3.  
  
Despite the successes of biomaterials for bone implants and bone substitutes, it is still 
unknown how biomaterial substrate surface characteristics are transduced by bone cells 
and their precursors into intracellular signals. Further, it is unknown how this transduction 
then mediates cellular response and therefore a materials overall osteogenic potential.  
Literature has shown substrate surface characteristics such as roughness, wettability, 
and surface height may enhance osteogenesis4–6. However, these studies provide 
conflicting results as to which substrate surface characteristic is inducing the observed 
changes specifically4–9. This conflict reveals how specific materials, surface 
characteristics, cell type, and culture conditions can vary the observed results and cell 
response. It also highlights one of the largest knowledge gaps that affects the field of 
biomaterials, which is that the mechanism by which substrate surface characteristics 
modulate and are transduced by the cell into intracellular signals, is largely unknown.  
 
Literature has suggested numerous mechanisms by which substrates are transduced by 
cells10–13. One proposed mechanism suggests that substrates may be transduced 
through cytoskeletal adhesion complexes, such as focal adhesions and cadherins, to the 
actin cytoskeleton. As the actin cytoskeleton remodels in response to changing tension 
generated by the focal adhesions, it can then alter nuclear morphology and gene 
expression, differentially regulating the cells in response to the substrate11,14. While this 
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model has garnered significant interest, it has also given rise to another proposed 
mechanism. This mechanism suggests that β-catenin may play a key role in in the 
transduction of substrate surface characteristics. It has been observed that β-catenin 
stabilizes adhesion junctions by binding ⍺-catenin, though it is unclear whether it actively 
binds ⍺-catenin at focal adhesion complexes12,15. It has also been determined that β-
catenin contributes to osteogenic regulation via the Wnt signaling pathway16. It has been 
hypothesized that β-catenin bound at focal adhesions may contribute to substrate surface 
transduction once liberated from focal adhesions11,17. Unfortunately, it has yet to be 
determined whether β-catenin bound at focal adhesions also translocates to the nucleus 
in response to changes in substrate surface characteristics.  
 
The goal of this research is two-fold. The first is to evaluate a novel aptamer-
functionalized fibrin hydrogel and the effect aptamer functionalization has on the induction 
of osteogenesis and angiogenesis. The second goal is to determine the mechanism by 
which biomaterial substrate characteristics are transduced enabling for the design and 
optimization of biomaterials with enhanced osteogenic properties. The overall hypothesis 
is that cellular transduction of a carbonated hydroxyapatite substrate occurs through a 
focal adhesion initiated β-catenin mediated mechanism. Specifically, as focal adhesion 
turnover and maturation occurs, β-catenin that is localized to the focal adhesion complex, 
is released when the complex disassembles. This release of β-catenin then allows for an 
increase in β-catenin concentration in the cytoplasm, and in turn an increase in nuclear 
translocation. Once β-catenin translocates, it is then able to regulate osteogenesis. 
Additionally, we hypothesize that formation of focal adhesions on the substrate is an 
accurate predictor of osteogenesis. Examination of the proposed mechanism and how it 
regulates osteoblastic differentiation will bridge a gap in our understanding of how 
substrate characteristics are transduced into the cell and evaluate focal adhesions 
correlation with osteogenesis.  
 
Aim 1. Evaluate the effects of VEGF loaded aptamer-functionalized fibrin hydrogel 
on angiogenesis and osteogenesis in a critical size cranial bone defect. 
Transduction of Substrate Surface Characteristics · Spring 2021 
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A novel VEGF specific aptamer-functionalized fibrin hydrogel (AFH) will be evaluated for 
morphological and physical properties as well as VEGF release kinetics compared to 
fibrin hydrogel (FH) alone. After evaluation of AFH release kinetics we will examine AFH 
in vivo in a murine critically sized cranial bone defect model to determine the effect 
aptamer functionalization of the fibrin hydrogel has on the induction of angiogenesis and 
osteogenesis. We will load both FH an AFH with 2.5ug/mL and 10ug/mL of VEGF and 
implant it into a critically sized cranial defect. We will also have a non-treatment group, a 
non-loaded FH group, and a non-loaded AFH group to serve as controls. We will evaluate 
all groups for angiogenesis using MICROFIL perfusion followed by microcomputed 
tomography (microCT). We will also evaluate all groups for osteogenesis using microCT 
to examine bone formation within the defect site. Our sub-hypothesis is that the use of 
AFH with a greater concentration of VEGF will result in significantly greater angiogenesis 
and osteogenesis due to the improved release kinetics associated with aptamer 
functionalization.  
Aim 2. Determine how modification of an emulsion synthesis technique allows for 
the controlled synthesis of carbonated hydroxyapatite particles for use in the 
synthesis of substrates with various surface characteristics.  
We will engineer carbonated hydroxyapatite particles (CHA) of various sizes to develop 
substrates with various surface characteristics. Using an emulsion technique described 
by Zhou et al.18, we will manipulate temperature, pH, and homogenization speed (RPM) 
during the emulsion synthesis in order to evaluate how these variables control particle 
size. Particles will then be characterized for morphology and chemical composition. After 
CHA synthesis we will engineer a polycaprolactone (PCL) and CHA substratum in which 
particle size and density are varied independently. CHA of 200nm, 500nm, and 900nm 
will be suspended in 2.5% PCL solution as well as 500nm CHA at 5%, 30%, and 50 wt/wt 
CHA to PCL. Each substrate will be evaluated for particle density, roughness, wettability 
and height.  Our sub-hypothesis is that modification of the emulsion process through 
variations in pH will enable tailored control over CHA particle size. In addition, 
incorporation of CHA particles at various concentrations will allow the generation of 
PCL/CHA substrates with various substrate characteristics.  
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Aim 3. Determine which substrate composition and surface characteristic induces 
the greatest osteoblastic differentiation and examine how focal adhesion 
maturation and β-catenin localization are affected.  
We will use the substrates engineered in Aim 2 to characterize the cell response to each 
substrate. hFOB 1.19 cells, a preosteoblastic cell line, cultured on tissue culture 
polystyrene (TCPS) and the various substrate will be evaluated using alkaline 
phosphatase activity, gene expression, and protein expression for key osteoblastic 
markers to determine overall osteogenic potential of the substrate. Examination of focal 
adhesion formation, turnover, and maturation will be performed using immunofluorescent 
imaging and enzyme-linked immunosorbent assay (ELISA) to determine focal adhesion 
activity over time. β-catenin localization and translocation will be evaluated using cell 
fractionation to isolate β-catenin within the various cell compartments over time and 
quantified with ELISA. β-catenin translocation and activity will be further assessed using 
a luciferase-based reporter assay. Our sub-hypothesis is that the substrate that induces 
the greatest osteoblastic differentiation will also induce the greatest focal adhesion 
turnover and maturation. In addition, β-catenin translocation will be more rapid on this 
pro-osteogenic substrate as it translocates from the membrane where it is bound at focal 
adhesions, to the nucleus where it can regulate pro-osteogenic pathways.  
Aim 4. Determine how inhibition of focal adhesion turnover affects β-catenin 
localization and translocation on pro-osteogenic substrate.  
Using the pro-osteogenic substrate determined in Aim 2 we will evaluate osteoblastic cell 
response in the presence and absence of an inhibitor of focal adhesion kinase, PF-
573228. We will evaluate osteoblastic differentiation using alkaline phosphatase activity, 
gene expression, and protein expression for key osteoblastic markers. Examination of 
focal adhesion formation, turnover, and maturation will be performed using 
immunofluorescent imaging and ELISA to determine focal adhesion activity over time. β-
catenin localization and translocation will be evaluated using cell fractionation to isolate 
β-catenin within the various cell compartments over time and quantified with ELISA. β-
catenin translocation and activity will be further assessed using a luciferase-based 
reporter assay. Our sub-hypothesis is that by inhibiting focal adhesion turnover and 
therefore focal adhesion disassembly, we will prevent the release of β-catenin from focal 
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adhesions and its translocation to the nucleus, mitigating the observed increase in 
osteoblastic differentiation in response to the pro-osteogenic substrate.  
 
SIGNIFICANCE  
As our population continues to increase in average age, has more musculoskeletal 
injuries, and trends towards a more sedentary lifestyle the comorbidities associated with 
these factors also increase. In 2019 roughly 700 million persons worldwide were age 65 
and older, with this number estimated to double to 1.5 billion persons by 2050. With a rise 
in population age also comes a rise in comorbidities associated with increased age, 
including an increase in bone diseases such as osteoporosis. As a result, injuries like hip 
fractures, associated with such diseases are also estimated to double, and possibly triple, 
increasing to 21 million hip fractures each year, with many necessitating a partial or total 
hip arthroplasty (replacement). In addition to injuries in the elderly population, significant 
musculoskeletal injuries are also becoming more prevalent in the younger population as 
well, with a roughly 150% increase in the number of injuries that occur in the United States 
each year. After injury, those who receive ACL reconstruction are seven times more likely 
to require a total knee arthroplasty. Lastly, with the increases in technology, the average 
sedentary time increased from 26 hours a week in 1965 to 38 hours a week in 2009, with 
this number only expected to rise. This lack of physical activity also contributes to bone 
diseases like osteoporosis, with the lack of activity resulting in bone resorption and a 
greater propensity for bone injury. This results in the need for improved biomaterials for 
use in bone implants and bone grafts. 
 
Biomaterials that are used today in bone implants and grafts function well, yet they still 
are not ideal. For example, cementless titanium implants having a roughly 30% failure 
rate 15 years after implantation. The majority of these failures, approximately 75%, are 
caused by aseptic loosening, or the failure of bone implants to osseointegrate. Failure 
necessitates revision surgeries, which are technically demanding, have a high 
complication rate, are expensive, and are strenuous on the patients. Consequently, this 
creates a significant clinical need to improve the overall osteogenic potential of these 
implants, reducing the overall failure rate. 
Transduction of Substrate Surface Characteristics · Spring 2021 
Otto J. Juhl IV · Ph.D. Dissertation · Biomedical Engineering · Virginia Commonwealth University 17 
 
Numerous research efforts have focused on the improvement of current, and 
development of, new biomaterials. Despite these efforts, significant improvements have 
not been made. One reason for this is because we do not fully understand how bone cells 
and their precursors, specifically mesenchymal stem cells and osteoblasts, transduce the 
substrate surface characteristics of implants and how this transduction contributes to the 
regulation osteogenesis. Without this foundational understanding of the cell-substrate 
interaction, optimization of biomaterials will remain difficult. Gaining a foundational 
understanding of the cell-substrate interaction will allow biomaterials to be tailored to both 
the nano and macro scale, improving their overall osteogenic potential. This study 
focuses on evaluating the cell-substrate interaction on it most fundamental level rather 
than designing an osteogenic biomaterial itself. Knowledge gathered from this study will 
allow us to address the clinical need for implants that are capable of greater 
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BONE OVERVIEW 
 
Bone is a complex tissue that provides structural support to the body, protects vital 
organs, acts as a reservoir for various factors and cells, and maintains homeostatic 
balance for certain minerals19. Bone is classified as either cortical or trabecular bone. 
Cortical bone is dense bone tissue that surrounds the marrow cavities, providing rigid 
structural support along the shaft or diaphysis20. Trabecular bone is a honeycomb like 
bone tissue that is within the marrow cavity and concentrated at the ends of most long 
bones in the metaphysis and epiphysis20. Trabecular bone gives bone the ability to 
withstand repeated loading and absorb greater forces than just cortical bone alone. 
Typically, the collagen fibrils of bone tissue are deposited in a lamellar, or interwoven 
pattern21. This pattern provides greater mechanical strength to the bone tissue allowing it 
to withstand physiological loads. In contrast, the collagen fibrils of woven bone are 
deposited in a random manner, generating bone tissue with significantly weaker 
mechanical properties than lamellar bone21. Woven bone is most often seen early in the 
bone development process and during bone healing19.  
 
Bone is composed of a mineral phase, primarily hydroxyapatite, and an organic phase, 
primarily type I collagen. Bone hydroxyapatite crystals are roughly 200nm in size, with a 
crystallinity ranging from 60-70%22. In addition, physiological hydroxyapatite is often 
carbonate substituted, allowing for greater solubility23. The mineral component of bone 
provides the rigidity and mechanical strength to the bone tissue, allowing the tissues to 
withstand greater compressive loading.  
 
Bone is constantly remodeled, undergoing a process of resorption and formation in 
response to mechanical loads. Bone resorption is primarily the results of osteoclasts cells, 
which differentiate from hematopoietic stem cells in a process known as 
osteoclastogenesis24. Osteoclasts form bone resorbing compartments in response to 
mechanical cues and signals from other bone cells. Resorption is achieved by creating 
an acidic environment within the bone resorbing compartment, allowing the mineralized 
bone matrix to be degraded and mobilized24. Bone formation is primarily the result of 
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osteoblastic cells, which differentiate from mesenchymal stem cells in a process known 
as osteoblastogenesis24. Osteoblasts deposit collagen matrix in response to mechanical 
cues and signals from other bone cells. Osteoblasts then induce collagen mineralization 
by releasing calcium and phosphate locally, triggering mineralization of the collagen 
fibrils20. Osteoblasts also line the outer surface of bone, and once entrapped in bone 
matrix differentiate into osteocytes. Osteocytes are the most abundant cell in bone tissue, 
comprising roughly 80% of the total cell volume25. These cells are known 
mechanosensors, regulating bone homeostasis through signaling to both osteoclasts and 
osteoblasts21.  
 
THE OSTEOINTEGRATION PROCESS 
 
Osseointegration is defined as a time dependent healing process whereby clinically 
asymptomatic rigid fixation of alloplastic materials is achieved, and maintained, in bone 
during functional loading26. It is necessary for implant success, as lack of osteointegration 
often results in micromotion of the implant resulting in inflammation, osteolysis, and 
implant failure21,27. The osteointegration process is complex and depends heavily on both 
the bone formation and remodeling process as well as the implant itself for successful 
integration.  
 
Osteointegration starts with the initial trauma during implant placement into the bone 
tissue. This trauma causes localized hemorrhage from damaged blood vessels. This 
results in hematoma formation that bridges the region between the existing healthy bone 
tissue and the implant surface (Figure 1a)21. The hematoma, composed largely of fibrin, 
provides an initial matrix for local immune cells to adhere and begin to releasescytokines 
to recruit a host of immune cells21,28. The recruited immune cells provide debridement of 
the injured site and damaged tissue. They also secrete various cytokines that recruit other 
immune, endothelial progenitor, and mesenchymal progenitor cells to the injury site 
(Figure 1b).  
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Figure 1. Schematic of the process of implant osteointegration. The process begins with the formation 
of a blood clot and fibrin bridge between implant and healthy bone tissue (a). Immune cell debridement 
and recruitment of various cells to the injury site (b). Differentiation of progenitor cells resulting in 
angiogenesis, woven, and intramembranous bone formation (c). Osteogenesis occurs bridging the gap 
between the healthy bone tissue and the implant surface (d). Woven bone is transformed into lamellar 
bone tissue. (e) Clot decomposition and bone homeostasis. Dc, decomposed clot; M, macrophage; MSC, 
mesenchymal stem cell; N, neutrophil; O, osteocyte; Ob, osteoblast; Oc, osteoclast. Reproduced with 
permission from Liu et al. Role of Implants Surface Modification in Osseointegration: A Systematic 
Review. © 2019 Journal of Biomedical Materials Research Part A. John Wiley & Sons, Inc. 
 
After hematoma formation, inflammation, and the recruitment of immune and progenitor 
cells the fibrovascular phase begins. During this phase both existing epithelial and 
differentiated progenitor cells revascularize the injury site through either angiogenesis or 
vasculogenesis (Figure 1c)21. During this time mesenchymal progenitor cells begin to 
differentiate into either chondrocytes or osteoblastic cells, with commitment to the 
chondrogenic lineage caused by an increase in SOX9 and a decrease in Runt related 
transcription factor-2 (RUNX2) and a commitment to osteoblastic lineage caused by an 
increase in RUNX2 and a decrease in SOX921,27.  
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Following the fibrovascular phase bone formation begins. Mature osteoblasts begin to 
deposit collagenous matrix and various ions to induce matrix mineralization forming 
intramembranous bone tissue (Figure 1d). Conversion of chondrocytes to a hypertrophic 
state results in the conversion of these collagenous callus to mineral forming 
endochondral bone. It is important to note that implant motion has been shown to cause 
greater endochondral ossification, whereas greater implant stability results in greater 
intramembranous ossification21. Because of this, intramembranous ossification primarily 
occurs directly along the healthy bone tissue surface, whereas endochondral ossification 
occurs in the gap between the implant and healthy bone tissue28. This process occurs 
until primary bone formation has been completed.  
 
Finally, after primary bone formation, osteoclast-mediated remodeling of the bone occurs. 
Provisional bone, known as woven bone, initially deposited during primary formation is 
resorbed and replaced with mature lamellar bone (Figure 1e)26,29,30. This process 
continues over the next 6 to 12 months, remodeling the deposited bone in response to 
mechanical stimuli. Once complete, the ingrowth of healthy bone tissue into the implant 
surface allows for full integration.  
 
BIOMATERIALS IN BONE REPAIR 
 
Both bone formation and resorption play a critical role in the bone healing process and 
are required for successful bone healing over time. However, certain defects and injuries 
necessitate the use of bone implants. These implants are typically composed of a 
combination of metals that favored for their biocompatibility, ease of use, and mechanical 
strength. However, cementless titanium implants, such as the ones commonly used for 
dental and hip procedures have a roughly 15% to 30% failure rate 15 years after 
implantation26. The majority of these failures, approximately 75%, are caused by aseptic 
loosening26. This loosening can be caused by stress shielding and poor osteointegration, 
which results in motion of the implant causing osteolysis and implant failure1. This 
highlights the need for improved or novel biomaterials with enhanced osteogenic 
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properties. Three approaches have been utilized in an attempt to improve materials: 
optimization of current material properties, utilization of osteoinductive factors, or 
development of novel biomaterials with enhanced osteogenic properties30,31.   
 
Optimization of current biomaterials has focused on increasing the osteoconductive 
nature of the material itself to promote osteointegration. This has primarily been done 
through modification of the substrate surface characteristics, specifically increasing the 
macro and nano roughness. Surface modifications that are typically performed include 
grit blasting, acid etching, anodization, and plasma spraying with either a metal or 
osteoconductive materials such as hydroxyapatite30. The intent of increasing surface 
roughness is two-fold. First it is meant to increase the surface area of the implant, 
therefore increasing the total area with which the bone can integrate. Second, previous 
studies have shown that increasing the surface roughness of the implant can facilitate 
biological changes such as bone cell migration, proliferation, differentiation, and protein 
absorption. In addition, more recent studies have also suggested that the methods used 
for the modification of the surface roughness varies the chemical composition of the 
implant. Modification of surface roughness can also cause changes in other surface 
characteristics. Variations in the height and wettability of substrate surfaces have been 
shown to be important in regulating cell adherence and differentiation, although these 
results are heavily dependent on the material, cell type, and other biological conditions. 
Aside from increasing surface roughness, enhancing the surface bioactivity has also 
yielded positive results for increasing implants osteogenic potential. Functionalization of 
ions and organic molecules onto the implant surface allow for binding of both cells and 
proteins onto the implant surface while also promoting osteogenesis32.  
 
Incorporation of osteoinductive factors into the biomaterial or onto the biomaterial surface 
has also allowed for significant improvements in implant osteointegration. One approach 
currently utilizes osteoinductive materials, such as hydroxyapatite, and bioinorganic ions, 
such as magnesium and zinc33. These osteoinductive materials are incorporated directly 
onto the implant surface. This has both the advantage of increasing the surface 
roughness of the implant itself while also providing pro-osteogenic chemical cues to 
Transduction of Substrate Surface Characteristics · Spring 2021 
Otto J. Juhl IV · Ph.D. Dissertation · Biomedical Engineering · Virginia Commonwealth University 24 
promote bone formation and implant integration. Another approach that has been utilized 
is the incorporation of biologics such as bone morphogenic protein-2 (BMP2), parathyroid 
hormone (PTH), platelet rich plasma (PRP), fibroblast growth factors (FGF), and vascular 
endothelial growth factor (VEGF)33. These agents positively regulate bone formation by 
encouraging angiogenesis and/or the maturation of osteoblast progenitors26. 
Unfortunately, use of biological factors is a temporary solution, designed to provide an 
initial increase in osteogenic and angiogenic potential. And as previously mentioned, 
implants perform well during initial implantation, with most failures occurring after an 
extended duration1. Without continued osteogenic promotion, successful osteointegration 
over time may not be successful.  
 
Development of novel biomaterials with enhanced osteogenic and angiogenic properties 
for use as orthopedic implants has garnered significant interest in the past few decades. 
New materials often utilize one or more osteoinductive material.  Polymers, typically 
polycaprolactone (PCL) or poly(lactic-co-glycolic acid) (PLGA) provide sufficient 
mechanical strength while also exhibiting good biocompatibility1,34. Novel ceramics, such 
as porous bioactive glass and alumina-based implants have also shown significant 
osteoconductive properties35,36. Hydrogels provide a highly conducive environment for 
cell integration and differentiation, mimicking the extracellular matrix more closely than 
other materials37,38. Additionally, hydrogels are easily loaded with osteoinductive factors 
allowing them to be modified to be optimally osteogenic and angiogenic1,39,40. 
Development of materials that utilize a combination of polymers, ceramics, and hydrogels 
have been studied and summarized in numerous reviews41,42. Through the combination 
of these materials the mechanical, angiogenic, and osteogenic properties can be tuned 
to create an implant that is optimally osteogenic while also providing the mechanical 
properties required to prevent loosening and induce osteointegration.  
 
Despite the significant advances in biomaterial design and development, engineering 
bone implants with low failure rates that integrate fully has been difficult10. This is in large 
part due to a lack of understanding of how substrates are transduced by bone cells and 
their progenitors10,43,44. While we understand that increasing roughness and optimizing 
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other substrate characteristics provides a more osteogenic implant overall, the 
mechanism by which the implant induces osteogenic differentiation and therefore bone 
formation is still unknown, preventing greater optimization of implant characteristics.  
 
CELL TRANSDUCTION OF SUBSTRATES 
 
Cell transduction of substrate surfaces is a highly complex process and the mechanism 
by which this occurs is largely unknown11. Mechanotransduction is traditionally thought of 
as an extracellular mechanical signal that is converted into intracellular chemical 
signals11,12,45. The relationship between substrate surface characteristics and the 
response by the cells is heavily reliant on the material, surface modifications, cell type, 
and culture conditions. Attempts at discerning a mechanism by which the cell translates 
substrate surface characteristics into intracellular signals have not yielded a definitive 
result. Despite this, researchers have concluded that the cytoskeleton plays an integral 
role in the transduction process46,47.  
 
The cytoskeleton is a dynamic structure that connects the regions of the cell and provides 
structure and tension and transmits mechanical forces throughout the cell. Inhibition of 
cytoskeleton formation and attachment prevents transduction of loading and fluid 
shear48,49. This evidence highlights that importance of the cytoskeleton in the transduction 
of mechanical signals. Numerous theories as to how this transmission of force through 
the cytoskeleton regulates intracellular signaling pathways have been hypothesized. One 
theory is the model of tensegrity48–50. In this model, increased tension on the cytoskeleton 
allows for the deformation of various cellular structures, including the nucleus. This 
deformation of the nucleus then differentially regulates various intracellular pathways and 
can explain various features of living cells51. However, this theory has not explained the 
observed changes in intracellular protein levels and localization.  
 
The cytoskeleton is regulated heavily through the Rho-family of guanosine triphosphate 
enzymes (GTPases), which includes RhoA, Rac1, Cd42. The cytoskeleton is connected 
to the extracellular matrix through the focal adhesion complex52. These adhesions create 
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traction forces that generate tension within the cell and help to regulated cytoskeletal 
organization53. In addition, these focal adhesions regulate various cell functions including 
migration, proliferation, differentiation, and apoptosis54–56. The transmembrane portion of 
the focal adhesions, the integrins, bind the extracellular matrix. They have been observed 
interacting differently based on the substrate surface characteristics that are 
presented7,57. On pro-osteogenic substrates it has been noted that focal adhesion 
maturation and formation is also increased58. With turnover of the adhesions occurring 
more rapidly on pro-osteogenic substrates, it also suggests that focal adhesions may be 
a key initiator of cell mechanotransduction, with the focal adhesion acting to initiate cell 
transduction of the substrate surface59.   
 
Focal adhesions share many components to cadherins and bind the actin cytoskeleton in 
a similar manner12. It is reasonable to hypothesize that focal adhesions use β-catenin to 
bind the actin cytoskeleton in the same manner that E-cadherins do. In this manner, β-
catenin binds and is stabilized by ⍺-catenin12. ⍺-catenin then binds actin directly or 
indirectly after binding vinculin60,61. Studies have also suggested that β-catenin may also 
bind vinculin directly and that this complex formation allows for the adhesion to be capable 
of supporting mechanical tension62.  	
 
β-catenin is part of the Wnt signaling pathway and is a key regulator of osteogenesis. As 
the main transcription factor, β-catenin, upon translocation to the nucleus, binds 
TCF/LEF. Once binding occurs this interaction acts to upregulate various genes 
associated with osteogenesis, including RUNX263. β-catenin is typically phosphorylated 
by a complex, that includes glycogen synthase kinase-3β (GSK-3β), Axin, and 
adenomatous polyposis coli (APC), which results in the degradation of β-catenin. 
Inhibition of β-catenin results in an osteopenic bone phenotype as a result of poor 
osteoblastic differentiation and increased osteoclastogenesis64,65. Conversely, 
stabilization of β-catenin causes higher bone mass, increased osteoblastogenesis, and 
greater ossification resulting in greater bone formation overall66. This highlights the 
integral role of β-catenin in regulating and directing osteogenesis.  
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Interestingly, it is unknown whether there are two separate pools of β-catenin, the one 
involved in adhesion stabilization and the one involved in intracellular signaling, 
overlap66,67. Current research suggests that these pools interact, with changes in β-
catenin phosphorylation occurring to allow the transition of β-catenin between the 
adhesion pool and the intracellular signaling pool68–73. If this interaction is occurring, 
further research is needed to evaluate a possible mechanism by which β-catenin 
commonly localized to focal adhesions may participate in intracellular signaling in 
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ABSTRACT 
 
An aging population, decreased activity levels and increased combat injuries, have led to 
an increase in critical sized bone defects. As more defects are treated using allografts, 
which is the current standard of care, the deficiencies of allografts are becoming more 
evident. Allografts lack the angiogenic potential to induce sufficient vasculogenesis to 
counteract the hypoxic environment associated with critical sized bone defects. In this 
study, aptamer-functionalized fibrin hydrogels (AFH), engineered to release vascular 
endothelial growth factor (VEGF), were evaluated for their material properties, growth 
factor release kinetics, and angiogenic and osteogenic potential in vivo. Aptamer 
functionalization to native fibrin did not result in significant changes in biocompatibility or 
hydrogel gelation. However, aptamer functionalization of fibrin did improve the release 
kinetics of VEGF from AFH and, when compared to fibrin hydrogels (FH), reduced the 
diffusivity and extended the release of VEGF several days longer. VEGF released from 
AFH, in vivo, increased vascularization to a greater degree, relative to VEGF released 
from FH, in a murine critical-sized cranial defect. Defects treated with AFH loaded with 
VEGF, relative to non-hydrogel loaded controls, showed a nominal increase in 
osteogenesis. Together, these data suggest that AFH more efficiently incorporates and 
retains VEGF in vitro and in vivo, which then enhances angiogenesis and osteogenesis 




Critical sized bone defects, defects that do not heal completely without intervention, 
continue to be an issue in clinical settings. Biomaterials used to treat critical sized bone 
defects do exceptionally well at inducing angiogenesis or osteogenesis, but rarely both, 
and fail roughly 13% of the time1,3,68,74. Many materials used impair self-healing, which is 
problematic when determining effective treatments for critical sized bone defects75,76. 
With the number of critical sized bone defects rising due to the increased prevalence of 
diseases such as osteoporosis, resulting in more severely comminuted fractures, and 
high-energy injuries such as those commonly seen in the armed forces it is important to 
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provide viable solutions to meet this growing need77. The development of new scaffolds, 
grafts, and other biomaterials has led to alternate forms of treatment for critical sized bone 
defects and bone nonunion78. However, bone allografts continue to be the most widely 
used graft material to heal critical sized defects.  
 
While allografts are often used to treat critical sized defects in both load bearing and non-
load bearing situations, they present several problems. For instance, allografts often do 
not resolve the hypoxic environment typically associated with large bone defects, 
because they fail to vascularize fully. Additionally, infection and rejection, often caused 
by the innate immune response to leftover cellular debris in the grafts themselves, prevent 
complete bone union and ossification68,75,79. If complete bone union is not achieved, then 
the patient risks a host of complications ranging from defect site pain to local or possible 
systemic infection80. The use of biomaterials in tandem with allografts allows for an 
improved angiogenic and osteogenic response, providing a greater healing response than 
allografts alone81. Current biomaterials are adequate at restoring both structure and 
function in smaller bone defects but often lack the angiogenic potential needed to 
sufficiently vascularize critical sized bone defects82–84. Thus, the hypoxic environment 
commonly associated with these defects is not resolved, preventing complete healing82. 
Hydrogels, a promising group of biomaterials that mimic the extracellular matrix and are 
conducive to both angiogenesis and osteogenesis, are being explored as a potential 
solution to this problem85. Hydrogels are flexible and multifaceted, allowing them to be 
tailored to improve various properties. Unfortunately, because hydrogels lack the 
mechanical stability needed for load-bearing defects, hydrogels are instead utilized in 
conjunction with a mechanically competent scaffold in load bearing situations or as a filler 
for non-load bearing situations38. With that stated, there are various types of hydrogels, 
with one of the most commonly used hydrogels being native fibrin hydrogel (FH).  
 
Native FHs are commonly used because of their simplicity and conduciveness to cell 
growth. Compared to other hydrogels, FHs are highly dynamic and biocompatible, making 
them advantageous for numerous healing applications80,85. In clinical application, FH 
forms a three-dimensional polymerized network anchored by fibroblasts, eventually 
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becoming stiff enough to regulate wound hemostasis83. FH has also been shown to 
moderately induce osteogenesis but does not enhance angiogenesis effectively, a 
necessity for critically sized defect repair85. Attempts at loading FH with growth factors 
such as vascular endothelial growth factor (VEGF), which induces endothelial cell 
mitogenesis and tubule formation, have had moderate success at resolving this problem. 
Unfortunately, FH, like other hydrogels, poorly incorporates or retains growth factors. 
Instead, FH exhibits a “burst release” kinetic with the majority of the growth factor being 
released over an initial 48-hour period83,86,87. To solve this, we have developed a novel 
nucleotide aptamer-functionalized fibrin hydrogel (AFH) with improved retention and 
release kinetics, compared to non-aptamer-functionalized FH.  
 
Aptamers, typically comprised of a highly specific sequence of oligonucleotides or 
peptides, bind to their target molecules with extremely high affinities88. The engineered 
aptamer conjugated to fibrinogen, and with the addition of thrombin, forms AFH with an 
enhanced affinity for a specific growth factor83. AFH exhibits similar structural qualities to 
native FH but also offers tailorable release kinetics89. Past studies have shown that AFH 
loaded with VEGF can be used to enhance vascularization in skin defects, but minimal 
research has been done to evaluate AFH in bone regeneration and healing83,87. This gap 
in knowledge has led us to examine how AFH loaded with VEGF affects angiogenesis 
and osteogenesis in a critical sized cranial bone defect.  
 
We implanted VEGF-loaded AFHs in an established murine cranial defect model55. We 
hypothesize that VEGF-loaded AFHs with improved VEGF release kinetics increase, 
compared to VEGF-loaded FHs, angiogenesis and osteogenesis.  
 
MATERIALS AND METHODS  
 
Materials.  
All chemicals used for aptamer functionalization and hydrogel synthesis were obtained 
from Sigma-Aldrich (St. Louis, MO). Fibrinogen and thrombin were purchased from 
Millipore (Billerica, MA). VEGF and enzyme-linked immunosorbent assay (ELISA) kits for 
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VEGF were purchased from PeproTech (Rocky Hill, NJ). VEGF-binding aptamer and 
complementary sequence of VEGF-binding aptamer (Table 1) were purchased from 
Integrated DNA Technologies (Coralville, IA). Nylon sutures were purchased from Ethilon 
(Johnson & Johnson Medical N.V., Belgium). Radiopaque MICROFIL solution was 
purchased from Flow-Tech Inc. (Microfil, Flow-Tech Inc., Carver, MA). Decalcification 
solution was purchased from Statlabs (StatLab, McKinney, TX). Eppendorf tubes used 
for scanning purposes were purchased through Thermo-Fisher Scientific (Waltham, MA). 
  
Hydrogel Preparations and Synthesis.  
Aptamer-conjugated fibrinogen was synthesized using methods previously reported 
(Figure 2a)55. Briefly, 50 mg of native fibrinogen was reacted with acrylic acid N-
hydroxysuccinimide (NHS) in NaHCO3 (0.1 M) solution for 4 hours. Unreacted NHS and 
byproducts were removed by washing with a 100 kDa centrifugal filter. Thiol-modified 
anti-VEGF aptamers were reduced in 50 mM tris(2-carboxyethyl) phosphine 
hydrochloride at room temperature. The reduced aptamers were purified, and 30 nmol of 
aptamer reacted with 50 mg of acrylate-modified fibrinogen in Tris-HCl buffer. Then the 
fibrinogen conjugated with the anti-VEGF aptamer was purified with a 100 kDa centrifugal 
filter and stored at −20 °C for future use.  
 
Table 1. DNA sequence of VEGF Aptamer 
DNA name Sequence (5’-->3’) 
Aptamer 
/ThiolMC6-D/AAAAA AAAAA CCCGT CTTCC AGACA 
AGAGT GCAGG G 
Complementary sequence of 
aptamer 
CCCTG CACTC TTGTC TGGAA GACGG G 
  
Fibrinogen and aptamer-conjugated fibrinogen were mixed to form a pre-gel solution (20 
mg/mL total fibrin). Thrombin and CaCl2 were then mixed to form the second pre-gel 
solution (2 U/mL of thrombin and 10 mM CaCl2). The two pre-gel solutions were then 
mixed and allowed to mature at 37 °C for 1 hour. To make VEGF-loaded hydrogels, VEGF 
was first added to either the fibrin solution or the aptamer-functionalized fibrin solution 
that was then used for hydrogel preparation. Native (no aptamer) fibrin hydrogel, with or 
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without VEGF, was used as a control. For all of the following experiments, the molar ratio 
of the aptamer to VEGF in the aptamer-functionalized hydrogel was kept at 20:1.  
 
Hydrogel Evaluation.  
Gelation Time.  
25μL of aptamer-conjugated fibrinogen (4 mg/mL) was mixed with 25μL of fibrinogen (16 
mg/mL) and transferred to a BMD-QuickCoag 1004 coagulometer (BioMedica, Nova 
Scotia, Canada). 25μL of CaCl2 (20 mM) was mixed with 25μL of thrombin (4 U/mL). The 
mixtures were allowed to equilibrate to 37°C. Then 50μL of the CaCl2 and thrombin 
solution was added to the coagulator to initiate the gelation process and the gelation 
process initiated on the coagulometer. Once the movement of the magnetic bar in the 
coagulator is stopped, gelation time was recorded. All gelation was measured at 37 °C.  
 
Dynamic Modulus.  
25μL of aptamer-conjugated fibrinogen (4 mg/mL) was mixed with 25μL of fibrinogen (16 
mg/mL). The two parts were mixed and transferred to a Discovery HR3 rheometer (New 
Castle, DE). A strain sweep was performed at a frequency of 10 rad/s from 0.1% to 15% 
to determine the linear viscoelastic region. The dynamic modulus was determined using 
an oscillatory strain sweep at a strain of 1% and a frequency of 1 Hz.  
 
Bulk Hydrogel Imaging.  
Hydrogels were stained with complementary sequences (4 μM) of the VEGF-binding 
aptamers at room temperature. Then the hydrogels were washed with PBS and stained 
with SYBR Safe. After washing with PBS 3 times, the hydrogels were imaged with a 
Maestro Imaging System (Woburn, MA).  
 
Scanning Electron Microscopy.  
Hydrogels were fixed with a 4% paraformaldehyde solution, washed with ddH2O 3 times, 
frozen at −80 °C, and then lyophilized. The lyophilized materials were sputter-coated with 
iridium and imaged with a scanning electron microscope (Zeiss Sigma, US). For all 
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images, a 5 kV acceleration voltage was used, and all images were taken at a working 
distance of 5.5 mm and a 2000 magnification.  
 
VEGF Release Profile.  
AFH loaded with 2 μM aptamer and 100 nM VEGF and native non-aptamer-functionalized 
FH loaded with 100 nM VEGF with diameters of 8 mm and thicknesses of 1 mm were 
incubated in 1 mL of release media (0.1% bovine serum albumin supplemented 
Dulbecco’s phosphate buffered saline (DPBS)). The release media was collected at 
predetermined time points and replenished with a new release media. The collected 
release media was stored at −20 °C. To quantify the amount of VEGF in collected release 
media, ELISA was performed according to the manufacture’s protocol. The effective 








𝑡%  Equation 1 
 
where Mt is the amount of released VEGF at time t, Mo is the total amount of VEGF, Mt 
/Mo is the fractional release, D is the effective diffusivity, l is the thickness of the hydrogel, 
and n is the diffusional exponent (n = 0.5).  
 
In Vivo Evaluation.  
All animal procedures were performed in accordance with the Virginia Commonwealth 
University Institutional Animal Care and Use Committee guidelines and requirements. 
Skeletally mature, 16-week-old male C57/B6J mice (Jackson Laboratories, Bar Harbor, 
ME) were housed in a light and temperature-controlled environment with free access to 
food and water. There were 7 experimental groups (Table 2). VEGF concentrations of 2.5 
μg/mL and 10 μg/mL were chosen to be similar to previous literature where 2 μg/mL was 
used in a skin defect model with similar aptamer-functionalized hydrogels, and 10 μg/mL 
was used in a femoral fracture model38,39.  
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Table 2. Hydrogel Treatment Groups  
Experimental Group 
 
Hydrogel Type  
 
VEGF Concentration 








Fibrin Hydrogel w/ 2.5μg/mL VEGF 
(2.5FH) 
 
Fibrin 2.5 μg/mL 
Fibrin Hydrogel w/ 10μg/mL VEGF 
(10FH) 
 





Aptamer-Functionalized Fibrin None 
Aptamer-Functionalized Fibrin 
Hydrogel w/ 2.5μg/mL VEGF 
(2.5AFH) 
 
Aptamer-Functionalized Fibrin 2.5 μg/mL 
Aptamer-Functionalized Fibrin 
Hydrogel w/ 10μg/mL VEGF 
(10AFH) 
Aptamer-Functionalized Fibrin 10 μg/mL 
 
Critical Sized Cranial Defect Model.  
The cranial defect was created as previously reported83. Mice were anesthetized with 
2.5% isoflurane, followed with a toe pinch to confirm the depth of the anesthesia. Mice 
then received 0.6 mg/kg of buprenorphine to relieve pain intra- and postoperatively. An 
incision that extends over the majority of the dorsal skull was created, and the skin was 
retracted to expose the parietal bone. Using a 4 mm external diameter trephine drill bit, a 
critically sized defect (Figure 1) was made in the parietal bone, using caution not to extend 
the defect into the underlying dura mater. 13μL of sterile hydrogel from each group listed 
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in Table 2 was then injected into the defect site. A non-injected control group without 
hydrogel served as the negative control with 6 mice per group per time point. The hydrogel 
was then allowed to cure for 3 minutes before the defect site was closed using a horizontal 
mattress suture technique.  
 
 
Figure 1. Representative images of the critical sized bone defect. (a) A superior view of the 4 mm defect 
created in the left parietal bone of 16-week-old male mice at 7 days post-defect introduction with no 
intervention performed, (b) 14 days post-defect introduction with no intervention performed, and (c) 21 
days post-defect introduction with no intervention performed. The images show little to no healing, 
affirming that a critical sized bone defect that will not heal without external intervention was created. 
 
Vascular Perfusion.  
After defect creation and treatment, animals were sacrificed at 7, 14, and 21 days. To 
assess angiogenesis, mice were perfused with a radio-opaque silicone-based contrast 
agent, MICROFIL, to visualize the vasculature as previously reported82,91. Mice were first 
anesthetized with 2.5% isoflurane, followed with a toe pinch to confirm the depth of the 
anesthesia. A catheter was placed into the apex of the left ventricle. Using a peristaltic 
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pump (Cole Parmer, Vernon Hills, IL), 7 mL-heparinized PBS (50 U/mL) was perfused 
through the mouse’s vasculature at 0.7 mL/min. Complete perfusion of the vasculature 
was assessed by hepatic filling and by the perfused solution leaving the right atrium of 
the heart. Following heparin perfusion, the animal’s vessels were perfused with 7 mL of 
10% neutral buffered formalin to maintain vessel structure and integrity at 0.7 mL/min. 3 
mL of prepared MICROFIL solution (53% MICROFIL, 42% diluent, 5% curing agent) was 
then perfused through the upper vasculature of the animal at 0.3 mL/min. The MICROFIL 
was then allowed to polymerize for 90 minutes at room temperature and then overnight 
at 4 °C to ensure complete polymerization. After polymerization, the head was dissected 
from the body and placed into 10% neutral buffered formalin until microCT analysis. 
 
Micro-CT Analysis.  
Micro-CT was used to examine both calcified and decalcified samples. Samples were first 
dried and then placed into 50 mL Eppendorf tubes. Specimens were then fixed to 
specimen holders in a Skyscan 1172 (Bruker, Billerica, MA). Scanning was performed at 
57 kV and 87 mA. The rotational step size and zoom were set to 0.2 degrees and 17.98 
μm voxels, respectively. The scan resolution was set to medium, creating a 1024 × 1024 
pixel image matrix.  
 
Images were reconstructed using a modified Feldkamp algorithm via N-Recon Software 
(Kontich, Belgium). Images were processed to remove noise and produce accurate 
structure before reconstruction. Beam hardening reduction was performed at 20%, and 
ring artifact reduction and post-alignment were performed at various steps based on the 
quality of each image. The histogram setting was held at a uniform range of 0 to 0.032168.  
 
After reconstruction, DataViewer (Kontich, Belgium) was used to select a volume of 
interest (VOI) that completely encompassed the defect based on visualization of the 
defect and normalization to the curvature of the skull. The cranial VOI was then analyzed 
using CTAn (Bruker, Billerica, MA). A binary representation of the bone was then created 
with a minimum threshold value of 110. Bone volume to total volume (BV/TV) was 
measured in three-dimensional space to normalize for variations in bone thickness.  
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After initial analysis using micro-CT to identify calcified bone healing, skulls were placed 
in a decalcification solution for 72 hours with gentle agitation. After decalcification, the 
samples were rinsed thoroughly and placed in 10% neutral buffered formalin until 
analysis. Decalcified skull samples underwent similar micro-CT scanning and 
reconstruction. After reconstruction, samples were evaluated to determine if the 
MICROFIL perfusion was successful. Complete perfusion of the carotid arteries on both 
sides of the skull was considered successful. If the carotid arteries were not perfused, the 
sample was excluded from analysis; 3 mice were excluded for this reason. A binary 
representation of the VOI was then created with a minimum threshold value of 125 and a 
maximum value of 210. Percent vascularization, which is a measure of vessel volume 
divided by total defect volume, vessel separation, which is a measure of the average 
distance between a vessel and its nearest neighboring vessel, and vessel density, which 
is a measure of the number of vessels per micron, were then quantified in a three-
dimensional space.  
 
Statistical Methods.  
Analysis between treatment groups was performed using one-way ANOVA followed by 
Tukey’s post hoc analysis with SigmaPlot statistical analysis software version 14 (Systat 
Software, Inc., San Jose, CA, USA). All hydrogel property analysis is shown as mean ± 
SD, while in vivo studies are shown as mean ± SEM. Correlation coefficients between 
data were determined using a Spearman nonparametric correlation test (GraphPad 
Software, La Jolla, CA, USA). Values of p < 0.05 were considered statistically significant.  
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Figure 2. Evaluation of aptamer-functionalized fibrin hydrogel properties in comparison to native fibrin 
hydrogels. (a) Schematic illustration of functionalization synthesis, native fibrinogen (F); aptamer-
functionalized fibrinogen (AF). (b) Secondary structure of the VEGF-binding aptamer. (c) Gelation time 
of FH and AFH, n ≥ 3, ns = not significant. (d) Dynamic modulus. G′ loss modulus; G′′, storage modulus. 
(e) Representative images of hydrogels. Left: Optical images of bulk hydrogels (top) and images of 




Aptamer Functionalization Prolongs Release of VEGF without Affecting Native 
Fibrin Hydrogel Material Properties.  
This study used anti-VEGF DNA, an aptamer with a 37-nucleotide sequence (Figure 2b). 
Due to the small size of the aptamer, the conjugation of this aptamer to fibrinogen did not 
significantly affect the gelation time of the hydrogel, which is around 40 seconds (Figure 
2c). The rheological evaluation showed that native FH and AFH exhibited similar 
mechanical properties as indicated by loss and storage moduli (Figure 2d). To confirm 
aptamer functionalization in the AFH, we stained the native FH and AFH with the 
complementary sequence followed with SYBR Safe. AFH showed strong green 
fluorescence, whereas native FH did not (Figure 2e). To further demonstrate that aptamer 
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functionalization did not affect the final hydrogel structure, we imaged the lyophilized 
hydrogels using scanning electron microscopy. Similar interconnected nanofibrillar 
networks were observed in both FH and AFH (Figure 2e), suggesting that the aptamer 
did not affect the structure of the final hydrogel.  
 
We next examined short-term VEGF release kinetics from FH and AFH and quantified 
the effective diffusivity (Figure 3a−c). Aptamer functionalization significantly decreased 
the effective diffusivity of VEGF from 0.49 ± 0.04 μm2 /s to 0.14 ± 0.04 μm2 /s (Figure 3b). 
It is important to note that this calculation may significantly underestimate the aptamer 
mediated decrease of diffusivity because the VEGF molecules that are initially released 
might not be bound to the aptamers during AFH synthesis. Thus, we further examined 
the long-term release of VEGF from AFH (Figure 3c). At day 1, FH released approximately 
68 ± 3% of the total VEGF, whereas AFH released 47 ± 4%. After 4 days, VEGF 
concentration was undetectable in the FH group, suggesting that all VEGF molecules 
were released within the first 72 hours to 96 hours. In contrast, we observed sustained 
VEGF release from AFH hydrogels over the next 10 days. Taken together, these data 
demonstrate that the aptamer functionalization prolonged the release of VEGF from the 
AFH.  
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Figure 3. Evaluation of aptamer-functionalized fibrin hydrogel (AFH) and native fibrin hydrogel (FH) 
VEGF release kinetics. (a) Fractional VEGF release within the first 4 hours. Mt is the VEGF release at 
time t; Mo is the initially loaded VEGF. Mt/Mo is the fractional release at time t. (b) Effective diffusivity 
calculated from a (c) daily release of VEGF. n ≥ 3, *** p < 0.05. 
 
Aptamer Functionalization with High Doses of VEGF Improves Angiogenesis 
Following Cranial Defect.  
Vascular fraction was quantified as a percentage of total defect volume (Figure 4). 
Groups, 2.5AFH and 10AFH, showed a significant increase in overall vascularization. At 
7 days, the 2.5AFH group had a significant 1.5-fold increase in percent vascularization 
over the non-hydrogel loaded control (Figure 4c) but did not have a significant increase 
compared to any other treatment group. At 21 days, 2.5AFH had a significant 2-fold 
increase compared to all other treatment groups, excluding the 10AFH group (Figure 4e). 
At this same time point, the 10AFH group showed a significant 2-fold increase compared 
to all treatment groups evaluated besides the 2.5FH and 2.5AFH groups (Figure 4e). 
Visual inspection confirmed successful perfusion with MICROFIL for all cranial 
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vasculature based on successful perfusion of the carotid arteries, as well as successful 
perfusion of the defect site (Figure 4a). Examination of the de novo vascularization within 
the defect, outlined in red in Figure 4a, with the surrounding vasculature removed, 
provides a clearer visualization of the variations in angiogenesis caused by each 
intervention. Removal of the surrounding vasculature reveals the increase in vascular 
formation in the 2.5AFH and 10AFH groups compared to all other treatment groups 
(Figure 4b), reaffirming the quantitative measures made previously.  
 
Vessel density (vessels/micron) was significantly increased in the 2.5AFH group 
compared to the E treatment group after 7 days. We also observed an increase in both 
the 2.5AFH and 10AFH groups over time, reaching statistical significance at day 21 
(Supplemental Information Figure S1). 2.5AFH and 10AFH groups showed a 68% and 
257%, respectively, increase in vessel density from 7 to 21 days. From day 7 to day 21, 
an approximately 1-fold increase in vessel density was observed in the E treatment group, 
while a 20% decrease in density was observed in the FH group. At day 21, both the 
2.5AFH and 10AFH groups displayed a 2-fold increase in vessel density relative to both 
the E and FH groups (Supplemental Information Figure S1c). The treatment groups 
receiving FH with VEGF at either concentration did not display a significant increase in 
the number of blood vessels formed compared to any other group evaluated. From day 7 
to 21, we observed a 97% and 63% increase in vessel density in the 2.5FH and 10FH 
groups, respectively. AFH alone only showed a 66% increase in vessel density from day 
7 to day 21.  
 
We observed a significant decrease in vessel separation between the 2.5AFH and E 
treatment groups 7 days postoperatively, with a 2.5-fold reduction in the distance between 
vessels. An approximately 66% significant decrease in vessel separation was observed, 
in both the 2.5AFH and the 10AFH groups, compared to the non-hydrogel loaded control, 
21 days post-hydrogel introduction (Supplemental Information Figure S1f). The average 
distance between vessels 21 days postoperatively was 217μm and 193μm in the 2.5AFH 
and 10AFH groups, respectively. The non-hydrogel loaded control defect had an average 
distance of 645μm between vessels 21 days after hydrogel introduction, while the FH, 
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2.5FH, and 10FH with groups had an average distance of 577μm, 319μm, and 358μm 
between vessels, respectively. The AFH group had an average separation of 350μm 
between vessels 21 days after hydrogel introduction, which was not significantly different 
than the 517μm separation observed with FH. At no other time point was the separation 
between the vessels significant for any treatment group (Supplemental Information Figure 
S1d, e).  
 
 
Figure 4. Total vascularization within the defect volume as a result of hydrogel treatment. (a) A 
representative image of the total skull vascularization for each intervention 21 days post defect 
introduction. (b) Enhanced view of the vascularization within the defect region outlined in red in part (a) 
for each intervention 21 days post defect introduction. Micro-CT analysis of the percent vascularization 
(vascular volume/total defect volume) of the defect at (c) 7 days post defect introduction for all 
intervention types, (d) 14 days post defect introduction for all intervention types, and (e) 21 days post 
defect introduction for all intervention types. * p < 0.05, ** p < 0.005, *** p < 0.001, n ≥ 3. 
 
Transduction of Substrate Surface Characteristics · Spring 2021 
Otto J. Juhl IV · Ph.D. Dissertation · Biomedical Engineering · Virginia Commonwealth University 44 
Aptamer Functionalization with High Doses of VEGF Improves Osteogenesis 
Following Cranial Defect.  
The non-hydrogel loaded control group showed minimal de novo bone formation in the 
defect site by day 21 (Figure 5). Seven days post-hydrogel introduction, no treatment 
group, AFH or FH with or without VEGF, was significantly different from the non-hydrogel 
loaded control defect or any of the other treatments evaluated (Figure 5a). However, at 
14 days, the 10AFH group showed significantly greater BV/TV than all other treatment 
groups, except AFH (Figure 5b). At 21 days postoperatively, BV/TV increased 3.8-fold 
(from 0.75% to 2.92%) in the 10AFH treatment group compared to the non-hydrogel 
loaded control group (Figure 5c). Qualitative visualization of bone formation and healing 
confirms the quantitative analysis, showing a significant decrease in defect size in the 
10AFH group 14 days after hydrogel introduction compared to all treatment groups 
besides AFH. Additionally, there was a slight decrease in defect size in the 10AFH group 
compared to the FH treatment groups 21 days postoperatively and a significant decrease 
in defect size compared to E (Figure 5d).  
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Figure 5. Analysis of bone healing in critical sized cranial defect. (a) Micro-CT analysis of the percent 
bone volume (bone volume/total defect volume, BV/TV) at 7 days post defect introduction for all 
intervention types, (b) 14 days post defect introduction for all intervention types, and (c) 21 days post 
defect introduction for all intervention types. (d) Representative images of each experimental group 21 




The design and use of novel biomaterials for bone healing applications, especially in large 
bone defects, is of critical importance due to increasing rates of disease, disuse, and 
injury92. Hydrogels loaded with growth factors have proven to be effective in treating 
smaller bone defects, but critical sized bone defects have proven challenging to treat, 
because of the inadequate release kinetics associated with most hydrogels83,86. To 
address this problem, we developed a novel AFH loaded with VEGF, and used it to treat 
a critical sized cranial defect in mice. Our results show that this novel hydrogel increases 
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the sequestration and retention of VEGF compared to FH. More importantly, this 
improvement in VEGF kinetics in AFH, relative to FH, was able to promote greater 
vascularization and osteogenesis in a critically sized calvarial defect, suggesting AFH is 
a promising avenue for clinical wound healing applications.  
 
The results of this study show that we can successfully increase VEGF incorporation and 
retention by utilizing an anti-VEGF aptamer while maintaining mechanical and structural 
properties similar to those of native fibrin hydrogel (Figures 2 and 3). AFH maintained a 
similar elastic and viscous response as well as similar morphological properties to FH93–
95. The literature has shown that the physical properties of FH facilitate wound healing. 
FH alone promotes and aids in cell proliferation, differentiation, and migration, all of which 
are necessary for healing critical sized defects96. The mechanical properties of FH also 
allow for the proper stability to support angiogenesis; therefore, maintaining similar 
physical properties to FH with AFH is highly desirable97. In addition to maintaining similar 
physical and mechanical properties to FH, AFH improves the fractional release of VEGF 
over an initial 4-hour period, diminishes diffusivity, and significantly elongates, compared 
to FH, measurable VEGF release over 14 days. Our results, corroborated by previous 
studies with AFH, also show a diminished burst release and an elongated release profile 
through the use of VEGF-specific aptamers83. The improved release kinetics of AFH and 
diminished diffusivity also suggest that AFH not only maintains VEGF release over a 
longer period but also improves VEGF localization and bioavailability at the defect site. 
Previous studies have shown VEGF is not only important in the promotion of 
vascularization but also critical in the facilitation of bone formation by recruiting 
mesenchymal stem cells, activating osteoblast differentiation, and promoting 
mineralization98. Due to the typical release kinetics exhibited by most hydrogels including 
FH, VEGF is not localized to the defect long enough to facilitate bone healing, which 
typically begins 2−3 weeks postinjury79,99. Although this issue lacks a complete resolution, 
even with the use of AFH, the extended diffusivity still has significant implications for bone 
healing. Previous studies have shown that between 7 and 10 days, the presence of VEGF 
enhances mesenchymal stem cell recruitment and survival, with VEGF playing a 
synergistic role with bone morphogenic protein-4 (BMP4), resulting in a significant 
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increase in bone formation after 28 days compared to situations where VEGF was not 
present78,95. This suggests that by using AFH, the extended diffusivity and localization of 
VEGF will enhance bone formation.  
 
The effects of the improved incorporation and release of VEGF observed in vitro were 
validated in vivo. An overall increase in vascularization was observed 21 days after 
hydrogel introduction for AFH compared to all FH treatment groups (Figure 4). Groups 
receiving AFH loaded with VEGF showed significant changes in vessel separation and 
vessel density compared to nontreated defects (Figure 3). Similar to previous studies, 
there was an inverse correlation between the observed increase in vessel density and 
decrease in vessel separation, validating both measurements, with R-values ranging 
between −0.6901 and −0.9736 (Data not shown)100. Both vessel density and vessel 
separation are critical for the successful healing of critical sized bone defects because of 
the hypoxic environment created in most such bone defects101,102. Because of the size of 
critical defects, diffusion is often the rate limiting factor. Unless the vessels achieve 
anastomosis, proper intramembranous ossification and bone remodeling, necessary for 
a successful repair, are highly unlikely98,103. This is because the hypoxic environment 
needs to be relieved for mesenchymal stem cells to infiltrate the defect site and begin the 
intramembranous ossification process88,104,105.  
 
Our data also suggest the effect AFH with VEGF has on vascularization may be 
underestimated. Vessel density and vessel separation (Supplemental Information Figure 
S1) are measures of only mature vessels or vessels that have undergone anastomosis. 
Overall vascularization accounts for total vessel volume regardless of maturity and 
interconnection (Figure 4). The observed changes in overall vascularization were of 
greater significance than the changes we observed in vessel density and number. This 
increase in overall vascularization suggests that more vessel anastomosis may occur if 
this study investigated vascularization at longer time points since some vessels may have 
yet to reach maturity at the time points currently evaluated. Alternatively, we are aware of 
the limitations of MICROFIL and its limited perfusion in vessels less than 10μm in 
diameter106. However, this limitation would underestimate the effect of AFH with VEGF 
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has on vasculogenesis, as it may not have allowed quantification of all newly formed 
vessels that are less than 10μm in diameter. Thus, this would not change the 
interpretation of our results.  
 
In vivo evaluation shows a moderate increase in bone healing 14 days postoperatively 
between the 10AFH treatment group compared to the empty and FH treatment groups. 
An observable difference was only seen between the 10AFH and empty treatment groups 
21 days postoperatively (Figure 5); however, there were no differences observed between 
the treatment groups at 7 days. Although there was a trend at day 7, suggesting the 10FH 
and 10AFH groups were inducing greater bone formation, the variance between samples 
as well as limited sample size did not yield significant differences. The lack of greater 
significance in bone healing, relative to vascularization, may also be due to the time points 
evaluated in this study. Because this study aimed to evaluate the properties and release 
kinetics of AFH and how these may affect vascularization, we evaluated earlier time 
points than those typically used in bone healing studies106,107. This prevents bone healing 
from being characterized fully within the scope of this study, as the bone formation 
process can take up to 3 months, and vascularization occurs rapidly over the first 3 
weeks108–110. Despite this, information gathered 14 and 21 days postoperatively suggests 
AFH with VEGF has improved bone formation and healing, a trend that would likely 
continue at later time points.  
 
Although VEGF is known as an important growth factor in angiogenesis and 
osteogenesis, intramembranous bone healing is highly complex and utilizes numerous 
growth factors and chemokines. Because of this, codelivery of multiple factors, such as 
platelet-derived growth factor and bone morphogenic protein-2 (BMP2), has been studied 
extensively using other biomaterial systems with varied success7,109. The specificity of the 
aptamers used in our AFH system would allow for codelivery of multiple growth factors, 
allowing for improved healing and a more targeted approach to wound healing. Therefore, 
AFH is of significant interest for future biomedical applications. The high affinity and 
specificity of aptamers allow for multiple factors to be investigated simultaneously and 
various steps in the intramembranous healing process to be promoted. Our AFH system 
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would allow for the development of a proactive and targeted approach for critically sized 




This study shows the ability to successfully engineer a functionalized anti-VEGF aptamer 
into native fibrin and then into AFH. These hydrogels showed no significant changes in 
structural or mechanical properties compared to FH alone, based on the rheological 
assessment and nanoscale surface (scanning electron microscopy) evaluation. The AFH 
showed enhanced retention and release profile of VEGF in vitro, extending the release of 
VEGF for more than a week longer compared to native FH without aptamer 
functionalization. Engineered AFH loaded with 10 μg/mL of VEGF enhanced bone 
formation 14 days postintervention compared to the FH treatment groups and empty 
controls, but this increase was not observed 21 days postintervention compared to the 
FH treatment groups. Additionally, the novel hydrogels loaded with VEGF at both 
concentrations showed a greatly increased ability to induce angiogenesis, increasing 
vessel density, reducing the separation between blood vessels, and greatly increasing 
overall vascularization compared to the FH and non-hydrogel loaded defects. The study 
revealed that AFH, relative to nonfunctionalized FH, has a greater release and retention 
profile of VEGF, improved bone reparative effects, and induced increased vasculogenesis 
while maintaining similar structural and mechanical properties to nonfunctionalized FH. 
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ABSTRACT 
 
Synthetic biomimetic carbonated hydroxyapatite (CHA) has shown significant promise in 
bone tissue engineering for its mechanical and chemical biocompatibility and osteogenic 
potential. Variations in the size of hydroxyapatite particles have also been shown to 
contribute to the hydroxyapatite's osteogenic success. However, synthesizing biomimetic 
CHA with optimal osteogenic properties using a simple synthesis methodology to make 
highly reproducible, biomimetic, and osteogenic CHA has not been evaluated fully. The 
objective of this study was to synthesize submicron CHA particles using a nanoemulsion 
method. We hypothesized that by varying the synthesis technique we could control 
particle size while still creating highly biomimetic CHA typically produced during 
nanoemulsion synthesis. Furthermore, we hypothesized that 500 nm CHA particles would 
induce greater osteoblastic differentiation compared to larger or smaller CHA particles. 
X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, 
and dynamic light scattering were used to characterize the chemical composition, shape, 
and size of CHA synthesized through variations in pH, temperature and stirring speed 
during synthesis. Manipulation of pH showed the ability to selectively tailor CHA particle 
size from 200 nm to 900 nm in a reproducible manner while maintaining the chemical 
composition. In addition, 500 nm particles elicited the most rapid increase in osteoblastic 




The use of synthetic biomimetic carbonated hydroxyapatite (CHA) for bone tissue 
engineering has been evaluated in great depth over the last 20 years. As the main 
inorganic phase of bone, hydroxyapatite is comprised of two main constituents, calcium 
and phosphorus, at a stoichiometric ratio of 1.67 Ca/P. Biological hydroxyapatite exhibits 
a rod-shaped morphology, has a crystallite size ranging from 5–200nm, a crystallinity 
between 60% and 80%, and agglomerates into larger particles that exist on the micron 
scale110,111. Biological hydroxyapatite, being a ceramic, also has high-compressive 
strength and significant osteoconductive properties that allow it to create a mechanically 
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stable matrix111. Because of these favorable qualities, synthesis of synthetic 
hydroxyapatite that can be utilized in bone tissue engineering applications has been 
extensively studied. 
 
As a result of the extensive examination into hydroxyapatite synthesis, it was determined 
that the size and shape of hydroxyapatite particles resulted in significant variations in the 
apatite's overall osteogenic potential112–114. Previous studies have shown that the use of 
submicron hydroxyapatite particles increases the apatite's overall osteogenic properties 
both in vitro and in vivo111,115. This may be a result of various submicron topographies, 
including particle shape, size, and surface features, differentially affecting 
osteogenesis7,9,116–118. For example, submicron hydroxyapatite particles synthesized by 
Kalia et al. determined that “rice” shaped particles were far less effective than round 
particles at inducing osteoblastic differentiation and preventing cell apoptosis119,120. The 
majority of other studies examining the effect of hydroxyapatite particle shape on 
osteogenesis have corroborated this observation, suggesting that despite natural 
apatite's rod-like morphology; rod-shaped synthetic hydroxyapatite does not elicit the 
greatest osteogenic response121. Instead, spherical hydroxyapatite is more conducive to 
cell viability and osteogenesis122. 
 
Despite the consensus as to which shape of CHA particle best promotes osteogenesis, 
the size of the particle that best promotes osteogenesis is still not agreed upon. Numerous 
studies by our group and others have shown the importance of surface topography in 
promoting osteogenesis123. One way in which surface topography can be modified is 
through incorporation of various sizes of nano and submicron particles into a bone implant 
or scaffold124. However, conflicting results as to which size hydroxyapatite particle is most 
osteogenic has hindered the fabrication of synthetic bone grafts incorporating 
hydroxyapatite particle of optimized size125. For example, a study by Yang et al. evaluated 
submicron hydroxyapatite particles and their effect on osteogenesis. They determined 
that roughly 570nm hydroxyapatite particles were optimally osteogenic125–127. However, 
a study by Cai et al. observed an increase in osteogenesis on 20nm hydroxyapatite 
particles18,128. Additional studies have noted that larger features, 500nm to 700nm pillars, 
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reduced apoptosis and increased osteogenesis to a greater degree than smaller features 
of roughly 200nm127,129. These results illustrate the vast range of hydroxyapatite particle 
sizes that can increase osteogenesis, thus highlighting the challenge of identifying 
optimally osteogenic particles based on published results alone. The lack of agreement 
on what hydroxyapatite particle size induces the greatest osteogenic response makes it 
challenging to reproducibly and easily create hydroxyapatite particles that will be optimally 
osteogenic. 
 
Successful attempts have been made at creating synthetic biomimetic hydroxyapatite 
with a variety of methodologies ranging from wet precipitation to chemical synthesis 
methods130. Variations within each method allows for the creation of chemically pure CHA 
with a range of sizes, shapes, distributions, and costs of synthesis. These various 
synthesis methods have been examined extensively and summarized in numerous 
reviews18,131,132.  
 
Microemulsion, dry synthesis and chemical synthesis are all challenging to use. This can 
be because of various factors including not consistently creating a controlled particle size 
and shape, implementing harsh chemicals for synthesis, requiring extreme conditions 
such as high temperatures or surfactants, or a combination of one or more of these 
factors124,129. These syntheses methods necessitate extensive purification and washing 
to make the synthesized hydroxyapatite suitable for biological applications and to 
maintain a narrow particle size distribution, with even commercially available 
hydroxyapatite particles not maintaining a narrow distribution18. Because of these 
challenges, there is a need for simple, consistent methods for synthesizing CHA particles 
within the submicron range and evaluating their osteogenic potential. 
 
In this study, we utilized a nanoemulsion synthesis methodology based on techniques 
created by Nelson and Featherstone18, but as modified by others18,125,126,129,133. This 
process is favorable because it does not require harsh chemicals, is highly reproducible, 
rapid, and produces spherical particles on the submicron scale. We hypothesized that by 
modifying this nanoemulsion synthesis methodology through the manipulation of 
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temperature, pH, and homogenization speed we can selectively tailor the size of CHA 
particles. Based on previous studies of cell response to various substrate features such 
as particle size and nanopillars18, we hypothesize that the synthesized CHA particles 
would be biocompatible and that 500 nm CHA particles would elicit the greatest 
osteogenic response in vitro. 
 
MATERIALS AND METHODS 
 
Materials.  
All chemicals used for nanoparticle synthesis were obtained from Sigma-Aldrich (St. 
Louis, MO). Chemicals used for nanoparticle characterization were obtained from Thermo 
Fisher Scientific (Waltham, MA) 
 
Carbonated Hydroxyapatite Synthesis. 
Standard Submicron Carbonated Hydroxyapatite Particle Synthesis. 
Submicron CHA particles were synthesized following methods described previously125,126. 
Briefly, the calcium source (calcium nitrate tetrahydrate) was dissolved in 5 ml acetone 
and stirred for 30 minutes at a standard temperature of 21°C while the phosphate source 
(hydrogen phosphate and ammonium bicarbonate) was dissolved in 5 ml ultrapure water, 
brought to the standard pH of 11 using a 1 M NaOH solution, and stirred for 30 minutes 
at the desired temperature of 21°C. The calcium source was then added into the 
phosphate source rapidly and allowed to homogenize for 30 sec at the standard of 
500RPM before 50 ml of ultrapure water was added to the slurry to quench the reaction 
and homogenization discontinued. The slurry was then vacuum filtered and rinsed with 1 
L of ultrapure water. The paste that remained after filtration was then removed and dried 
for 24 hours at 80°C.The resulting dried CHA was then ball milled at a 20:1 bearing weight 
to dried CHA weight ratio using a 4.05 g stainless steel bearing at 1000RPM for 1 hour 
yielding a powder with submicron particles. This powder was then heat-treated at 600°C 
for 30 minutes with a ramp rate of 5°C min−1.  
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The standard values for synthesis of the CHA throughout this study were pH 11, 21°C, 
and 500 RPM. These values were determined based on the methods described 
previously129,133,134. Using these standard values, a reproducible CHA was generated. 
The effects of each variable; pH, temperature, or RPM were then manipulated individually 
while maintaining the standard values of the other two variables to effectively characterize 
how manipulation of pH, temperature, or RPM individually would affect particle size, 
crystallite morphology and chemical composition. 
 
pH Variant Submicron CHA Particle Synthesis.  
pH variant CHA was created following a procedure identical to that listed above with 
variation occurring as to the desired pH obtained in the phosphate source (Table 3). 
Again, using 1 M NaOH, the phosphate sources were brought to a pH of either pH 10, pH 
11, or pH 12 before being stirred for 30 seconds at the standard temperature of 21°C and 
500 RPM. The paste resulting from calcium source introduction and filtration was then 
dried for 24 hours at 80°C, ball milled at 1000RPM for 1 hour then heat-treated yielding a 
powder.  
 
The pH values that were used in this study were determined from a review of previous 
literature18,135,136. To yield what we hypothesized would be the greatest distribution of size 
between experimental groups, while creating biomimetic CHA, we evaluated the 
nanoemulsion methodology at the extremes of pH 10 and pH 12 and at the median value 
of pH 11. We chose a value of pH 11 because it was examined in previous studies where 
CHA was created and was shown to reliably create CHA particles18. However, pH values 
less than 10 resulted in rod-like particles that were not conducive to cell growth135, and 
values greater than 12 resulted in poor control over the distribution of particle size as well 
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 pH 10 pH 10 21°C 500 RPM PH10 
pH pH 11 pH 11 21°C 500 RPM PH11 
 pH 12 pH 12 21°C 500 RPM PH12 
 4°C pH 11 4°C 500 RPM T4 
Temp 21°C pH 11 21°C 500 RPM T21 
 55°C pH 11 55°C 500 RPM T55 
 200 RPM pH 11 21°C 200 RPM R200 
RPM 500 RPM pH 11 21°C 500 RPM R500 
 800 RPM pH 11 21°C 800 RPM R800 
 
Homogenization Speed (RPM) Variant Submicron CHA Particle Synthesis. 
RPM variant CHA was created following a procedure identical to that listed above with 
variation occurring during the homogenization speed of the phosphate and calcium 
source (Table 3). Again, the calcium source and phosphate source were synthesized as 
described above at the standard values of 21°C and a pH of 11. When the calcium source 
was added to the phosphate source the homogenization speed (RPM) was manipulated 
to either 200 RPM, 500, RPM or 800 RPM for 30 seconds before water was introduced 
and the stirring discontinued. The paste resulting from calcium source introduction and 
filtration was then dried for 24 hours at 80°C and then ball milled at 1000 RPM for 1 hour 
and heat-treated yielding a powder.  
 
The homogenization speeds that were used in this study were determined from a review 
of previous literature18,136–138. A homogenization speed of 500 RPM being the value 
examined in previous studies that created CHA18. It was determined by Salimi et al. that 
higher agitation rates, those above 1200 RPM, would begin to produce elongated 
hydroxyapatite particles but decreased the overall size consistency of the particles 
formed, whereas lower rates allowed for a more controlled particle size136. It was also 
found that slower agitation speeds below 200 RPM resulted in cuboid shaped 
hydroxyapatite particles, which based on previous literature, would be less osteogenic 
and therefore less favorable138. Therefore, we evaluated the homogenization speeds of 
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200 RPM, 500 RPM, and 800 RPM to maintain what we hypothesized would be spherical 
CHA, while maintaining a high reproducibility of CHA during synthesis. 
 
Temperature Variant Submicron CHA Particle Synthesis.  
Temperature variant particles CHA was created following a procedure identical to that 
listed above with variation in the temperature at which the solutions were maintained and 
mixed (Table 3). Again, the calcium and phosphate source were synthesized as described 
above at the standard value of pH 11 but were maintained at either 4°C, 21°C, or 55°C, 
verified by handheld thermometer, before the addition of the calcium source to the 
phosphate source, throughout the entirety of the synthesis process. The paste resulting 
from calcium source introduction, after 30 seconds of stirring at the standard value of 500 
RPM and filtration, was then dried for 24 hours at 80°C and then ball milled at 1000 RPM 
for 1 hour and heat-treated thus yielding a powder.  
 
The temperature values that were used in this study were determined from a review of 
previous literature136. A temperature of 21°C, was used in previous studies that had 
created CHA137,139. A study by Elhendawi et al. reported synthesis of hydroxyapatite at 
−10°C, 37°C, and 60°C using a coprecipitation methodology. They determined that 
increasing temperature allowed for greater hydroxyapatite crystallinity as well as larger 
particle sizes. In addition, increasing the temperature over 60°C resulted in less control 
over hydroxyapatite size and shape140,141. Others have reported successful synthesis of 
hydroxyapatite particles at 50°C, although the crystallinity and morphology were not 
conducive to osteogenesis142. Furthermore, Eldendawi et al. determined that 
hydroxyapatite synthesized at −10°C has low crystallinity, roughly 10%, a percentage 
significantly lower than biological apatite143. Additional studies have reported apatite with 
a crystallinity more similar to biological hydroxyapatite when using temperatures between 
0°C and 5°C143. For these reasons, we used 4°C, 21°C, and 55°C to prepare our CHA. 
We hypothesized that this would allow the creation of CHA with biomimetic crystallinity 
and maintain the spherical morphology desired. 
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Figure 6. XRD showing each CHA variant with similar phase characteristics. XRD spectra of all 
synthesized CHA variants showing similar phase characteristics and intensities.  
 
CHA characterization.  
X-ray Diffraction Analysis. 
The phase composition, crystallite size and crystallinity of prepared samples were 
analyzed by X-ray diffraction (XRD, X'Pert Pro PANAnalytical) using a CuKα radiation 
generated at 45 kV and 40 mA from 10° to 70° with a step size of .026° (2θ), a speed of 
.016°/second, and a time of 4 seconds per step. Crystallite diameter responsible for the 
(002) plane was calculated using the Scherrer relationship shown in Equation 2144. 
 
𝜏 = 	 (𝜅𝜆) (βcos 𝜃)⁄   Equation 2 
 
where κ is the dimensionless shape factor of 0.9, λ is the wavelength of the X-ray (0.15918 
nm), β is the full width at half maximum for the diffraction peak under consideration (rad), 
is the diffraction angle (°), and τ is the mean crystal size in nanometers145. The crystallinity 
fraction (Xc) was calculated using Equation 3145.  
 
𝑋& = 1 −	7𝑉''(/*++ 𝐼*++⁄ :  Equation 3 
Transduction of Substrate Surface Characteristics · Spring 2021 
Otto J. Juhl IV · Ph.D. Dissertation · Biomedical Engineering · Virginia Commonwealth University 59 
 
where V112/300 is the intensity of the peak area between (112) and (300) and I300 is the 
intensity of the (300) reflection peak106. 
 
Fourier Transform Infrared Analysis. 
Examination of chemical group composition and formation of each variant of CHA was 
performed using Fourier transform infrared spectroscopy (FTIR) (Nicolet–Nexus 670 FT-
IR) with a flat diamond cell probe. Absorbance was gathered over the wavelength 
spectrum from 400 cm−1 to 4000 cm−1. 
 
Scanning Electron Microscopy Analysis.  
CHA morphology was examined using scanning electron microscopy (SEM, Hitachi FE 
SEM Su-70). A 0.02 mg/ml solution of CHA and analytical grade ethanol was created and 
sonicated for 10 minutes. 10μL of the CHA solution was then placed on a pure silica wafer 
and the ethanol allowed to evaporate. The remaining CHA particles deposited on the 
surface of the wafer were then platinum sputter coated for 60 seconds to generate a 2 Å 
coating. The samples were then imaged using a 5 kV acceleration voltage and a 5 mm 
working distance. 
 
Dynamic Light Scattering Analysis. 
Particle size of CHA was analyzed using dynamic light scattering (DLS) (Zeta Sizer 
Nanoseries Nano-zs90, Malvern). A 0.01 mg/ml solution of CHA in analytical grade 
ethanol was created. Immediately before analysis, each suspension was vortexed briefly 
then sonicated for 10 minutes before 1 ml of the CHA solution was placed into a cuvette 
and analyzed. Thirty collections were performed per measurement and each sample 
measurement was repeated three times. The three replicates were then averaged to 
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In vitro characterization.  
Cell Viability Assay.  
hFOB 1.19 cells, a human preosteoblastic cell line, were cultured at 30,000 cells per well 
in a 24 well tissue culture polystyrene (TCPS) plate. Cells were cultured under 
proliferative conditions at 33.5°C and 5% CO2 and Dulbecco's Modified Eagle Medium: 
Nutrient Mixture F-12 media (Thermo Fisher Scientific, Waltham, MA) supplemented with 
10% fetal bovine serum (FBS) and 1% penicillin streptomycin (Gibco, Gaithersburg, MD). 
After 24 hours, a 0.02 mg/ml solution of CHA and standard growth media was created. 
The suspension was then vortexed briefly and sonicated for 10 minutes before 250 ul of 
the various media and CHA suspensions were added to the respective wells. Cells were 
then incubated in proliferative conditions with the media and CHA suspension for 48 
hours. Following incubation, cell viability was quantified using a ReadyProbes Cell 
Viability Imaging Kit (Thermo Fisher Scientific, Waltham MA). The cells were then imaged 
for either blue stain (all cells) or green stain (dead cells) using an EVOS microscope. The 
images were then quantified using Fiji image analysis software18,139,146. 
 
Particle Effect on Osteoblast Differentiation.  
For the following, because no variation in CHA chemical composition was determined 
between the pH, temperature or homogenization variants, only particles synthetized using 
the pH synthesis methodology were used to evaluate the effect of CHA size on 
osteoblastic differentiation. This is because pH synthesis was the only methodology that 
allowed significant manipulation of particle size. hFOB 1.19 cells were cultured at 30,000 
cells per well in a 24 well TCPS plate in differentiation conditions at 33.5°C in Dulbecco's 
Modified Eagle Medium: Nutrient Mixture F-12 media (Thermo Fisher Scientific, Waltham, 
MA) supplemented with 10% FBS, 1% penicillin streptomycin (Gibco, Gaithersburg, MD), 
100 ug/ml ascorbic acid, and 100uM Vitamin-D3 for 24 hours. A 0.02mg/ml CHA and 
differentiation media solution was created using CHA synthesized with either the pH 10, 
pH 11, or pH 12 methodology. Immediately before use the solutions were vortexed briefly 
and sonicated for 10 min. The media in each well was then replaced with the respective 
solution of either pH 10, pH 11, or pH 12 CHA and media and cultured for 7 days under 
differentiation conditions. The media was changed every 3 days. At 1, 3, and 7 days after 
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the addition of the media and CHA suspension, whole cell protein lysate was collected, 
and cellular alkaline phosphatase (AP) enzymatic activity was quantified as previously 
described18. Briefly, cells were freeze thawed in 400μL of 0.05% Trition-X100 in 
phosphate buffered saline twice and then the cell lysate collected. 10μL of each sample 
lysate was removed and used to quantify total protein concentration using Pierce BCA 
protein assay kit (Thermo Fisher, Waltham, MA). AP enzymatic activity was then 
determined by conversion of p-nitrophenyl phosphate to p-nitrophenol. 200μL of AP 
reaction buffer was then added to each sample and incubated at room temperature for 
30 minutes. After incubation 50μL of each sample was moved to 200μL of 0.1 NaOH in a 
96 well plate to quench the reaction. All samples were then measured at 410nm and 
SIGMA units calculated based on the standard curve. All readings were then normalized 
to total protein concentration to control for variations in cell number between samples. 
 
Conditioned Media Effect on Osteoblast Differentiation. 
For the following, because no variation in CHA chemical composition was determined 
between the pH, temperature or homogenization variants, only particles synthetized using 
the pH synthesis methodology were used to evaluate the effect of CHA size on 
osteoblastic differentiation because pH allows significant variations in particle size to be 
achieved during synthesis. A 0.02mg/ml CHA and differentiation media solution was 
created. The media was then conditioned for 7 days at 4°C with the CHA under gently 
agitation. After 7 days, the conditioned media was sterile filtered using a 0.11μm filter to 
remove all CHA particles. hFOB 1.19 cells were then cultured at 30,000 cells per well in 
a 24 well TCPS plate for 24 hours. After 24 hours the differentiation media was replaced 
with conditioned media. The cells were then cultured under differentiation conditions and 
the conditioned media changed every 3 days. 1, 3, and 7 days after the addition of 




Variations in crystallite size and crystallinity were assessed with a two-way ANOVA 
followed by Tukey's post hoc analysis and are reported as mean ± SD. Variations in 
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particle size were assessed using an unpaired t-test followed by Bonferroni post-hoc 
analysis and are reported as mean ± SEM. Variations in cell viability were assessed with 
a two-way ANOVA and are reported as mean ± SD. Post-hoc analysis was not performed 
on cell viability data. Osteoblastic AP activity after particle or conditioned media exposure 
was assessed using two-way ANOVA followed by Tukey's post hoc analysis and are 
reported as mean ± SD. All analysis was performed using GraphPad Prism version 8.1.1 




Figure 7. XRD spectra confirming synthesis of carbonated hydroxyapatite. (a) XRD spectra of 
representative CHA synthesized via the T4 method with significant carbonated hydroxyapatite peaks 
labeled. (b) Comparison of XRD spectra of representative CHA synthesized via the T4 method and 




Variation in Synthesis Methodology does not Affect Particle Composition or 
Morphology.  
XRD analysis of each CHA variant showed that all variants had similar spectra (Figure 
6). The similarities between the peaks of each CHA variant suggests that the changes in 
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synthesis methodology did not alter the crystallinity or phase composition of the 
respective samples. In addition, a representative sample of CHA, synthesized using the 
T4 methodology, is compared to that of standard CHA (01–0172–1243) in Figure 7b. 
Similar peaks of the CHA and CHA variant are labeled in Figure 7a. Crystallinity 
percentage of each CHA variant was then quantified using the observed spectra with 
degree of crystallinity ranging from roughly 60% to 88% (Table 4).  
 
Table 4. CHA crystallite size and crystallinity of all synthesized CHA variants. n = 3 samples with each 
sample being the average of 3 measurements. Groups not sharing the same letter are significantly different 
(p < 0.05) within the same column. 
Variant Group Synthesized Crystallite Size (nm) Crystallinity (%) 
 pH 10 27.7 ±1.5 65.6% 
pH pH 11 23.9±1.4 64.1% 
 pH 12 25.4±1.3 62.0% 
 4°C 24.0±5.1 84.0%a 
Temp 21°C 23.9±3.6 78.4%a 
 55°C 20.8±2.4 88.8%a 
 200 RPM 24.2±1.6 60.5% 
RPM 500 RPM 24.6±0.6 61.6% 
 800 RPM 25.4±3.1 63.6% 
 
FTIR analysis of each variant of CHA can be seen in Figure 8a, with a representative 
image of CHA, synthesized via the T55 methodology, shown in Figure 8b. The FTIR 
analysis revealed the presence of both carbonate (CO32−) and phosphate groups (PO4 3−) 
detected at wavelengths of 1454cm−1, 1414cm−1, and 873cm−1 for carbonate and 
1016cm−1, 1088cm−1, and 962cm−1 for phosphate. The crystallinity of each variant can be 
qualitatively characterized through observation of the FTIR peaks. Sharp distinguished 
peaks such as those seen in Figure 8a between the 1454cm−1 and 1414cm−1 peaks as 
well as the peaks at 1016cm−1 and 962 cm−1 suggests that the synthesized CHA is of 
high crystallinity 
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Figure 8. FTIR showing each CHA variant has similar chemical composition (a) FTIR of CHA variants 
from top; PH12, PH11, PH10, R800, R500, R200, T55, T21 and T4. (b) FTIR analysis of representative 
CHA variant T55 with significant carbonated hydroxyapatite peaks labeled. 
 
CHA crystallites and particle morphology was similar for all CHA variants. CHA 
crystallites, which are indicated by the black arrows in Figure 9, clearly shows the 
crystallites to be sphere or almost sphere like in shape. CHA particles indicated by the 
black dotted outline (Figures 9a), ranged in shape from a roughly spherical morphology 
to a more random morphology. The CHA particles that were produced consisted of 
numerous single spherical crystallites that are sintered together during the heat treatment 
process and create a distinct topography on the outer surface of the agglomerations 
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Figure 9. Analysis of CHA particle and crystallite morphology. SEM images of each CHA variant at 180 
K magnification with CHA crystallites indicated with black arrow and CHA particles shown with black 
dotted outline (a) CHA variant synthesized using pH 11 methodology. (b) CHA variant synthesized using 
R500 methodology (c) CHA variant synthesized using T4 methodology. 
 
Variation in pH Allows Selective Manipulation of pCHA Size.  
The nanoemulsion method forms two distinct functional units, the spherical crystallites 
that are nanometer in scale, noted by arrows (Figure 9), and the particles, noted by a 
black outline (Figure 9a), that are submicron in scale and are agglomerations of multiple 
crystallites. These agglomerations are the result of the sintering that occurs during the 
heat treatment process. CHA crystallite size was visually approximated to be 15–30nm in 
diameter for each variant of CHA. Moreover, each variant of CHA crystallite maintained 
a spherical morphology regardless of synthesis methodology used (Figure 9). The z-
average diameter, the diameter as measured through DLS analysis, reflects the diameter 
of the CHA particles for each variant, not the individual CHA crystallites (Figure 10). No 
significant variation in the CHA particle size was evident from the RPM synthesis 
methodology, as all particle agglomerations remained roughly 550nm in size (Figure 10). 
Clear variations in CHA particles size were achieved through both pH and temperature 
variation, although the pH synthesis methodology was the only variation to show a 
significant difference between all test groups (p < 0.05). 
 
The temperature synthesis methodology allowed for CHA particles to be created with 
average diameters of 288.6nm ± 53.43, 558.6nm ± 17.24, and 776.8nm ± 10.33 using the 
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T55, T21 and T4 methodologies respectively (Figure 10). Overall, the variation in size 
was 488.2nm. Manipulation of the pH during synthesis was the only variation able to 
significantly affect CHA particle size. This manipulation allowed successful creation of 
CHA particles with average diameters of 176.3nm ± 22.74, 474.4nm ± 6.97, and 955.1nm 
± 36.29 using the pH 10, pH 11 and pH 12 methodologies respectively, an overall variation 
in size of 602.5nm. Manipulation of temperature did not create a significant variation in 
the CHA particle size. This may be due to uneven heating or cooling in the solution as 
well as uneven flux of thermal energy during homogenization despite all precautions to 
have the solution be at a uniform temperature. This highlights an additional challenge 
associated with manipulating the temperature of the solutions. In addition, the pH and 
temperature methodologies resulted in a narrow distribution of particles in each synthesis 
and creation of the desired size particles was highly repeatable (Figure 10). 
 
 
Figure 10. Average CHA particle agglomeration size for each synthesis technique. Average z-diameter 
(nm) of each CHA synthesis methodology evaluated. * p < .05, n = 3 samples with each sample being 
the average of three separate measurements. 
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The crystallite size for each CHA variant was calculated using Scherrer's equation (Table 
4). The crystallite size ranged from 20–28 nm with the largest crystallite being 27.7 nm, 
which resulted from the pH 10 variant, while the smallest crystal size of 20.8 nm resulted 
from the T55 synthesis variant. Narrow distributions of crystallite size were maintained 
regardless of the synthesis methodology despite the varying CHA particle size. 
 
500nm CHA Particles Increase Osteoblastic Alkaline Phosphatase Activity 
without Affecting Viability. 
The effect that all CHA variants had on hFOB 1.19 cells was then evaluated to determine 
the cytotoxicity of the CHA as well as the potential of CHA to influence osteoblastic 
differentiation. Osteoblasts cultured in media conditioned with the various CHA variants 
did not show a significant difference in cell viability compared TCPS controls (Figure 11).  
 
 
Figure 11. CHA effect on osteoblastic cell viability. Percent cell viability (# alive cells/# total cells) of 
hFOB 1.19 preosteoblastic cells after being cultured with CHA for 48 hr. n = 4–12 samples.  
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Both the effects of CHA directly and indirectly were evaluated in this study. First, CHA 
particles of 200nm, 500nm, and 900nm were added directly to media used to cultured 
hFOB1.19 cells. Addition of the 500nm particles directly to media resulted in a 2-fold 
increase in cell AP activity after 1 day of culture compared to cells in media without CHA 
and cells cultured in media with either 200nm or 900nm CHA particles (Figure 12a). 
Further, culturing cells with CHA particles did not result in any significant changes in 
osteoblast morphology compared to cells cultured on TCPS or variations between CHA 
particle sizes (Supplemental Figure S2). To determine if the release of ions from the CHA 
was contributing to the observed increase in AP activity, hFOB 1.19 cells were cultured 
in media conditioned with either 200nm, 500nm, or 900nm CHA particles. Conditioned 
media did not induce a significant variation in AP activity compared to nonconditioned 
culture media over the course of 7 days regardless of the particle size (Figure 12b). 
Furthermore, no significant differences were observed between media conditioned with 
either 200nm, 500nm, or 900nm. This suggests that the ions, if any, released from the 
CHA were not contributing to the observed osteoblastic differentiation and therefore an 
ion release profile of the hydroxyapatite was not performed. 
 
 
Figure 12. Evaluation of the effect each CHA variants has on osteoblastic differentiation. (a) Normalized 
alkaline phosphatase enzymatic activity of hFOB 1.19 preosteoblastic cells after 1, 3, and 7 days in 
culture with media conditioned with each CHA variant. (b) Normalized alkaline phosphatase enzymatic 
activity of hFOB 1.19 preosteoblastic cells after 1, 3, and 7 days in culture with particles from each CHA 
variant. * p < 0.05 compared to all other groups, n = 3–6 samples with each sample being the average 
of two replicates. 
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As the design and use of novel biomaterials for bone tissue engineering becomes of 
greater importance to meet the demand of increasing bone graft procedures, the use of 
CHA alone or in tandem with other materials is becoming more common22,147. Tailoring 
the size of hydroxyapatite is a common practice, although it is still not agreed upon as to 
which size of hydroxyapatite particles is most osteogenic. Moreover, current synthesis 
methodologies utilize caustic chemicals, surfactants, and extremely high or low 
temperatures to produce submicron and nano sized hydroxyapatite particles22,148. To 
address these issues, we have modified a simple methodology for the synthesis of 
biomimetic hydroxyapatite that does not require harsh synthesis techniques and creates 
a ready to use product that is osteogenically favorable149. Our results show that we are 
able to reproducibly create a range of submicron CHA particles through the manipulation 
of pH to modify a nanoemulsion technique. In addition, the synthesized CHA maintained 
similar chemical properties, morphology, and biological characteristics regardless of 
synthesis methodology used. 
 
The results of this study show that we can selectively manipulate CHA particle size 
through the manipulation of pH during synthesis (Figure 10). The variation in CHA size 
we observed through changes in temperature manipulation also looks to be an avenue to 
manipulate the size of CHA in the submicron range, though it did not induce significant 
changes in size. Although the ability to control the CHA particle size through pH 
manipulation has been shown in previous studies, the synthesis methodology used in 
these previous studies necessitated the use of caustic chemicals or surfactants to 
produce and manipulate the size of the CHA150,151. Despite the efficacy of these synthesis 
methodologies, reproducibility of these methods is often difficult. The precise conditions 
that are needed to recreate a narrow distribution of CHA particles in a reproducible 
manner are often challenging, due to the volatility of the chemicals and temperatures 
required to synthesize biomimetic hydroxyapatite. The methodology developed during 
this study does not utilize any caustic chemicals or surfactants and is easily reproduced. 
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In addition to selectively tailoring the CHA particle size, the CHA synthesized during this 
study also exhibited highly biomimetic qualities. Biological apatite exhibits a range of 
crystallinity from 60% to 70% depending on the location of the apatite124,152; our 
synthesized CHA exhibited a crystallinity range of roughly 60% to 85%. Differences in 
peak intensity between the standard CHA and the representative samples can be 
observed (Figure 8b). These differences are likely due to variations in the crystallinity of 
the synthesized apatite, which in the representative sample is roughly 80%, and typical 
biological apatite, which is roughly 70%. For this reason, the pH synthesis methodology 
also has advantages over the other methodologies, as it maintains an ideal crystallinity 
(between 60% and 70%) while temperature manipulation generated higher crystallinity 
CHA. This is significant because synthetic hydroxyapatite with a crystallinity between 60 
and 70% is more bioactive and more osteoconductive than hydroxyapatite that falls 
outside of the 60–70% range153–155. This suggests that the CHA synthesized with the pH 
methodology is also optimally osteogenic. To examine this further, we evaluated CHA in 
vitro to determine its overall osteogenic potential. 
 
CHA examined during this study was not cytotoxic, with no synthesis methodology 
resulting in particles that induced a significant decrease in cell viability compared to cells 
cultured on TCPS. Interestingly, cells cultured with 500nm hydroxyapatite particles 
expressed a significantly higher level of AP activity after just 1 day in culture compared to 
both 200nm and 900nm particles. A review by Chen et al., reported that multiple studies 
highlighted the fact that 500nm topographic features induced the greatest osteogenic 
response from stem cells and preosteoblastic cells101,118. These features were created 
using a variety of synthesis techniques ranging from electrospinning and anodization to 
nanoimprinting156–158. The diversity of these synthesis techniques and the corroborating 
result, that 500nm topographic features promote osteogenesis, highlights an observation 
made in our study that 500nm CHA particles induce the greatest AP activity compared to 
other particle sizes. Moreover, studies noted that 500nm topographic features allowed for 
an increase in cell stiffness, spreading, and adhesions, which is hypothesized to 
upregulate osteogenesis159,160.  
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It is important to note that many factors influence the cell response to an associated 
material. Factors such as chemical composition, pH, and crystallinity have all been shown 
to mediate osteoblastic differentiation110,121. In the study presented here chemical 
composition, crystallinity of the various compositions, and pH, while not shown in this 
study, are not significantly different between any of the particle sizes evaluated in this 
study for osteoblastic differentiation. This suggests particle size is the main contributor to 
osteoblastic differentiation observed in this study. These findings suggest a further 
avenue of study and, based on the results of the study presented here, suggest 





This work demonstrates that it is possible to repeatably synthesize monophasic, highly 
crystalline, spherical CHA in the submicron range through the use of a nanoemulsion 
methodology that eliminates the use of caustic chemicals or surfactants. Moreover, this 
work demonstrates the ability to vary CHA particle size through manipulation of the 
synthesis methodology, specifically by manipulating the pH. This knowledge allows a 
more thorough understanding of a nanoemulsion techniques that reproducibly generates 
carbonated biomimetic hydroxyapatite particles of submicron scale quickly and safely and 
at a low cost, allowing this method of hydroxyapatite production to be scaled. In addition, 
we determined that 500nm CHA particles increased AP activity, suggesting an increase 
in osteoblastic differentiation, after only 1 day, compared to 200nm and 900nm particles. 
The further development of the nanoemulsion method for CHA enables further research 
into the osteogenic potential of hydroxyapatite particles. By tailoring CHA size, the ability 
to create synthetic biomimetic bone scaffolds with predictable and optimized submicron 
properties is possible. This will enable investigation and eventual use of submicron and 
nanoscale environments to facilitate osteogenesis. 
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ABSTRACT 
 
Substrate surface characteristics such as roughness, wettability and particle density are 
well-known contributors of a substrate’s overall osteogenic potential. These 
characteristics are known to regulate cell mechanics as well as induce changes in cell 
stiffness, cell adhesions, and cytoskeletal structure. Pro-osteogenic particles, such as 
hydroxyapatite, are often incorporated into a substrate to enhance the substrates 
osteogenic potential. However, it is unknown which substrate characteristic is the key 
regulator of osteogenesis. This is partly due to the lack of understanding of how these 
substrate surface characteristics are transduced by cells. In this study substrates 
composed of polycaprolactone (PCL) and carbonated hydroxyapatite particles (HAp) 
were synthesized. HAp concentration was varied, and a range of surface characteristics 
created. The effect of each substrate characteristic on osteoblastic differentiation was 
then examined. We found that, of the characteristics examined, only HAp density, and 
indeed a specific density (85 particles/cm2), significantly increased osteoblastic 
differentiation. Further, an increase in focal adhesion maturation and turnover was 
observed in cells cultured on this substrate. Moreover, β-catenin translocation from the 
membrane bound cell fraction to the nucleus was more rapid in cells on the 85 
particle/cm2 substrate compared to cells on tissue culture polystyrene. Together, these 
data suggest that particle density is one pivotal factor in determining a substrates overall 
osteogenic potential. Additionally, the observed increase in osteoblastic differentiation is 
a at least partly the result of β-catenin translocation and transcriptional activity suggesting 
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Studies evaluating the effect of substrate surface characteristics on osteogenesis have 
determined that there is a significant interplay between surface characteristics and bone 
cell response110,121,161. For instance, recent studies have demonstrated that micro and 
nano-scale topographies, by affecting surface characteristics such as roughness, 
wettability, and height, effect changes in the cell’s cytoskeletal structure90,110. These 
topographies also promote osteogenesis and direct mesenchymal stem cells toward the 
osteoblastic lineage90. Frequently, the substrate surface characteristics are created by 
incorporating a pro-osteogenic material, such as hydroxyapatite particles (HAp), directly 
into the substrate.  
 
Hydroxyapatite is the main mineral component of bone and is highly osteoconductive. 
HAp is synthesized in a variety of sizes, from the nanometer to micron scale, and a variety 
of shapes, from spheres to needle-like rods162–164.  The effect of various HAp sizes and 
shapes on their osteogenic potential has been summarized in numerous reviews that 
suggest spherical HAp less than 1 micron in size facilitate osteogenesis to the greatest 
degree152. Unfortunately, hydroxyapatite is not a viable material for all load bearing 
applications because of its extreme brittleness during shear124. To overcome this, HAp is 
typically combined with other materials, including polymers such as polycaprolactone 
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(PCL), which is biocompatible, bioresorbable, and exhibits mechanical properties more 
similar to that of bone43,44.  
 
Combining HAp and PCL has resulted in materials that have unique and tunable surface 
characteristics. By increasing or decreasing the ratio of HAp to PCL, variations in 
substrate surface characteristics such as roughness, particle density, wettability, and 
height can be achieved165. Studies investigating these substrate properties have yielded 
conflicting results because the substrates examined have numerous properties that differ. 
This has made identifying a singular property that is causing osteogenesis challenging. 
To overcome this, previous studies have cultured cells on nanoposts, limiting the 
differences in substrate characteristics and instead varying only post-size, post-height, 
and post-density. These studies determined that the presentation of denser nanoposts to 
human mesenchymal stem cells resulted in more adipogenic differentiation, while less 
dense substrates resulted in a more osteogenic differentiation11,17. Moreover, nanoposts 
that were between 200nm and 700nm in diameter were the most osteogenic, but this was 
also dependent on post-height and stiffness166. These studies suggest that the ability of 
the cell to form the correct cell-substrate adhesion, known as a focal adhesion, is a 
significant contributor to inducing osteogenesis. However, translation of these results to 
materials that can be utilized in vivo such as PCL and HAp have yielded conflicting results.  
 
One reason it is still challenging to create novel substrates with increased osteogenic 
potential is because it is still unknown how substrate surface characteristics are 
transduced and how this signal then regulates osteogenesis15,167. Numerous attempts 
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have been made to determine the mechanism by which substrate surface characteristics 
are transduced into intracellular signals. This has given rise to the concept that surface 
characteristics induce cytoskeletal changes that then alter nuclear morphology and gene 
expression12. Previous data also suggest β-catenin, a protein found at cell adhesions and 
a key contributor in the Wnt signaling pathway, transduces substrate surface 
characteristics, but this concept has yet to be validated60,61.  
 
The canonical Wnt signaling pathway relies on β-catenin translocation to the nucleus to 
regulate transcription factors, which in the case of osteoblastic cells, regulate pro-
osteogenic genes168. Another role of β-catenin is its contribution to the formation and 
stabilization of cell adhesions such as focal adhesions and cadherins169. At E-cadherins, 
β-catenin binds the cadherin directly at the N-terminus, where it is then stabilized by α-
catenin. α-catenin then either binds directly to actin or indirectly to vinculin that then binds 
actin55. More recent studies have also suggested that vinculin may directly bind β-catenin 
after activation and that the β-catenin/vinculin complex is capable of supporting 
mechanical tension170–173. Interestingly, vinculin is also a component of another adhesion 
complex, focal adhesions, although the role of β-catenin, if any, at focal adhesions is still 
unknown174.  
 
Focal adhesion complexes are composed of greater than 50 proteins and are known to 
contribute to mechanosensing within the cell175. The transmembrane portion is comprised 
of integrins that bind to the extracellular matrix. Previous studies suggest that integrins 
respond differentially to various surface characteristics, with different forms of integrins 
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adhering preferentially to pro-osteogenic substrates compared to sub-optimal 
substrates13,17,176. Focal adhesions, well-known mechanosensors, also increase in size 
in response to increased actin fiber tension. This phenomenon, known as the growth 
model of force-induced focal adhesion, is driven by actomyosin-mediated tension174. 
Previous studies examining human mesenchymal stem cell differentiation have observed 
a correlation between nanopost density, focal adhesion formation and maturation, and 
the differentiation state of the cell144. These studies found the median densities often elicit 
the greatest increase in focal adhesion maturation and differentiation. In addition, 
evidence presented by Dubrovskyi et al. suggests that β-catenin may localize to focal 
adhesions as well, binding paxillin during Rac activation144. However, the contribution β-
catenin may have facilitating focal adhesion formation and binding of actin stress fibers 
has not been fully explored. The relationship between focal adhesion maturation, 
osteoblastic differentiation, and β-catenin localization has led to the examination of 
whether focal adhesions transduce substrate surface characteristics to mediate 
osteogenesis and, if so, the mechanism by which this occurs57.  
 
To better understand the mechanism by which substrate surface characteristics affect 
osteogenesis we varied the concentration of HAp independent of PCL to create 
substrates with a range of surface characteristics. We hypothesized that substrates with 
a concentration of 30% HAp to PCL would increase osteoblastic differentiation compared 
to lower (5%) or higher (50%) concentrations of HAp to PCL, similar to that which has 
been observed in previous studies using various densities of nanoposts177. Furthermore, 
the mechanism by which this occurs may involve the regulation of β-catenin by, or 
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liberation from, proteins at adhesion complexes, located at the cell membrane. This would 
result in increased β-catenin translocation form these adhesion complexes to the nucleus 
on the more osteogenic substrate.  
 
To evaluate this hypothesis, we examined osteoblastic differentiation, as assessed by 
osteoblastic gene expression and alkaline phosphatase (AP) activity, on 5%, 30%, and 
50% HAp to PCL substrates. We also evaluated focal adhesion morphology and number 
over time, β-catenin localization over time, and nuclear β-catenin activity. We observed 
that cells on substrates with a concentration of 30% HAp to PCL displayed increased 
expression of genes associated with osteoblastic differentiation and osteoblastic activity, 
relative to cells on other substrates examined. However, the substrates examined did not 
exhibit significant changes in surface roughness, wettability, or height. Moreover, focal 
adhesion turnover and maturation of cells on the substrate with a concentration of 30% 
HAp to PCL occurs more rapidly compared to cells on tissue culture polystyrene (TCPS). 
This more rapid turnover and maturation also corresponded with a more rapid release of 
β-catenin from the membrane bound fraction, where β-catenin is retained at adherens 
junctions and focal adhesions, to the nucleus. 
 
MATERIALS AND METHODS 
 
Materials.  
All chemicals used for nanoparticle and substrate synthesis were obtained from Sigma-
Aldrich (St. Louis, MO). 
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Substrate Synthesis and Characterization. 
Polycaprolactone and Hydroxyapatite Substrate Synthesis. 
To create a pro-osteogenic substrate to test our hypothesis, various formulations of HAp 
and PCL substrates were fabricated. Five thousand molecular weight PCL was 
suspended at a 2.5% wt./vol. ratio in chloroform. The mixture was then homogenized until 
all PCL was dissolved into solution. After homogenization, 500nm HAp was added into 
the solution at a ratio of 5%, 30%, or 50% wt./wt. with the PCL. Using a dip-coating 
technique, 22mm coverslips were coated with one of the following: PCL solution only 
(PCL), 5% HAp to PCL solutions, 30% HAp to PCL solutions, or 50% HAp to PCL solution. 
After coating, the various substrates were allowed to dry at room temperature for 24 
hours.  
 
Substrate Surface Roughness and Height Characterization.  
Substrate surfaces were characterized for roughness and height (z-range) using a 
Dimension ICON atomic force microscopy platform (Veeco, Plainview, NY). Briefly, each 
substrate was rinsed with 70% ethanol to remove debris left on the surface after synthesis 
and the ethanol allowed to evaporate. The substrates where them imaged by atomic force 
microscopy using a TESPSS antimony doped silicon cantilever (Bruker, Billerica, MA). 
The cantilever used a single tip with a resonance frequency in the range of 230 KH to 410 
KHz. The probe radius was 5nm, with a tip height of 10µm to 15µm, spring constant of 42 
N/m and a cone angle of less than 10° over the first 200 nm of tip length. All evaluations 
were performed in air. The set point voltage was kept between 0.1 V and 0.3 V with the 
cantilever force kept constant. The frequency employed was manipulated based on the 
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substrate in order to accurately quantify the surface roughness and height. The scan 
resolution was 256 × 256 pixels with a scan frequency of 0.85 Hz over a 5µm × 5µm area 
scanned. The average height and roughness of three random areas per substrate was 
determined and used to estimate each substrate’s overall roughness and height. 
 
Substrate Surface Energy Characterization.  
Surface energy, also referred to as wettability, was characterized using contact angle 
measurements with a 590 Advanced Automated Goniometer/Tensiometer (Ramé-Hart, 
Succasunna, NJ). Briefly, each substrate was rinsed with 70% ethanol to remove any 
debris left on the surface after synthesis and the ethanol allowed to evaporate. The 
substrates then underwent contact angle measurement using doubly distilled water. 
Three random areas were evaluated on each substrate and the average of the three 
measurements was taken as the substrate’s overall wettability. Image analysis was 
performed by using the DROPimage version 2.4 software (Ramé-Hart, Succasunna, NJ).  
 
Substrate Particle Density Characterization.  
Particle density for the various substrates was quantified using an EVOS light 
microscope. Images of the substrate were taken at three random locations. Using Fiji 
image software145, HAp was isolated by increasing the contrast between the HAp, which 
auto-fluoresces, and the background image using a 0.3% increase in saturated pixel 
contrast. The images were then converted to an 8-bit file format and then the background 
image subtracted using a 5-pixel rolling ball radius leaving only HAp visible. The particles 
were then outlined before being quantified using the Analyze Particles tool package in 
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Fiji178. The average particle number of the three random locations was then determined 
and divided by the field of view to determine the substrates areal particle density 
(particles/cm2). 
 
Mechanistic Evaluation of Substrates. 
Osteoblast Cell Culture.  
To assess osteogenesis, the differentiation capacity of human fetal osteoblasts (hFOB 
1.19 cells), a preosteoblastic cell line, was assessed as previously described179. Briefly, 
for proliferation of hFOB 1.19 cells, cells were cultured at 33.5°C with 5% CO2 to 80% 
confluence in standard DMEM:F12 media supplemented with 10% fetal bovine serum 
(Gibco, Gaithersburg, MD) and 1% Penicillin/Streptomycin mixture (Sigma, St. Louis, 
MO). To induce differentiation of the hFOB 1.19 cells, the standard media was 
supplemented with 100µg/mL ascorbic acid, 10−8 M menadione, and 10−8 M dihydroxy-
vitamin D3 (Sigma, St. Louis, MO), and the cells were cultured at 39.5°C with 5% CO2 
until the desired timepoint. Media was changed every 3 days unless otherwise stated for 
all experimental methods. All substrates used were sterilized by completely submerging 
the substrates in 70% ethanol for 5 minutes before the ethanol was aspirated and 
remaining ethanol allowed to evaporate for 1 hour under UV light. 
 
Osteoblastic Gene Expression. 
hFOB 1.19 cells were cultured on tissue culture polystyrene (TCPS), PCL, 5% HA/PCL 
substrate, 30% HA/PCL substrate, or 50% HA/PCL substrate and cultured under 
differentiation conditions for 1 and 7 days. At each time point RNA was isolated using a 
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RNeasy Mini Kit (Qiagen, Hilden, Germany). Quantitative real time PCR (RT-qPCR) was 
performed using a C1000 Touch Thermal Cycler with CFX96 Real-Time System (Bio-Rad 
Laboratories, Hercules, CA). PowerUp Sybr Green Master Mix was used to quantify gene 
expression (Thermo Fisher Scientific). The genes we evaluated are associated with the 
various stages of osteoblastic differentiation and are as follows; alkaline phosphatase 
(ALPL), Osteocalcin (BGLAP), Collagen1-a1 (COL1A1), Runt related transcription factor-
2 (RUNX2), and Sp7 Transcription Factor (SP7), the gene that control Osterix (OSX) 
protein expression. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) was used as 
a reference gene for all samples. All primers used in this study were PrimePCR Sybr 
Green Assay Primers (Bio-Rad Laboratories, Hercules, CA) and the unique assay ID 
numbers are provided in Table 5. The ∆∆Ct method used to quantify fold-change in gene 
expression relative to the housekeeping gene Gapdh, as previously described180,181.   
 
Table 5. Reference numbers associated with each osteoblastic gene evaluated using primers purchased 
from Bio-Rad Laboratories, Hercules, CA. 







Collagen1-a1 COL1A1 qHsaCEP0050510 
Runt related transcription factor-2 RUNX2 qHsaCID0006726 
Sp7 Transcription Factor SP7 qHsaCEP0025867 
Glyceraldehyde-3-Phosphate Dehydrogenase GAPDH qHsaCEP0041396 
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Alkaline Phosphatase (AP) Activity. 
hFOB 1.19 cells were cultured on either tissue culture polystyrene (TCPS), PCL 
substrate, 5% HA/PCL substrate, 30% HA/PCL substrate, or 50% HA/PCL substrate at 
15,000 cells/cm and cultured under differentiation conditions for 7 days. Differentiation 
was evaluated using a colorimetric AP enzymatic activity assay as previously 
described182. Briefly, cells were freeze thawed in 400µL of 0.05% Trition X-100 in 
phosphate buffered saline twice and then the cell lysate collected. 10μL of each sample 
lysate was removed and used to quantify total protein concentration using Pierce BCA 
protein assay kit (Thermo Fisher, Waltham, MA). AP enzymatic activity was then 
determined by conversion of p-nitrophenyl phosphate to p-nitrophenol. Two hundred 
microliter of AP reaction buffer was then added to each sample and incubated at room 
temperature for 30 minutes. After incubation 50µL of each sample was moved to 200µL 
of 0.1 NaOH in a 96 well-plate to quench the reaction. All samples were then measured 
at 410nm and SIGMA units calculated based on the standard curve. All readings were 
then normalized to total protein concentration to control for variations in cell number 
between samples.  
 
Mineralization Staining. 
hFOB 1.19 cells were cultured on either tissue culture polystyrene (TCPS), PCL 
substrate, 5% HA/PCL substrate, 30% HA/PCL substrate, or 50% HA/PCL substrate at 
15,000 cells/cm and cultured under differentiation conditions for 7, 10 and 14 days. 
Mineralization was evaluated using alizarin red staining as previously described183. 
Briefly, cell cultured medium was removed, and cells were fixed in 4% paraformaldehyde 
for 15 min at room temperature. After fixation, cells were gently washed twice with 
deionized water. After washing 500uL of Alizarin Red Staining Solution (Sigma Aldrich, 
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St. Louis, MO) was added to each well and incubated for 1 hour at room temperature. 
After incubation, excess dye was removed, and cells were gently washed 2 times with 
deionized water. 400uL of acetic acid was then added to each well and incubated for 30 
minutes at room temperature under agitation. Cells were released from substrate by 
scarping, and then acetic acid and cell mixture was transferred to a 1.5mL microcentrifuge 
tube. The sample was then vortexed for 30 seconds before being heated to 85C for 10 
minutes. Immediately following incubation samples were placed on ice for 5 minutes and 
then immediately centrifuged for 15 minutes. Supernatant was then removed, and all 
samples measured at 405nm and mineralization quantified.   
 
Focal Adhesion Staining. 
hFOB 1.19 cells were cultured on either glass, PCL, 5% HA/PCL substrate, 30% HA/PCL 
substrate, or 50% HA/PCL substrate at 15,000 cells/cm and cultured under differentiation 
conditions for 1, 2, 4, 12, 24, or 48 hours. At the selected time point, cells were stained 
using a FAK 100 Actin Cytoskeleton and Focal Adhesion Staining Kit (Sigma, St. Louis, 
MO). Briefly, cell culture medium was removed, and cells were fixed in 4% 
paraformaldehyde for 15 min at room temperature. After fixation, cells were washed twice 
with wash buffer consisting of 0.01% Tween-20 in PBS. Cells were then permeabilized 
with 0.1% Trition-X100 in PBS for 3 minutes. After permeabilization cells were washed 
twice with wash buffer and then blocked for 30 minutes at room temperature in Odyssey 
Blocking Buffer (Thermo Fisher Scientific, Waltham, MA). After blocking anti-vinculin 
antibody was diluted to 1:250 in blocking buffer and incubated for 1 hour at room 
temperature. Cells were then washed three times in wash buffer. After washing 
ReadyProbes AlexaFluor 488 (Thermo Fisher Scientific, Waltham, MA) was diluted in 
PBS according to the manufactures protocol. Samples were then incubated in the PBS 
solution for 1 hour at room temperature and protected from light. After incubation samples 
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were washed three times in wash buffer and then DAPI stain, diluted at 1:1,000 in PBS, 
was added and incubated at room temperature for 5 minutes. After incubation samples 
were mounted on glass slides using ProGold Antifade Mounting Solution (Thermo Fisher 
Scientific, Waltham, MA).  
 
Focal Adhesion Characterization. 
Confocal images of the various samples were gathered using an LSM 710 Confocal 
Microscope (Zeiss, Jena, Germany). Briefly, a 30µm z-stack of each sample was taken 
with 10 slices per stack. The image that provided the greatest resolution of vinculin 
(GFP+) was then used for further analysis and quantification. Using custom MATLAB-
based software, images were analyzed for focal adhesion size and morphology, and 
number normalized to cell number. A contrast threshold of 0.450 was selected and 
applied to all images allowing segmentation of the individual focal adhesions. If the 
segmentation did not accurately represent the original image, a different threshold value 
was chosen manually until segmentation of the focal adhesions was representative of the 
original images. Thresholding analysis was then performed and focal adhesion number, 
length and width dimensions (µm), and area (µm2) were output and recorded. 
Representative images are shown in supplemental figure S3. 
 
β-Catenin Cellular Dynamics. 
The 30% HA/PCL substrate, which elicited the greatest increase in focal adhesion 
maturation and osteoblast differentiation, along with TCPS (control), were further 
evaluated to assess β-catenin cellular dynamics. hFOB 1.19 cells were seeded onto 
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either TCPS or pro-osteogenic (30% HA/PCL) substrates at 100,000 cells/cm2 and 
cultured under differentiation conditions for 4 hours, 12 hours, 24 hours, 48 hours, 72 
hours, or 96 hours. After culture, cells underwent protein fractionation using the 
Subcellular Protein Fractionation kit for Cultured Cells (Thermo Fisher Scientific, 
Waltham, MA). After fractionation, 10µL of cell lysate from each fraction was removed 
and used to quantify total protein concentration using a Pierce BCA protein assay kit 
(Thermo Fisher, Waltham, MA). 25µg of total protein from each cell fraction at the various 
time points was then used to quantify total β-catenin protein concentration in the various 
cell fractions over time using a Human Total β-catenin DuoSet IC ELISA (R&D 
Biosystems, Minneapolis, MN). All cell fractions were then normalized to total β-catenin 
concentration at the respective timepoints. 
 
Luciferase Based β-Catenin Translocation Reporter Assay. 
To validate nuclear β-catenin translocation and activity from cell fractionation 
experiments, hFOB 1.19 cells were examined using a luciferase-based reporter assay 
(Promega Corporation, Madison, WI) as previously described184. Briefly, hFOB1.19 cells 
were transiently transfected with either a TOPFLASH reporter construct, which contains 
a firefly luciferase reporter that is activated by TCF/LEF binding or a FOPFLASH reporter 
construct, which has a mutated TCF/LEF protein that prevents β-catenin activation of the 
firefly reporter. After 24 hours, 100,000/cm2 cells were seeded onto either TCPS or the 
pro-osteogenic substrate (30%) and cultured for 48 hours and 72 hours. After culture, the 
cells were lysed and a TOPFLASH/FOPFLASH quantified. β-catenin translocation and 
activity in cells on TCPS or the pro-osteogenic substrate was then calculated.  
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Inhibition of β-Catenin Binding to TCF/LEF.  
To determine if observed changes in differentiation were, in part, a result of β-catenin 
activity, we inhibited β-catenin binding to TCF/LEF using a small molecule inhibitor PNU-
74564179. Under normal physiological conditions β-catenin binds TCF/LEF upon 
translocation to the nucleus, which then activates transcription of various genes 
associated with osteoblastic differentiation and other genes such as AXIN2180. Upon 
introduction of PNU-74564, the binding of β-catenin is inhibited, thus inhibiting 
downstream effector gene expression. hFOB 1.19 cells were seeded onto either TCPS 
or pro-osteogenic (30% HA/PCL) at 100,000/cm2. The cells were then exposed to either 
differentiation media supplemented with 0.1% dimethyl sulfoxide (DMSO) or 
differentiation media supplemented with 0.1% DMSO and 25µM PNU-74564 determined 
by TOPFLASH expression evaluate at 10µM, 25µM, and 50µM (Supplemental Figure S4). 
Cells were then cultured under differentiation conditions for 2 days, 3 days, or 7 days with 
media changed every 2 days. At each time point cells were evaluated for AP activity as 
described previously in the section Alkaline Phosphatase (AP) Activity, or for AXIN2 gene 
expression using methods described previously in section Osteoblastic Gene Expression. 
GAPDH was used as a reference gene for all samples. All primers used were PrimePCR 
Sybr Green Assay Primers (BioRad Laboratories, Hercules, CA). The ΔΔCt methodology 
was used as described previously to compared changes in gene expression relative to 
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Statistical Evaluation.  
Changes in substrate surface properties were assessed with 3 or more samples with each 
sample being the average of three replicates. Gene expression was assessed for 3 to 4 
samples with each sample being the average of three replicates. Focal adhesion 
quantification and characterization was assessed with 3 samples with each sample 
consisting of approximately 5 to 75 cells or roughly 500 to 5000 focal adhesions per 
sample. β-catenin localization was assessed for 4 to 6 samples with each sample 
consisting of two replicates. Osteoblastic gene expression and differentiation in response 
to β-catenin inhibitor PNU-74564 was assessed for 5 to 6 samples with each sample 
being the average of 3 replicates or 2 replicates for gene expression and AP activity, 
respectively. Changes in surface properties and osteoblastic AP activity were assessed 
using two-way ANOVA followed by Tukey’s post-hoc analysis and are reported as mean 
± SD. Changes in osteoblastic gene expression and focal adhesion size and eccentricity 
were assessed using two-way ANOVA followed by Tukey’s post-hoc analysis and are 
reported as mean ± SD. Changes in β-catenin localization were assessed using two-way 
ANOVA followed by Tukey’s post-hoc analysis and are reported as mean ± SD. Changes 
in β-catenin translocation and activity, determined using a luciferase-based reporter 
assay, was assessed using an unpaired t-test followed by Bonferroni post-hoc analysis 
and are reported as mean ± SD. The effect of β-catenin inhibitor, PNU-74564, on AXIN2 
gene expression and AP activity were assessed using two-way ANOVA followed by 
Tukey’s post-hoc analysis and are reported as mean ± SD. All analysis was performed 
using GraphPad Prism version 8.1.1 for Windows (GraphPad Software, La Jolla California 
USA). Values of p < 0.05 were considered statistically significant. 
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Substrate Surface Roughness and Particle Density Varied Based on HA 
Concentration. 
Characterization of the roughness, substrate height, particle density, and wettability for 
the glass substrate, PCL substrate, 5% HA/PCL, 30% HA/PCL, and 50% HA/PCL 
substrates is summarized in Table 6. The PCL coating in HA/PCL substrates alone was 
150nm thick in areas that did not include a particle, affirming that the HA particles were 
not covered but embedded during the dip coating process (Supplemental Figure S5). The 
substrate height of glass and PCL only substrates did not vary significantly from each 
other with observed values of 543 ± 8nm and 598 ± 82nm, respectively. However, these 
values were significantly different than all other substrates evaluated. No significant 
variation in substrate height was observed between the 5% and 30% substrates with 
observed heights of 1063 ± 229nm and 969 ± 361nm, respectively, while the 50% 
substrate with an average height of 2165 ± 121nm was significantly different than all other 
substrates evaluated. Substrate wettability did not vary significantly between any of the 
evaluated substrates, but surface roughness of the 50% HA/PCL substrate was greater 
than all other substrates. Particle density did vary significantly between the Glass, TCPS, 
and 5% substrates with particles densities of 0 ± 0p/cm2, 3 ± 1p/cm2, and 16 ± 2p/cm2, 
respectively, compared to the 30% and 50% substrates with particle densities of 86 ± 
2p/cm2 and 165 ± 8p/cm2, respectively. The 30% and 50% substrates were significantly 
different than all other substrates and significantly different from each other.  
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Table 6. Substrate characteristic characterization and evaluation of osteoblastic differentiation. n ³ 3 with 
each sample being the average of 3 replicates. Groups sharing the same letter are not significantly different 














543 ± 8a 
-- 
2 ± 2.19 
-- 
84.32 ± 1.11 
-- 
  0 ± 0a 
13 ± 4.9 
13 ± 5.4 
PCL 598 ± 82a 8 ± 19.16 85.88 ± 1.11   3 ± 1a 13 ± 6.4 
5%  1063 ± 229b 21 ± 9.58 88.24 ± 0.73          16 ± 2a 17 ± 9.8 
30%   969 ± 361b 25 ± 7.97 87.42 ± 0.98         86 ± 2b   32 ± 9.2a 
50% 2165 ± 121 94 ± 3.53a  92.03 ± 0.36       165 ± 8c 15 ± 9.9 
 
Osteoblastic Differentiation Is Increased On 30% HA/PCL Substrate. 
In order to assess osteogenic potential of the various substrates, expression of key 
osteoblastic differentiation markers was assessed at days 1 and 7 (Figure 13). At day 1, 
BGALP expression was significantly upregulated in cells on the 30% substrates vs. all 
other substrates. SP7 expression was significantly upregulate in cells on the 5% substrate 
compared to all other substrates, however these results varied based on HA/PCL 
composition.  
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Figure 13. Osteoblastic gene expression on the various PCL/HA substrates. Evaluation of osteoblastic 
gene expression of (a) alkaline phosphatase (ALPL), (b) osteocalcin (BGLAP), (c) collagen1-a1 
(COL1A1), (D) RUNX2, and (E) Osterix (SP7) at 1 and 7 days on the various substrates evaluated in this 
study. Substrates sharing the same letter denotes a lack of significance at the same time point, * 
significantly different compared to all other groups at the same time point. n = 3–4 samples with each 
sample being the average of three replicates. 
 
Trends were more apparent after 7 days of culture. RUNX2 gene expression, a marker 
of commitment to the osteoblast lineage, was significantly increased in cells on substrates 
that contained HA (5%, 30%, and 50%) compared to cells that were seeded on substrates 
that did not contain HA (TCPS, PCL). This suggests HA has a significant impact on 
osteoblastic differentiation, regardless of the substrate characteristics. Cells on the 30% 
HA/PCL substrate had significantly greater gene expression in genes related to bone 
matrix deposition (ALPL, COL1A1, and BGLAP) and SP7 than all other groups. This 
indicated that the 30% HA/PCL substrate promotes greater osteoblastic differentiation 
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compared to other substrates. To confirm the results observed at day 7 on the various 
substrates, AP activity and mineralization was quantified for cells on each substrate. After 
7 days of culture cells on the 30% substrate exhibited a significant 1-fold increase in AP 
activity compared to cells on any of the other substrates (Table 6). Significant variations 
in AP activity were not observed in cells on any of the other substrates. After 14 days in 
culture, only cells cultured on the 30% substrate exhibited a significantly greater amount 
of mineralization compared to cell cultured on any of the other substrates (Supplemental 
Figure S6). No significant variations in mineralization were observed on any substrate at 
after either 7 or 10 days in culture. 
 
Osteoblast Focal Adhesion Maturation Was Increased by 30% HA/PCL Substrate. 
The number of focal adhesions per cell was evaluated for all substrates (Figure 14a). 
Over the first 12 hours all substrates demonstrated a dramatic increase in focal adhesion 
number. After 24 hours the number of adhesions per cell begins to decrease on all 
substrates aside from the PCL substrate. From 12 hours to 24 hours, the 30% substrate 
had the greatest decrease in adhesion number, decreasing by roughly 100 adhesions per 
cell. Conversely, the total number of adhesions per cell on glass, 5% HA/PCL and 50% 
HA/PCL substrates decreased by roughly 50 adhesions per cell. The decrease in 
adhesion number continued at 48 hours when the evaluation concluded. Again the 30% 
HA/PCL substrate had the greatest decrease in adhesion number per cell compared to 
the glass, 5% and 50% HA/PCL substrates. The number of adhesions per cell in cells on 
the PCL substrate did decrease drastically between 24 hours and 48 hours but remained 
higher than all other substrates. 
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Figure 14. Focal adhesion number, size, and morphology over time on each of the evaluated substrates. 
Temporal quantification of focal adhesion (a) number, (b) area, and (c) eccentricity over time on either 
glass, PCL, 5%, 30%, or 50% substrates. * p < 0.05 compared to all other groups at the same time point. 
n = 3 samples with each sample consisting of approximately 5–75 cells or roughly 500 to 5000 focal 
adhesions per sample. 
 
To further evaluate focal adhesion maturation, both adhesion size and eccentricity were 
quantified. The average area of focal adhesions in cells on the 30% HA/PCL substrate 
was significantly increased 24 hours and 48 hours after cell seeding compared to all other 
substrates (Figure 14b). Furthermore, compared to cells on all other substrates, a 1-fold 
and 3-fold increase in adhesion eccentricity (value closer to 1) was observed in cells on 
the 30% HA/PCL substrate 24 hours and 48 hours, respectively, after cell seeding. We 
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also observed differences in focal adhesion morphology in cells cultured on other 
substrates 2 hours after cell seeding (Figure 14c). These variations in adhesion 
morphology were not as much as those observed 24 hours and 48 hours after cell seeding 
on the 30% substrate and therefore are not discussed in detail. The increase in focal 
adhesion area and decrease in overall number are typical markers of focal adhesion 
maturation4. These results indicate that the 30% HA/PCL substrate caused more rapid 
focal adhesion turnover and maturation compared to all other substrates evaluated. 
 
More Rapid β-Catenin Protein Translocation from Cell Membrane to Nucleus on 
Pro-Osteogenic Substrate (30% PCL/HA). 
To further examine our hypothesis, we examined sub-cellular β-catenin localization with 
protein fractionation and ELISA to quantify β-catenin localization within the cell. We also 
evaluated transcriptional activity using a TOPFLASH reporter assay (Figure 15). Because 
we sought to evaluate the mechanism by which substrate surface characteristics induce 
osteoblastic differentiation, and because the 30% HA/PCL substrate was the only 
substrate that induced osteoblastic differentiation (Table 6 and Figure 13), it was the only 
substrate that was evaluated in further detail. We will refer to the 30% substrate as the 
“pro-osteogenic substrate” henceforth because it enhanced pro-osteogenic capacity and 
induced greater focal adhesion maturation. Data from cells cultured on TCPS is presented 
as a reference to more clearly illustrate the observed variations of β-catenin localization 
and activity in cells cultured on the 30% substrate which have undergone significant 
differentiation compared to cells cultured on a substrate that did not induce differentiation.  
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Figure 15. β-catenin localization and total β-catenin concentration over 96 hours and transcriptional 
activity at 48 hours and 72 hours in hFOB 1.19 cells cultured on either TCPS or pro-osteogenic substrate. 
Quantification of normalized β-catenin concentration in either the (a) membrane bound cell fraction, (b) 
nuclear cell fraction, or (d) total β-catenin concentration. (c) Nuclear β-catenin activity quantified by 
TOPFLASH activity on either TCPS or pro-osteogenic substrate after 48 hours and 72 hours. n = 4–6 
samples with each sample consisting of two replicates. * p < 0.05. 
 
At each time points, cytoplasmic, membrane, nuclear, and cytoskeletal fractions were 
isolated and normalized to total β-catenin concentration at the respective timepoint. β-
catenin concentration in the cytoplasmic and cytoskeletal fraction was not significantly 
different at any time point and is therefore not shown. At 4 hours, 12 hours, and 96 hours 
after seeding cells onto either TCPS or pro-osteogenic substrate, no cell fraction exhibited 
significant differences in β-catenin concentration. 24 hours after cell seeding, no 
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significant variations in total β-catenin concentration in the nuclear fraction was observed 
between cells cultured on TCPS or pro-osteogenic substrate. However, in the membrane 
bound fraction, where β-catenin is localized at adherens junctions or focal adhesions, we 
observed a significant increase in β-catenin concentration in cells on pro-osteogenic 
substrates compared to cells on TCPS (Figure 15a). At 48 hours, in the membrane bound 
fraction we observed a significant increase in β-catenin concentration in cells on TCPS 
compared to cells on the pro-osteogenic substrate (Figure 15a). Cells on pro-osteogenic 
substrates also displayed a significant increase in β-catenin concentration within the 
nuclear fraction compared to cells cultured on TCPS (Figure 15b). At 72 hours, no 
significant variations in normalized β-catenin concentration within the membrane bound 
fraction was observed between cells on TCPS and cells on the pro-osteogenic substrate. 
However, there was a significant increase in normalized β-catenin concentration in the 
nuclear fraction of cells on TCPS compared to cells on pro-osteogenic substrate.  
 
To confirm these findings, we used a luciferase-based TOPFLASH reporter assay that 
indicates increased transcriptional activity of TCF/LEF caused by β-catenin binding within 
the nucleus (Figure 15c). We observed a significant increase in TOPFLASH activity in 
cells on the pro-osteogenic substrate compared to cells on TCPS at 48 hours. At 72 hours 
we observed a significant increase in TOPFLASH activity in cells on TCPS compared to 
cells on pro-osteogenic substrate. Both of these results corroborate our finding as regards 
the translocation of β-catenin observed when using protein fractionation coupled with 
ELISA. Total cellular βcatenin was also quantified and no significant difference in cells on 
TCPS compared to cells on pro-osteogenic substrate at any of the examined time points 
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(Figure 15d). Interestingly, at 4 hours and 12 hours the total, concentration of β-catenin, 
i.e., combining membrane and nuclear fractions, was roughly 4,500pg/mL. At 24 hours 
the total concentration of β-catenin within the cells decreased almost 1.5-fold, to roughly 
1500pg/mL, in cells cultured on both the TCPS and pro-osteogenic substrate. The total 
β-catenin concentration within the cells cultured on TCPS and pro-osteogenic substrate 
then remained at the lower concentration for the remainder of the study. 
 
Inhibition of β-Catenin Binding to TCF/LEF Prevents Substrate-Induced Increases 
in Osteoblastic Differentiation. 
To examine whether the observed changes in osteoblastic differentiation were, in part, a 
result of the observed increase in β-catenin translocation to the nucleus we then inhibited 
β-catenin’s ability to bind to TCF/LEF using PNU-745645. We examined the inhibitor’s 
efficacy by evaluating AXIN2, a downstream effector gene of TCF/LEF6. After 2 days in 
culture, in the absence of PNU-74564, AXIN2 gene expression increased significantly in 
cells cultured on pro-osteogenic substrates compared to cells cultured on TCPS (Figure 
16a). However, the observed increase in AXIN2 expression in cells on pro-osteogenic 
substrates was inhibited in the presence of PNU-74564. After 3 days in culture, cells 
cultured on either TCPS or pro-osteogenic substrate, in the absence of PNU-74564, 
displayed a significant increase in AXIN2 gene expression compared to cells cultured on 
the same substrate in the presence of PNU-74564. Moreover, in the absence of PNU-
74564, AXIN2 gene expression in cells cultured on TCPS was significantly increased 
compared to cells cultured in the absences of PNU-74564 on pro-osteogenic substrate. 
After 7 days in culture, no significant changes in AXIN2 gene expression were observed 
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in any of the groups evaluated. AP activity was significantly increased after 7 days in cells 
cultured on pro-osteogenic substrate not in the presence of PNU-74564. This increase 
was inhibited in cells exposed to PNU-74564 (Figure 16b). 
 
 
Figure 16. Inhibition of β-catenin binding to TCF/LEF in hFOB 1.19 cells on TCPS or Pro-Osteogenic 
Substrates. Evaluation of effect of β-catenin inhibitor, PNU-74564, on (a) Axin2 gene expression and (b) 
AP Activity in cells cultured in media with inhibitor (+) or without inhibitor (–) on either TCPS or Pro-
Osteogenic substrates. * p < 0.05, # p < 0.05 compared to all other groups at same time point. n = 5–6 





Development of substrate surface characteristics to promote osteointegration has been 
an area of intense interest for decades. However, the specific mechanism by which 
substrate surface characteristics are transduced, as well as what substrate characteristic 
may regulate this mechanism, are still largely unknown. We hypothesized that the 30% 
HAp particle density may be a key regulator of osteogenesis. Further, liberation of β-
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catenin from focal adhesions as they undergo maturation and the subsequent 
translocation of β-catenin to the nucleus is a possible mechanism by which substrate 
surface characteristics are transduced. We observed that only one of the evaluated 
substrates, the 30% PCL/HA substrate, induced an increase in osteogenic gene 
expression, AP activity and focal adhesion maturation (Figure 13). We also determined 
that the cells on the 30% PCL/HA substrate had more rapid β-catenin translocation from 
the cell membrane to the nucleus than cells on TCPS. These results suggest that focal 
adhesion turnover, by releasing β-catenin, increases cellular osteogenic activity by 
increasing nuclear β-catenin transcriptional activation.  
 
Upon evaluation of the 30% HAp substrate surface characteristics, only particle density 
differed significantly between all other substrates examined in this study. Substrate 
height, roughness, and wettability were not significantly different between the substrates 
examined (Table 6). However, literature suggests that the determination of which 
substrate surface characteristics regulate osteogenesis is highly complex. 
 
Investigation by Dalby et al.67 and Khang et al.7 determined that substratum roughness 
and height directly affected osteoblastic response, a finding not corroborated by our 
study. Specifically, they determined that micron scale topographies with a substrate 
height between 100nm to 300nm and nanoscale roughness between 12nm and 14nm 
elicited increased osteoblastic differentiation. Lim et al. proposed that substratum surface 
height was responsible for inducing osteoblastic differentiation8,57,185. They determined 
that isotropic topography with a height of 11nm induced greater osteoblastic 
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differentiation, proliferation, focal adhesion formation and cell spreading compared to 
35nm and 85nm high topographies in vitro8,185. A study by Loiselle et al. evaluated 
substratum topography in vitro and in vivo152, with findings contradictory to those 
observed by Lim et al. Loiselle et al. observed that 50nm to 60nm substratum height 
induced the greatest osteoblastic differentiation in vitro as well as greater in vivo 
mineralization compared to 10nm to 15nm and 45nm substratum height124. In the study 
presented here we found no significant differences in surface roughness between the 5%, 
30%, and 50% substrates, with roughness averages of 21, 25, and 94, respectively. 
Although this study evaluated significantly larger substratum surface heights (0.5µm – 
2µm), variations in substratum surface height also varied independently of osteoblastic 
differentiation. These conflicting results suggests more investigation is needed to 
determine conclusively if substrate roughness and height significantly contribute and 
regulate osteogenesis.  
 
Similar to substrate roughness and height, studies examining substrate wettability have 
yielded conflicting results. Although a correlation between substrate wettability and 
osteoblastic differentiation has been reported, the osteoblastic response observed has 
been inconsistent and varied depending on surface topography, chemistry, and the 
specific cell line being evaluated7,186. In the study presented here, surface wettability was 
not significantly altered between any of the substrates examined suggesting substrate 
wettability may not have as significant a role in regulating osteoblastic differentiation as 
previous studies have suggested11,118,187. 
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Particle density, unlike the other characteristics examined in this study, was significantly 
different on the 30% substrate compared to the other substrates examined. The 30% 
substrate had a particle density of 86 particles per centimeter, roughly 70 particles per 
centimeter greater than the 5% substrate and 80 less particles per centimeter than the 
50% substrates, which had particle densities of 16 and 165 particles per centimeter, 
respectively. A study by Ahn et al. examined how nanopost density influenced osteogenic 
commitment of human mesenchymal stem cells (hMSCs) and observed a parabolic 
correlation between post-density and osteogenic differentiation12, similar to the response 
observed in this study. It was determined that lower and higher nanopost densities did 
not induce a sufficient amount of cell spreading to increase cell stiffness and induce 
osteogenic differentiation. Another study by Kuo et al. corroborated these findings. They 
determined that 500nm to 700nm nanopillars reduced apoptosis and increased focal 
adhesion formation to the greatest extent. They also determined that roughly 900nm 
between pillars was the ideal spacing to induce cell spreading181. Our findings, coupled 
with the previously mentioned studies, suggest that there is an optimal density, when 
using roughly 500nm topographic features that induces an increase in osteogenesis. 
However, the results observed in this study and others suggest that the relationship 
between substrate characteristics and osteogenesis is highly complex. It depends heavily 
on the specific materials, surface characteristics, cell type, and culture conditions being 
used, and further study is required before definitive assertions can be made as to which 
substrate characteristic is responsible for inducing osteogenesis. 
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Interestingly, in the previously mentioned studies that examined substrate characteristics 
there was a commonality, despite the conflicting results as to which substrate 
characteristic induces osteogenesis. The substrate that resulted in the greatest increase 
in osteoblastic differentiation also induced an increase in focal adhesion formation and 
maturation13,66,166. In a proliferative state, cells exhibit numerous, small, oblong focal 
adhesions. These adhesions probe the surrounding environment to evaluate the 
substrate. As the focal adhesions mature, they become larger and decrease in overall 
number. Upon investigation of the 30% HAp substrate, we observed similar changes that 
suggest a maturation of focal adhesions (Figure 14). This maturation was observed on 
the 30% substrate in conjunction with upregulation of key osteoblastic differentiation 
genes as well as increased AP activity, suggesting a relationship between focal adhesion 
maturation and osteoblastic differentiation. This suggests that while substrate surface 
characteristics may be variable, the substrate’s ability to induce focal adhesion formation 
and maturation may be a key factor in regulating osteoblastic differentiation. Evidence of 
this interaction has been observed in previous studies examining cell adhesion 
complexes and osteogenesis188. However, these studies have failed to identify a 
mechanism by which focal adhesion maturation may contribute to the regulation of 
osteoblastic differentiation. This unknown question has been succinctly summarized in a 
review by Jamora and Fuches175,189–191. The question is as follows: it is known that 
disassociation of adhesion complexes occurs in response to various stimuli, but what 
happens to the proteins, such as β-catenin, that make up the adhesion complexes after 
disassociation? Do they participate in other facets of cell mechanotransduction, or are 
they broken down and recycled within the cell? 
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To probe the question posed by Jamora and Funches, we examined β-catenin sub-
cellular localization over time. Interestingly on the pro-osteogenic substrate, β-catenin 
concentration remained high in the membrane after 24 hours before decreasing at 48 
hours then returning to a concentration similar to that observed over the first 12 hours. At 
48 hours, β-catenin concentration in cells on the pro-osteogenic substrate exhibited an 
increase in nuclear translocation of β-catenin, which coincided with the decrease in β-
catenin at the membrane. After 48 hours nuclear β-catenin concentration returned to 
levels observed over the first 24 hours. Cells on TCPS exhibited the same shift of β-
catenin from the membrane to the nucleus and then back to basal levels over a 24-hour 
period, similar to that observed on the pro-osteogenic substrate. However, unlike cells on 
the pro-osteogenic substrate, in cells on TCPS the shift of β-catenin from the membrane 
to the nucleus did not begin until 48 hours after seeding, 24 hours later than the pro-
osteogenic substrate (Figure 15). This more rapid translocation of β-catenin in cells on 
pro-osteogenic substrate is likely due to one of the three mechanism discussed 
previously. The increase in nuclear localization of β-catenin at 48 hours on the pro-
osteogenic substrate also coincided with an increase in TOPFLASH activity indicating an 
increase in TCF/LEF transcriptional activity, which is pivotal in the regulation of 
osteogenesis (Figure 15d). It is also worth noting that AXIN2 gene expression closely 
mirrors the transcriptional activity of β-catenin as measured by the TOPFLASH reporter 
assay, further corroborating the observed changes (Figure 16a). 
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We further confirmed that the observed increase in AP activity on the pro-osteogenic 
substrate is, in part, a result of the more rapid translocation of β-catenin to the nucleus as 
well as the observed increase in transcriptional activity. Inhibiting β-catenin binding to 
TCF/LEF inhibits upregulation of downstream effector genes, many of which regulate 
osteoblastic differentiation60. Upon inhibition using PNU-74564, a significant decrease in 
AXIN2 gene expression was observed in cells cultured on pro-osteogenic substrates and 
TCPS after 2 and 3 days, respectively (Figure 16a). Importantly, the significant increase 
in AP activity that is typically associated with the pro-osteogenic substrate was inhibited 
in cells cultured in the presence of PNU-74564 (Figure 16b). This suggests that the 
observed increase in AP activity is a consequence of the more rapid β-catenin 
translocation and increase in transcriptional activity. Taken together these results support 
our hypothesis that the osteogenic substrate we identified in this study induces the 
liberation of β-catenin from adhesion complexes allowing β-catenin to translocate to the 
nucleus and activate osteoblastic differentiation. This also provides further evidence that 
β-catenin bound at adhesion complexes and β-catenin that actively participates in 
intracellular signaling come from the same pool, a concept suggested by results from 
previous studies167. 
 
We hypothesized that β-catenin, a protein bound at the cell adhesion complexes, is 
liberated and is then free to translocate to the nucleus where it can bind TCF/LEF and 
regulate osteogenic gene expression. Evidence from the study presented here, as well 
as previous studies, suggests one of three mechanism by which focal adhesions may 
mediate the observed change in β-catenin localization and activity. The first is that as 
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maturation of focal adhesions occurs, greater intracellular tension is generated. 
Increasing tensile force within the cells then causes disassociation of cadherin complexes 
therefore liberating β-catenin. This concept is supported by previous studies that have 
observed increased breakdown and turnover of E-cadherins in response to increased 
contractile activity16,63,192,193. The second is that β-catenin may participate in the binding 
of vinculin to actin filaments at focal adhesions similar to that observed at adherens 
junctions. As focal adhesion turnover occurs, β-catenin can then be liberated from the 
focal adhesion complexes. Recent studies suggest β-catenin interacts with paxillin during 
increased Rac1 activation, which occurs during focal adhesion turnover116,186. In addition, 
it is reasonable to suggest that β-catenin binds vinculin at focal adhesions in a manner 
similar to what is observed at adherens junctions, and then as turnover occurs it is 
liberated from the adhesion complex63,194,195. The third possibility is that while β-catenin 
may assist in focal adhesion formation and stabilization, and therefore localize at these 
locations, focal adhesions may mediate β-catenin translocation through a secondary 
messenger. One proposed mechanism is that focal adhesion phosphorylation, which 
occurs during adhesion turnover, causes AKT phosphorylation which then inhibits GSK-
3β, a protein that phosphorylates β-catenin. The decreased β-catenin phosphorylation 
leads to an increase in cytosolic β-catenin and, in turn increased β-catenin nuclear 
translocation and activity124,174. However, this mechanism has only been examined in 
mesenchymal stem cells with respect to adipogenesis. It has not been evaluated in 
osteoblastic cells with respect to osteogenesis.  
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Further examination of the interplay between focal adhesion maturation, β-catenin 
shuttling, and osteoblastic differentiation is required to evaluate our hypothesized 
mechanism. Wnt signaling is known to be regulated by various stimuli and the study 
presented here does not encompass or evaluate the wide array of upstream and 
downstream Wnt targets such as AKT phosphorylation9,149,196. The studies discussed 
previously have observed noticeable changes in focal adhesion size and shape on pro-
osteogenic substrates30. Unfortunately, the focal adhesions were not characterized fully 
for maturation and therefore do not allow for a determination to be made on the 
relationship between focal adhesion maturation and osteogenesis. Lastly, inhibition of this 
pathway further upstream, ideally at the focal adhesion complex, would provide greater 
insight into the mechanism by which β-catenin is liberated from focal adhesions. However, 
inhibitors that more directly interfere with β-catenin signaling or the focal adhesions cause 
significant phenotypic changes regardless of the substrate they are being cultured on, 




This study examined the role of substrate surface characteristics to determine if a singular 
characteristic was regulating osteoblastic differentiation. Additionally, this study examined 
the correlation between osteoblastic differentiation, focal adhesion formation and 
maturation, and suggested and evaluated a novel mechanism to explain this correlation. 
We found that one substrate, the pro-osteogenic 30% HA/PCL substrate, increased AP 
activity and expression of genes associated with osteoblastic differentiation as a result of 
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a more rapid translocation and increase in β-catenin transcriptional activity. We concluded 
that in this study only particle density, and therefore the distance between topographic 
features, was significantly different. Thus, our findings, in addition to information from 
previous studies11,12,45, suggest that particle density is possibly one substrate 
characteristic which regulates osteogenic potential. However, more study is needed as 
the relationship between substrates and osteogenesis is complex and depends on 
various factors such as cell type and substrate materials. 
 
Cells on the 30% substrate also exhibited variations in focal adhesion formation and 
morphology, becoming larger and more eccentric compared to cells on all other 
substrates. These observations are indicative of focal adhesion turnover and maturation 
and similar to those seen on other pro-osteogenic substrates. Additionally, we found that 
there is a translocation of β-catenin from the membrane fraction at 24 hours to the nuclear 
fraction at 48 hours on pro-osteogenic substrate, 24 hours earlier than that which was 
observed in cells on TCPS. Furthermore, β-catenin was not only more localized to the 
nucleus on 30% HA/PCL, but it also bound TCF/LEF more frequently, indicating 
increased β-catenin transcriptional activity. It was further determined that by inhibiting β-
catenin binding of TCF/LEF, the increase in osteoblastic differentiation typically observed 
in cells cultured on the pro-osteogenic substrate was inhibited. Taken together these 
results suggest that as focal adhesions mature, reducing in number in response to 
topography, the liberated β-catenin is then translocated to the nucleus and actively binds 
TCF/LEF. This would indicate that a focal adhesion initiated β-catenin mediated 
mechanism contributes to the transduction of substrate surface characteristics. More 
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study is required to determine which of the three possible mechanisms described 
previously of β-catenin and focal adhesion interaction are occurring and causing the 
observed β-catenin translocation and enhanced osteogenic response. 
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CHAPTER 6. Inhibition of Focal Adhesion Turnover Prevents 
Osteoblastic Differentiation through β-catenin Mediated 
Transduction of Pro-Osteogenic Substrate 
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ABSTRACT 
 
The mechanism by which substrate surface characteristics are transduced by 
osteoblastic cells and their progenitors is not fully known. Data from previous studies by 
our group suggests the involvement of β-catenin in the mechanism by which substrate 
surface characteristics are transduced. This focal adhesion initiated, β-catenin mediated 
mechanism functions as β-catenin is liberated from focal adhesion complexes as 
turnover in response to pro-osteogenic substrates occurs. After liberation, β-catenin can 
translocate and participate in the upregulation genes associated with osteogenesis. 
Unfortunately, determining if the observed correlation between focal adhesion turnover 
and β-catenin translocation was a direct result of focal adhesion turnover was 
challenging. In this study we inhibited focal adhesion turnover using a FAK inhibitor PF-
573228. We found that inhibition of focal adhesion turnover resulted in an abrogation of 
the more rapid translocation and increased transcriptional activity of β-catenin induced 
by pro-osteogenic substrate. In addition, inhibition of focal adhesion turnover mitigated 
the increase in osteoblastic differentiation induced by pro-osteogenic substrate as 
measured by alkaline phosphatase enzymatic activity and key protein and gene 
expression. Together, these data coupled with previous findings suggests that the 
observed β-catenin translocation is a result of focal adhesion turnover, providing 
evidence for the proposed focal adhesion initiated, β-catenin mediated mechanism of 




Ongoing development of biomaterials for use in orthopedics and bone tissue 
engineering has yielded promising results through the modification of substrate surface 
characteristics43,197. Surface modifications that are typically include grit blasting, acid 
etching, anodization, and plasma spraying with either metal or osteoconductive 
materials such as hydroxyapatite59. These modifications aim to increase the surface 
roughness, wettability, and protein absorbance of the substrate. However, studies 
investigating biomaterial characteristics have not come to a consensus as to how 
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implant and substrate surface characteristics are transduced by bone cells and their 
progenitors11. Such information would allow for optimization of biomaterial 
characteristics for osteogenesis and osteointegration. Focal adhesions are well-known 
mechanosensors, regulating force and load-responsive transcription factors in 
osteoblastic cells in response to changes in intracellular tension and external stimuli12. 
Previous studies suggest changes in focal adhesions and changes in the cytoskeleton 
may at least partly contribute to the mechanism by which substrates are 
transduced59,173.   
 
Focal adhesion complexes are located at the membrane of the cell and bridge the gap 
between the extracellular matrix (ECM) and the intracellular environment15. Cell 
signaling from the ECM to the intracellular compartment is mediated by focal adhesions 
and other transmembrane cell receptors, such as cadherins13,60,61. Various cell 
pathways including matrix assembly, cell migration, and spatially organized signaling 
are regulated by these adhesions63,198. Focal adhesions also share many proteins 
including vinculin and ⍺-catenin with cadherins as well and binds the actin cytoskeleton 
in a similar manner to cadherins199. Interestingly, one of the proteins that localize at 
cadherins is β-catenin199. At cadherin complexes β-catenin stabilizes the ⍺-catenin and 
vinculin complex to allow binding to the actin cytoskeleton200,201. This suggests it may a 
similar role at focal adhesion complexes. 	
 
The accumulation of β-catenin in the cytoplasm and stimulation of its release results in 
translocation to the nucleus, where it regulates pro-osteoblastic gene expression201. The 
importance of β-catenin in the promotion of osteogenesis and bone development is 
highlighted in a study Case et al43,58. They observed that β-catenin-deficient bone cells 
developed poor skeletal structures. Further, treatment with lithium chloride, prevents 
inactivation of β-catenin, enhanced the response of bone cells to mechanical signals174. 
These results highlight the vital role β-catenin plays in bone formation.  
 
Focal adhesion kinase (FAK) activation is also a prominent signaling mechanism via 
ECM-integrin interactions that enhance the Wnt/β-catenin signaling pathway in bone 
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cells58. These data suggest a relationship between focal adhesions, FAK, and β-
catenin-transcription mediated and mechanical activation of osteogenesis. However, 
despite the extensive research on FAK and β-catenin’s role in transduction of pro-
osteogenic substrate(s) (POS), the mechanism by which the transduction occurs is still 
unknown58.  
 
To better understand this mechanism, it is essential to understand the interaction 
between substrate surface characteristics and their resulting effect on cell FA turnover 
and β-catenin translocation. Evidence shows that substrates with varying surface 
densities influence FA maturation and differentiation202. A previous study by our group 
characterized various substrates that combined polycaprolactone (PCL) and varying 
wt./wt. concentrations of hydroxyapatite particles (HAp)58. We determined that the 30% 
HAp/PCL substrate induced significantly more osteoblastic differentiation. Upon further 
evaluation, we observed greater focal adhesion maturation and more turnover of focal 
adhesions on the 30% HAp/PCL substrate, referred here as the pro-osteogenic 
substrate (POS), compared to all other substrates examined.  Interestingly, this turnover 
and maturation of focal adhesion coincided with a more rapid translocation of β-catenin 
from the membrane-bound protein fraction to the nucleus58. This led us to hypothesize a 
novel mechanism by which substrate surface characteristics are transduced by 
osteoblastic cells. We hypothesized that the mechanism by which this occurs may 
involve the regulation of β-catenin by, or liberation from, proteins at focal adhesion 
complexes, located at the cell membrane. This would result in increased β-catenin 
translocation form these focal adhesion complexes to the nucleus on the more 
osteogenic substrate. We have previously evaluated this proposed focal adhesion 
initiated, β-catenin mediated mechanism202. However, to evaluate the more rapid 
translocation of β-catenin is a consequence of the observed focal adhesion turnover, 
focal adhesion turnover would need to be differentially regulated, and the resulting β-
catenin translocation examined. We hypothesized that inhibition of focal adhesion 
turnover would result in a decrease in osteoblastic differentiation, a delay in the 
translocation of β-catenin from the membrane-bound protein fraction to the nucleus, and 
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a decrease in nuclear activity in cells cultured on POS compared to cells cultured on 
POS without FAK inhibition.  
 
To evaluate this hypothesis, we examined the effect of a focal adhesion inhibitor, PF-
573228, which is known to inhibit focal adhesion turnover in vitro202, on osteoblastic 
differentiation, focal adhesion turnover and maturation, and β-catenin localization and 
activity over time on a previously examined POS93,97. We observed that cells cultured 
on the POS displayed increased osteoblastic differentiation, greater focal adhesion 
maturation, a more rapid (24 hours) translocation of β-catenin from the membrane-
bound fraction to the nuclear fraction, and greater nuclear activity compared to cells 
cultured on tissue culture polystyrene (TCPS), corroborating previous findings7,57,58. 
However, upon addition of the FAK inhibitor, focal adhesion turnover was significantly 
inhibited, the rapid translocation of β-catenin was prevented, and osteoblastic 
differentiation was significantly downregulated. Indeed, cells cultured on POS in the 
absence of FAK inhibitor more closely mimicked cells cultured on TCPS in the absence 
of FAK inhibition.  
 
MATERIALS AND METHODS 
 
Materials.  
All chemicals used for nanoparticle and substrate synthesis were obtained from Sigma-
Aldrich (St. Louis, MO). 
 
Substrate Synthesis. 
Polycaprolactone and Hydroxyapatite Substrate Synthesis. 
To create a pro-osteogenic substrate (POS), we synthesized a substrate composed of 
PCL and hydroxyapatite particles in a ratio that was determined previously to be optimally 
osteogenic58. Briefly, five thousand molecular weight PCL was suspended at a 2.5% 
wt./vol. ratio in chloroform. The mixture was then homogenized until all PCL was 
dissolved into solution. After homogenization, 500nm HAp was added to the solution at a 
ratio of 30% wt./wt. with the PCL. Using a dip-coating technique, 22 mm coverslips were 
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coated and allowed to dry at room temperature for 24 hours. Prior to use all substrates 
were submerged in 70% ethanol for 5 minutes before the ethanol was aspirated and 




Osteoblast Cell Culture.  
To assess osteogenesis, the differentiation capacity of human fetal osteoblasts (hFOB 
1.19 cells), a preosteoblastic cell line, was assessed as previously described. Briefly, for 
proliferation of hFOB 1.19 cells, cells were cultured at 33.5°C with 5% CO2 to 80% 
confluence in standard DMEM:F12 media supplemented with 10% fetal bovine serum 
(Gibco, Gaithersburg, MD) and 1% Penicillin/Streptomycin mixture (Sigma, St. Louis, 
MO). To induce differentiation of the hFOB 1.19 cells, the standard media was 
supplemented with 100µg/mL ascorbic acid, 10−8 M menadione, and 10−8 M dihydroxy-
vitamin D3 (Sigma, St. Louis, MO), and the cells were cultured at 39.5°C with 5% CO2 
until the desired timepoint. In experiments where we focal adhesion kinase (FAK) 
inhibitor, PF-573228, which is known to inhibit focal adhesion turnover in vitro58, was 
suspended in dimethyl sulfoxide (DMSO), and added to differentiation media at a molar 
concentration of 200nM. This concentration was determined based on levels of focal 
adhesion kinase phosphorylation activity at varying FAK inhibitor concentrations 
(Supplemental Figure S7). In addition, an identical amount of DMSO without FAK inhibitor 
was added to control media. Media was changed every 3 days unless otherwise stated 
for all experimental methods.  
 
Alkaline Phosphatase (AP) Activity. 
hFOB 1.19 cells were cultured on either TCPS or the pro-osteogenic substrate in either 
the presence or absence of the FAK inhibitor PF-573228 at 15,000 cells/cm and cultured 
under differentiation conditions for 7 days. Differentiation was evaluated using a 
colorimetric AP enzymatic activity assay as previously described. Briefly, cells were 
freeze thawed in 400µL of 0.05% Trition X-100 in phosphate buffered saline twice and 
then the cell lysate collected. 10uL of each sample lysate was removed and used to 
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quantify total protein concentration using Pierce BCA protein assay kit (Thermo Fisher, 
Waltham, MA). AP enzymatic activity was then determined by conversion of p-nitrophenyl 
phosphate to p-nitrophenol. 200µL of AP reaction buffer was then added to each sample 
and incubated at room temperature for 30 minutes. After incubation 50µL of each sample 
was placed in 200µL of 0.1 NaOH in a 96 well-plate to quench the reaction. All samples 
were then assessed at 410nm and SIGMA units calculated based on the standard curve. 
All readings were then normalized to total protein concentration to control for variations 
in cell number between samples.  
 
Osteoblastic Gene Expression. 
hFOB 1.19 cells were seeded on TCPS or the POS in either the presence or absence of 
the FAK inhibitor PF-573228 at 100,000 cells/cm2 and cultured under differentiation 
conditions for 1 and 7 days. At each time point RNA was isolated using a RNeasy Mini 
Kit (Qiagen, Hilden, Germany). Quantitative real time PCR (RT-qPCR) was performed 
using a C1000 Touch Thermal Cycler with CFX96 Real-Time System (Bio-Rad 
Laboratories, Hercules, CA). PowerUp Sybr Green Master Mix was used to quantify gene 
expression (Thermo Fisher Scientific). The genes we evaluated are associated with the 
various stages of osteoblastic differentiation and are as follows; alkaline phosphatase 
(ALPL), Osteocalcin (BGLAP), Collagen1-A1 (COL1A1), Runt related transcription factor-
2 (RUNX2), and Sp7 Transcription Factor (SP7). Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) was used as a reference gene for all samples. All primers used 
in this study were PrimePCR Sybr Green Assay Primers (Bio-Rad Laboratories, Hercules, 
CA) and the unique assay ID numbers are provided in Table 5. The ∆∆Ct method was 
used to quantify fold-change in gene expression relative to the housekeeping gene 
GAPDH, as previously described.   
 
Focal Adhesion Kinase Activity.  
hFOB 1.19 cells were cultured on either TCPS or the pro-osteogenic substrate at 100,000 
cells/cm and cultured under differentiation conditions for 12 hours, 24 hours, 48 hours, 72 
hours, or 96 hours. At each time point protein was harvested as previously described. 
Briefly, 400uL of a solution of 1x RIPA buffer and protease inhibitor cocktail (Thermo 
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Fisher, Waltham, MA) was placed into each well for 15 minutes on ice. After 15 minutes, 
the wells were scrapped using a cell scrapper and the cell slurry was then moved to a 
1.5mL conical tube. The cells were then lysed further by pipetting cells 10 times through 
a 21-gauge needle. Cells were then centrifuged at 13,000 RPM for 20 minutes and the 
supernatant harvested. Cell lysate was then analyzed for focal adhesion kinase activity 
using FAK (Total) Human ELISA Kit and FAK (Phospho)[pY397] Human ELISA Kit 
(Thermo Fisher, Waltham, MA). Phosphorylated FAK was normalized to total FAK in each 
sample.  
 
Focal Adhesion Staining. 
hFOB 1.19 cells were cultured on TCPS or the POS in either the presence or absence of 
the FAK inhibitor PF-573228 at 15,000 cells/cm and cultured under differentiation 
conditions for 12 hours, 24 hours, 48 hours, 72 hours, or 96 hours. At the selected time 
point, cells were stained using ab196454, an anti-vinculin antibody conjugated to 
AlexaFluor 488 (Abcam, Cambridge, United Kingdom). Briefly, cell culture medium was 
removed, and cells were fixed in 4% paraformaldehyde for 15 min at room temperature. 
After fixation, cells were washed twice with wash buffer consisting of 0.05% Tween-20 in 
PBS. Cells were then permeabilized with 0.1% Trition-X100 in PBS for 5 minutes. After 
permeabilization cells were washed twice with wash buffer and then blocked for 1 hour at 
room temperature in Odyssey Blocking Buffer (Thermo Fisher Scientific, Waltham, MA). 
After blocking anti-vinculin antibody was diluted to 1:250 in blocking buffer and incubated 
overnight at room temperature. Cells were then washed three times in wash buffer. DAPI 
stain, diluted at 1:1,000 in PBS, was added and incubated at room temperature for 5 
minutes. After incubation samples were mounted on glass slides using ProGold Antifade 
Mounting Solution (Thermo Fisher Scientific, Waltham, MA). Representative images for 
each group and timepoint are shown in supplemental figure S8.  
 
Focal Adhesion Characterization. 
Confocal images of the various samples were gathered using an LSM 710 Confocal 
Microscope (Zeiss, Jena, Germany). Using custom MATLAB-based software, images 
were analyzed for focal adhesion size and morphology, and number normalized to cell 
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number. A contrast threshold of 0.450 was selected and applied to all images allowing 
segmentation of the individual focal adhesions. If the segmentation did not accurately 
represent the original image, a different threshold value was chosen manually until 
segmentation of the focal adhesions was representative of the original images. 
Thresholding analysis was then performed and focal adhesion number, length and width 
dimensions (µm), and area (µm2) were output and recorded.  
 
GTPase Activity. 
hFOB 1.19 cells were seeded on the pro-osteogenic substrate at 100,000 cells/cm2 and 
cultured under differentiation conditions for 4 hours, 12 hours, 24 hours, 48 hours, and 72 
hours. After culture, cells were lysed in accordance with the protocol from the G-LISA 
Activation Assay Kit (Cytoskeleton Inc., Denver, CO) for RhoA, Rac1, or Cd42. 10uL of 
each sample lysate was removed and used to quantify total protein concentration using 
Pierce BCA protein assay kit (Thermo Fisher, Waltham, MA). Cell lysates were then 
examined using either the RhoA, Rac1, or Cd42 G-LISA activation assay kits as per the 
designated protocol and GTPase activity quantified. All cell fractions were normalized to 
total protein content.  
 
β-Catenin Cellular Dynamics. 
hFOB 1.19 cells were seeded on TCPS or the pro-osteogenic substrate in either the 
presence or absence of the FAK inhibitor PF-573228 at 100,000 cells/cm2 and cultured 
under differentiation conditions for 4, 12, 24, 48, 72, or 96 hours. After culture, cells 
underwent protein fractionation using the Subcellular Protein Fractionation kit for Cultured 
Cells (Thermo Fisher Scientific, Waltham, MA). After fractionation, 10µL of cell lysate from 
each fraction was removed and used to quantify total protein concentration using a Pierce 
BCA protein assay kit (Thermo Fisher, Waltham, MA). 25µg of total protein from each cell 
fraction at the various time points was then used to quantify total β-catenin protein 
concentration in the various cell fractions over time using a Human Total β-catenin 
DuoSet IC ELISA (R&D Biosystems, Minneapolis, MN). All cell fractions were then 
normalized to total β-catenin concentration at the respective timepoints. 
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Luciferase Based β-Catenin Translocation Reporter Assay. 
To validate nuclear β-catenin translocation and activity from cell fractionation 
experiments, hFOB 1.19 cells were examined using a luciferase-based reporter assay 
(Promega Corporation, Madison, WI) as previously described. Briefly, hFOB1.19 cells 
were transiently transfected with either a TOPFLASH reporter construct, which contains 
a firefly luciferase reporter that is activated by TCF/LEF binding or a FOPFLASH reporter 
construct, which has a mutated TCF/LEF protein that prevents β-catenin activation of the 
firefly reporter. After 24 hours, 100,000/cm2 cells were seeded onto either TCPS or the 
pro-osteogenic substrate in the presence or absence of the FAK inhibitor, PF-573228, 
and cultured for 12 hours, 24 hours, 48 hours, 72 hours or 96 hours. After culture, the 
cells were lysed and a TOPFLASH/FOPFLASH quantified. β-catenin translocation and 
activity in cells on TCPS or the pro-osteogenic substrate in the presence or absence of 




Osteoblastic Differentiation and FAK Activity are Increased in Cells Cultured on 
POS in the Absence of Focal Adhesion Kinase Inhibitor. 
We first wanted to corroborate previous findings demonstrating that cells cultured on POS 
display greater osteoblastic differentiation than cells cultured on TCPS. hFOB1.19 cells 
were cultured on TCPS or POS in the absence of FAK inhibitor and AP enzymatic activity 
quantified at 1, 3, and 7 days (Figure 17). After 1 day in culture, cells cultured on POS 
exhibited a significant 1-fold increase in AP enzymatic activity compared to cells cultured 
on TCPS. After 3 and 7 days in culture, cells cultured on POS again exhibited a 
significantly greater 2-fold and 1-fold increase in AP enzymatic activity, respectively, 
compared to cells cultured on TCPS.  Moreover, the total increase in AP enzymatic 
activity from day 1 to day 7 was greater in cells cultured on POS (.069 U/µG) compared 
a in cells cultured on TCPS (.039 U/µG) suggesting greater osteoblastic differentiation in 
cells culture on POS overall.   
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Figure 17. Normalized alkaline phosphatase enzymatic activity of hFOB 1.19 preosteoblastic cells 
cultured on TCPS or Pro-Osteogenic substrate in the presence (+) or absence (-) of FAK inhibitor PF-
573228 after 1, 3, and 7 days in culture. Significance is considered p < 0.05 only within the same 
timepoint. * = significantly different than all other groups, $ = significantly different than TCPS-,  ★ = 
significantly different than TCPS+, ⅹ= significantly different than Pro-Osteogenic+. n = 4 samples with 
each sample being the average of two replicates. 
 
We then assessed gene expression of key osteoblastic differentiation markers after 1 and 
7 days in culture in cells cultured on TCPS or POS in the absence of FAK inhibitor (Figure 
18). At day 1 no significant differences were observed between cells cultured on TCPS 
and cells cultured on POS in the absence of FAK inhibitor. At day 7, gene expression of 
ALPL, COL1A1, RUNX2 was significantly increased in cells cultured on POS compared 
to cells cultured on TCPS in the absence of FAK inhibitor, similar to what has been 
observed previously. The roughly 1-fold increase in expression observed in ALPL, 
BGLAP, and RUNX2 also suggest a greater maturation of osteoblasts cultured on POS 
compared to those cultured on TCPS, as these markers are indicative of mature 
osteoblast differentiation.  
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Figure 18.  Osteoblastic gene expression on TCPS or Pro-Osteogenic substrate in the presence (+) or 
absence (-) of FAK inhibitor PF-573228. Evaluation of osteoblastic gene expression of (a) Alkaline 
Phosphatase (ALPL), (b) Osteocalcin (BGLAP), (c) Collagen1-a1 (COL1A1), (d) RUNX2, and (e) Osterix 
(SP7) at 1 and 7 days in culture. Significance is considered p < 0.05 only within the same timepoint. * = 
significantly different than all other groups, $ = significantly different than TCPS-,  ★ = significantly 
different than TCPS+, ⅹ= significantly different than Pro-Osteogenic+. n = 4 samples with each sample 
being the average of two replicates. 
 
To determine if the observed changes in gene expression correlated to changes in protein 
expression, we examined the expression of key proteins indicative of osteoblastic 
differentiation in cells cultured on TCPS and POS in the absence of FAK inhibitor (Figure 
19). At day 1, no significant differences, in any protein examined, was observed between 
cells cultured on TCPS and cells cultured on POS. At day 3 however, cells cultured on 
POS exhibited a 3-fold increase in the COL1A1 protein expression (Figure 19a), a marker 
of early commitment to the osteoblastic lineage. Neither Osteocalcin (OCN) nor 
Osteopontin (OPN) were significantly regulated at day 3 between cells cultured on POS 
and cells cultured on TCPS. At day 7 all proteins examined were significantly upregulated 
in cells cultured on POS compared to cells cultured on TCPS. Cells cultured on POS in 
the absence of FAK inhibitor exhibited a roughly 1-fold increase in both OCN (Figure 19b) 
and OPN (Figure 19c), both indicative of mature osteoblastic differentiation, and a 0.5-
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fold increase in COL1A1 protein expression compared to cells cultured on TCPS. These 
data coupled with both the AP enzymatic activity and gene expression data confirms that 
cells cultured on the POS differentiate significantly more compared to cells cultured on 
TCPS as previously observed58.    
 
Figure 19. Osteoblastic protein expression on TCPS or Pro-Osteogenic substrate in the presence (+) or 
absence (-) of FAK inhibitor PF-573228. Evaluation of normalized expression of proteins related to 
osteoblastic differentiation (a) Collagen1-a1 (COL1A1), (b) Osteocalcin (OCN), and (c) Osteopontin 
(OPN) at 1, 3 and 7 days in culture. Significance is considered p < 0.05 only within the same timepoint. 
* = significantly different than all other groups, $ = significantly different than TCPS-,  ★ = significantly 
different than TCPS+, ⅹ= significantly different than Pro-Osteogenic+. n = 3-4 samples with each sample 
being the average of three replicates. 
 
After confirming that POS induced significantly greater osteoblastic differentiation 
compared to TCPS, we then examined FAK activity (Figure 20). Normalized FAK activity 
was quantified by examining concentration of phosphorylated FAK divided by total 
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concentration of FAK over time in cells cultured on TCPS and cells cultured on POS in 
the absence of FAK inhibitor. We observed significant increases in normalized FAK 
phosphorylation at 24 hours in cells cultured on POS compared to cells cultured on TCPS. 
The observed increase remained until 72 hours, where normalized FAK phosphorylation 
then decreased and was significantly less in cells cultured on POS relative to cells 
cultured on TCPS. Interestingly, cells cultured on POS and TCPS followed a similar trend. 
Normalized FAK phosphorylation over time increased and remained elevated for 48 hours 
before returning to basal level, with the POS inducing a more rapid increase in FAK 
phosphorylation. Interestingly, activation levels of Rac1, Cd42, and RhoA, GTPases, 
which participate in actin cytoskeleton and focal adhesion formation51, were unchanged 
over the course of 72 hours (Supplemental Figure S9).  
 
Figure 20. Focal adhesion kinase activity over 96 hours in hFOB 1.19 cells cultured on either TCPS or 
Pro-Osteogenic substrate. Significance is considered p < 0.05 only within the same timepoint. n = 6 
samples. 
 
Inhibition of Focal Adhesion Turnover Prevents Pro-Osteogenic Substrate 
Induced Increase in Osteoblastic Differentiation. 
To examine the role of focal adhesion turnover in the proposed mechanism, we exposed 
cells to the FAK inhibitor, PF-573228, that prevents focal adhesion turnover in vitro58. To 
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confirm the concentration of inhibitor necessary to prevent FAK phosphorylation we 
examined FAK phosphorylation using ELISA at 3 different concentrations 100nM, 150nM, 
and 200nM in cells cultured on TCPS (Supplemental Figure S7). We observed significant 
decreases in normalized FAK phosphorylation at a 200nM concentration and therefore 
200nM was used for all following experiments.  
 
Figure 21. Focal adhesion number, size, and morphology over time in hFOB 1.19 cells cultured on either 
TCPS or Pro-Osteogenic substrate in the presence (+) or absence (-) of FAK inhibitor PF-573228. (a) 
number, (b) area, and (c) eccentricity of focal adhesions examined. Significance is considered p < 0.05 
only within the same timepoint. * = significantly different than all other groups. n = 3 samples with each 
sample consisting of 2-3 replicates. Each image consists of 500-5000 focal adhesions and between 5-
50 cells per image. 
 
To evaluate changes in focal adhesion turnover and maturation, we first examined how 
introduction of FAK inhibitor to cells cultured on POS would affect focal adhesion number, 
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area, and eccentricity over time. We observed that from 4 hours to 12 hours after seeding 
in cells cultured on POS in the absence of FAK inhibitor that a significant increase 
(approximately 100 adhesions per cell) in focal adhesion number occurred (Figure 21a). 
This number then decreased over the next 36 hours to roughly 75 adhesions per cell 
before again increasing to approximately 150 adhesions/cell. As expected, this cyclical 
pattern was not observed in cells cultured on POS in the presence of FAK inhibitor where 
the number of focal adhesions over time remained relatively stable at 100 adhesions per 
cell. In addition, cells cultured on POS in the absence of FAK inhibitor became 
significantly larger between 48 hours and 96 hours, increasing in size roughly 10µm 
(Figure 21b). This increase in area was not observed in cells cultured on POS in the 
presence of FAK inhibitor, with significantly smaller adhesions being present at 72 hours 
and 96 hours after cell seeding compared to cells cultured in the absence of FAK inhibitor. 
Moreover, as previously reported58, adhesion eccentricity decreased (became more 
circular) in cells cultured on POS in the absence of FAK inhibitor at 72 hours and 96 hours 
after cell seeding compared to cells cultured in the presence of FAK inhibitor (Figure 21c). 
These data suggests that the FAK inhibitor was preventing focal adhesion turnover and 
maturation over time, as typically resulted from culturing of cells on the POS.   
 
Following the observation that FAK inhibitor was in fact, preventing focal adhesion 
turnover and maturation, we then wanted to examine how the introduction of FAK inhibitor 
to cells cultured on POS affected osteoblastic differentiation. We observed, in cells 
cultured in the presence of FAK inhibitor on POS, a significant reduction in AP enzymatic 
activity at all timepoints compared to cells cultured on POS in the absence of FAK inhibitor 
(Figure 19). In addition, AP enzymatic activity was not significantly different in cells 
cultured on POS in the presence of FAK inhibitor and cells cultured on TCPS in the 
absence of inhibitor. This suggests that inhibition of FAK mitigates the positive effects 
POS has on AP enzymatic activity. Interestingly, introduction of FAK inhibitor to cells 
cultured on TCPS did not result in a significant change in AP activity compared to cells 
cultured on TCPS in the absence of the inhibitor.   
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We next examined osteoblastic gene expression in the presence and absence of FAK 
inhibitor. At day 1 no differences were observed in cells cultured on TCPS or POS 
regardless of the presence or absence of FAK inhibitor. However, at day 7 gene 
expression for ALPL, OCN, RUNX2, and SP7 in cells cultured in the presence of FAK 
inhibitor on the POS was significantly reduced compared to cells cultured on POS in the 
absence of FAK inhibitor. Unlike all other genes examined, COL1A1 gene expression 
was upregulated in cells cultured on both TCPS and POS in the presence of FAK inhibitor 
at day 7 to levels similar to, if not slight greater, those observed in cells cultured on the 
same substrate in the absence of FAK inhibitor.  
 
Lastly, we examined expression of key osteoblastic proteins over time in cells cultured on 
TCPS and POS in the presence and absence of FAK inhibitor. In cells cultured on POS 
in the presence of FAK inhibitor compared to cells cultured on POS in the absence of 
FAK inhibitor at day 3 we observed a significant 3-fold, 3-fold, and 4-fold reduction of 
COL1A1, OCN, and OPN protein expression, respectively. In cells cultured on TCPS, 
only OPN was significantly downregulated by the presence of FAK inhibitor at day 3. At 
day 7, similar to what we observed in osteoblastic gene expression, we observed a 
significant 4-fold and 3-fold reduction in OCN and OPN, respectively, in cells culture on 
POS in the presence of FAK inhibitor compared to cells cultured on POS in the absence 
of FAK inhibitor. We observed similar results in cells cultured on TCPS in the presence 
of FAK inhibitor at day 7, with a significant reduction in protein expression in both OCN 
and OPN compared to cells cultured in the absence of FAK inhibitor. Interestingly, 
conversely to what was observed in gene expression, COL1A1 protein expression was 
significantly downregulated (4-fold) in cells cultured on POS in the presence of FAK 
inhibitor compared to cells cultured on POS in the absence of FAK inhibitor.  
 
Rapid β-catenin Translocation and Nuclear Activity are Reduced by FAK 
Inhibition. 
To evaluate how inhibiting FAK turnover affects β-catenin localization and activity over 
time we examined β-catenin localization in cells on POS and TCPS in the presence and 
absence of FAK inhibitor. We observed, in the absence of FAK inhibitor, a more rapid (24 
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hours) translocation of β-catenin from the membrane bound fraction to the nucleus in cells 
cultured on POS compared to cells cultured on TCPS. In cells cultured on POS in the 
absence of FAK inhibitor β-catenin concertation was significantly increased in the 
membrane fraction 48 hours after cell seeding while nuclear β-catenin concentration 
remained low (Figure 22a, b).  72 hours after seeding, β-catenin concentration within the 
membrane bound fraction decreased while β-catenin concentration in the nuclear fraction 
significantly increased before the concentration of β-catenin in both the membrane and 
nuclear fraction returned to basal levels at 96 hours. Cells cultured on TCPS in the 
absence of FAK inhibitor followed an identical trend of β-catenin translocation, although 
the process was delayed roughly 24 hours, beginning at 72 hours. We corroborated the 
observed β-catenin translocation using a luciferase-based reporter assay and observed 
a similar 24-hour delay in the nuclear translocation of β-catenin in cells cultured on TCPS 
in the absence of FAK inhibitor compared to cells cultured in the absence of FAK inhibitor 
on POS. In addition, nuclear activity was significantly greater at 24 hours, 48 hours, and 
72 hours in cells cultured on POS in the absence of FAK inhibitor compared to cells 
cultured in the absence of FAK inhibitor on TCPS (Figure 22d). This is also indicative of 
the previously observed increases in osteoblastic differentiation, as nuclear activity of β-
catenin is known to upregulated various osteogenic pathways such as the Wnt signaling 
pathway166. 
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Figure 22. β-catenin localization, total β-catenin concentration, and β-catenin transcriptional activity over 
96 hours in hFOB 1.19 cells cultured on either TCPS or Pro-Osteogenic substrate in the presence (+) or 
absence (-) of FAK inhibitor PF-573228. Quantification of normalized β-catenin concentration in either 
the (a) membrane bound cell fraction, (b) nuclear cell fraction, or (c) total β-catenin concentration. (d) 
Nuclear β-catenin activity quantified by TOPFLASH activity. Significance is considered p < 0.05 only 
within the same timepoint. * = significantly different than all other groups, $ = significantly different than 
TCPS-, ★ = significantly different than TCPS+, ⅹ = significantly different than Pro-Osteogenic+. 
Membrane, Nuclear, and Total β-catenin, n=4. Nuclear activity, n= 3-4 samples, with each sample being 
the average of 2 replicates. 
 
Conversely, addition of FAK inhibitor to cells cultured on POS resulted in a significant 
reduction in β-catenin concentration and rate of translocation compared to cells cultured 
in the absence of FAK inhibitor. A 3-fold reduction β-catenin concentration in the 
membrane-bound fraction β-catenin (Figure 22a) and a roughly 1.5-fold reduction in β-
catenin concentration within the nuclear fraction was observed at 48 hours in cell cultured 
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on POS in the presence of FAK inhibitor compared to cells cultured on POS without FAK 
inhibitor (Figure 22b). Interestingly, the addition of FAK inhibitor to cells cultured on TCPS 
did not significantly reduce the β-catenin concentration within the membrane-bound 
fraction at 48 hours, although it was decreased. β-catenin concentration in the nuclear 
fraction was unchanged at 48 hours in cells cultured on TCPS in absence of FAK inhibitor 
compared to cells cultured on TPCS or POS in the presence of FAK inhibitor. 72 hours 
after cell seeding, β-catenin concentration in the membrane-bound fraction was 
significantly increased in cells cultured on POS in the presence of FAK inhibitor compared 
to compared to cells cultured on POS in the absence of FAK inhibitor. In the nuclear 
fraction, the presence of FAK inhibitor significantly reduced (5-fold) the concentration of 
β-catenin compared to cells cultured on POS in the absence of FAK inhibitor. β-catenin 
concentration in the membrane-bound fraction of cells cultured on POS in the presence 
of FAK inhibitor was significantly reduced (5-fold) compared to cells cultured on TCPS in 
the absence of FAK inhibitor. In the nuclear fraction at 72 hours, β-catenin concentration 
was not significantly different in cells cultured on TCPS in the absence of FAK inhibitor 
compared to cells cultured on POS or TCPS in the presence of FAK inhibitor. At 96 hours 
no significant changes in β-catenin concentration were observed in the membrane bound-
fraction between any of the groups. In the nuclear fraction, cells cultured on POS in the 
presence of FAK inhibitor had a significantly greater β-catenin concentration compared 
to cells cultured on POS in the absence of FAK inhibitor and cells cultured on TCPS in 
the presence of FAK inhibitor. In cells cultured on TCPS in the absence of FAK inhibitor 
we observed significantly 4-fold, 4.5-fold, and 1-fold increase in β-catenin concentration 
compared TCPS in the presence of FAK inhibitor, POS in the absence of FAK inhibitor, 
and POS in the presence of FAK inhibitor respectively.  Interestingly, introduction of FAK 
inhibitor to cells cultured on POS resulted in a 24-hour delay more similar to that of cells 
cultured on TCPS in the absence of FAK inhibitor compared to cells cultured on POS in 
the absence of FAK inhibitor.  
 
We again corroborated the observed β-catenin translocation with a luciferase-based 
reporter assay. We observed similar trends to those observed previously. Nuclear activity 
in cells cultured on POS in the absence of FAK inhibitor was significantly greater than all 
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other groups at 24 hours, 48 hours and 72 hours (Figure 22d). At 48 hours, nuclear activity 
was significantly greater in cells cultured on TCPS in the absence and cells cultured in 
POS in the absence of FAK inhibitor compared to cells cultured on TCPS in the absence 
of FAK inhibitor. At 96 hours, cells cultured on TCPS in the absence of FAK inhibitor 
possessed significantly greater nuclear activity compared to cells cultured on TCPS or 
POS in the absence of FAK inhibitor. However, this result was not corroborated by β-
catenin concentration in the nuclear fraction, suggesting a difference between the 
localization of β-catenin and the nuclear activity.  
 
Total β-catenin concentration varied significantly over time between the observed groups 
exhibiting the importance of normalizing all fractions to the total β-catenin concentration 
(Figure 22c). At 12 hours cells cultured on POS in the absence of FAK inhibitor expressed 
greater amounts of β-catenin compared to cells cultured on TCPS in the presence and 
absence of FAK inhibitor. No differences were observed at 24 hours between any of the 
groups. At 48 hours and 72 hours cells cultured on POS in the absence of FAK inhibitor 
expressed significantly greater total β-catenin concentration compared to all other groups. 
Total β-catenin concentration was also significantly greater in cells cultured on TCPS in 
the absence of FAK inhibitor compared to cells cultured on TCPS and POS in the 
presence of FAK inhibitor. At 96 hours, cells cultured on TCPS in the absence of FAK 
inhibitor expressed significantly greater total β-catenin concentration compared to all 




Determining a mechanism by which substrate surface characteristics are transduced by 
osteoblastic cells and their progenitors would provide avenues for the further 
optimization of bone implants and novel biomaterials for use in bone tissue engineering. 
Previous research by our group determined that cells cultured on POS exhibit greater 
osteoblastic differentiation, focal adhesion maturation, and focal adhesion turnover58. 
This turnover correlated with a more rapid translocation of β-catenin from the membrane 
bound fraction to the nuclear fraction58. Upon inhibition of β-catenin binding to TCF/LEF, 
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the observed increases in osteoblastic differentiation caused by the POS were 
abrogated58. This data led us to propose a focal adhesion initiated, β-catenin mediated 
mechanism by which substrate surface characteristics are transduced. The mechanism 
we proposed suggests that β-catenin, which is localized at the focal adhesion complex, 
is liberated upon focal adhesion turnover where it can then translocate and participate in 
the regulation of osteogenesis. While previous results suggest that β-catenin is liberated 
from focal adhesions and then participates in osteogenic regulation after nuclear 
translocation, we were unable to determine conclusively if the translocation was a result 
of focal adhesion turnover. Through the inhibition of FAK, we were able to determine the 
role focal adhesion turnover plays in the observed changes in β-catenin translocation, 
nuclear activity, and osteoblastic differentiation.  
 
We hypothesized that inhibition of focal adhesion turnover in cells cultured on POS 
would result in a delay in the translocation of β-catenin from the membrane-bound 
protein fraction to the nucleus, a decrease in nuclear activity, and a decrease in the 
resulting increase in osteoblastic differentiation compared to cells cultured on POS 
without FAK inhibition.  
 
We observed, as previously reported203, in cells cultured on POS in the absence of FAK 
inhibitor that a significant increase in osteoblastic differentiation occurred as measured 
by increases in the expression of key osteoblastic genes (Figure 18) and proteins 
(Figure 19) as well as increases in AP activity (Figure 17) compared to cells cultured on 
TCPS. In addition, cells cultured on POS in the absence of FAK inhibitor exhibited 
greater focal adhesion activity, as measured by an increase in FAK phosphorylation, 
which suggests an increase in focal adhesion turnover compared to cells cultured on 
TCPS in the absence of FAK inhibitor, which was observed in previous study by our 
group203. Moreover, a more rapid (24 hours) translocation of β-catenin from the 
membrane-bound protein fraction to the nucleus and greater nuclear activity was also 
observed (Figure 22). Study by Xie et al. observed that in adipose-derived stem cells 
cultured on POS of increasing substrate composed of polydimethylsiloxane, 
commitment to the osteogenic lineage was increased204. β-catenin nuclear translocation 
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was also upregulated on POS of increasing stiffness204. They also observed increased 
vinculin protein expression (~30%), suggesting greater focal adhesion formation in 
conjunction with the enhanced β-catenin nuclear translocation204. Study by Hamilton et 
al. also came to a similar conclusion. FAK activity and focal adhesion formation were 
both upregulated on a grooved pro-osteogenic substrate but were not observed on 
smooth non-pro-osteogenic substrates205.  These studies suggest that focal adhesions 
and FAK are key mediators of substrate surface characteristics and help drive 
commitment to osteoblastic differentiation.  
 
in the study presented here, addition of the FAK inhibitor to cells cultured on POS 
resulted in an observed decrease in the previous increases in osteoblastic 
differentiation caused by culture on the POS (Figure 17,18,19). AP activity of cells 
cultured on POS in the presence of FAK inhibitor at day 7 more closely resembled AP 
activity of cells cultured on TCPS in the absence of FAK inhibitor, suggesting that 
inhibition of FAK may inhibit transduction of the pro-osteogenic substrate. Again, 
Hamilton et al. observed a similar result. Upon inhibition of FAK phosphorylation, the 
previously observed increase in osteoblastic differentiation, as measured by RUNX2 
nuclear translocation, on the grooved POS was inhibited205. In addition, Sun et al. and 
Rajshankar et al. both reported that in mice lacking FAK in osteoblast and pre-
osteoblastic cells, a low bone mass phenotype and increased marrow adiposity was 
observed206,207. This was attributed to decreased osteoblastic proliferation, 
differentiation, and mesenchymal commitment to the osteoblastic lineage, thus 
reaffirming the results presented here that FAK, and therefore focal adhesion formation 
and turnover regulate osteoblastic differentiation206. It is worth noting, that in both cells 
cultured on POS or TCPS in the presence of FAK inhibitor, gene expression of ALPL, 
RUNX2, SP7 were significantly down regulated, however COL1A1 gene expression was 
not. COL1A1 gene expression was the same if not slightly elevated in cells on both 
substrates when FAK inhibitor was introduced. This observed increase was not mirrored 
in protein expression after 7 days, with COL1A1 protein significantly downregulated in 
cells cultured in the presence of FAK inhibitor compared to cells cultured in the absence 
of FAK inhibitor on POS. A previous study by Hori et al. reported similar protein 
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expression findings in fibroblasts58. They reported that increases in FAK (Tyr397) 
phosphorylation resulted in increases in collagen-I expression. Upon inhibition of FAK 
phosphorylation using PF-573228, the same inhibitor used in this study, collagen-I 
protein expression was significantly decreased58. We hypothesize that the increased 
COL1A1 may be a direct result of the lack of COL1A1 protein expression. Because the 
cell is unable to form a stable adhesion and because it cannot deposit collagen to form 
a stable extracellular matrix to adhere to, it upregulates gene expression COL1A1 in an 
attempt to compensate for the dysregulation caused by the addition of FAK inhibitor. 
Rajshankar et al. also postulated a similar hypothesis, as dysregulation of FAK in vivo 
resulted in significant collagen deficiencies, as well as poor bone phenotype as a result 
of decreased osteoblastic differentiation and bone formation207.  
 
β-catenin translocation was also significantly affected by the addition of FAK inhibitor. 
The more rapid translocation (12 hours prior to TCPS) of β-catenin (Figure 22a,c), and 
the significant increase in nuclear transcriptional activity (Figure 22d) were no longer 
observed after the addition of FAK inhibitor. Instead, we observed that cells cultured on 
POS in the presence of FAK inhibitor appeared to also have the same 24-hour delay in 
β-catenin translocation from the membrane-bound protein fraction to the nuclear fraction 
that was observed in cells cultured on TPCS in the absence of FAK inhibitor. 
Transcriptional activity of β-catenin in cells cultured on POS in the presence of FAK 
inhibitor mirrored the transcriptional activity of cells cultured on TCPS in the absence of 
FAK inhibitor almost identically. However, at 96 hours, we observed a decrease in 
transcriptional activity in cells cultured on POS in the presence of FAK inhibitor 
compared to the increase observed in cells cultured in the absence of FAK inhibitor in 
on TCPS or POS. Taken together, data presented here, and previously12,204–206, 
suggests that focal adhesion turnover plays a critical role in the observed increase in β-
catenin translocation and transcriptional activity that results in the increased 
osteoblastic differentiation in response to the POS.  
 
The study presented here and previously12, also seeks to answer the question posed by 
Jamora and Fuchs. The question is as follows, it is known that disassociation of 
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adhesion complexes occurs in response to various stimuli, but what happens to the 
proteins, such as β-catenin, that make up the adhesion complex after disassociation208? 
Do they participate in other facets of cell mechanotransduction or are they broken down 
and recycled208? We observed that inhibition of focal adhesion turnover prevented the 
previously observed increase in β-catenin translocation and upregulation of 
transcriptional activity it is reasonable to suggest that the changes are a direct result of 
focal adhesion turnover. This supports the conclusion that β-catenin does participate in 
other facets of cell mechanotransduction after focal adhesion turnover. A study by Kam 
and Quaranta has also provided evidence to suggest a similar conclusion208. By labeling 
β-catenin with a GFP+ fluorophore they concluded that in E-cadherins, a similar 
adhesion junction, disassembly allowed for the accumulation of GFP+ β-catenin in the 
endocytic recycling compartment13,15,66,208. GFP+ β-catenin then participated in nuclear 
translocation, increasing transcriptional activity as measured by TOPFLASH reporter15. 
Various other studies have also suggested a similar result, although these studies 
evaluated β-catenin translocation from cadherin complexes as well13,15,66.  It has also 
been noted in previous studies that β-catenin is sequestered by both adhesions and the 
transcriptional pool, and therefore when decreases in adhesions occur, upregulation of 
β-catenin transcriptional activity can occur193,201,209. This has led to the suggestion that 
adhesions function as a reservoir for β-catenin, allowing rapid increases in intracellular 
β-catenin concentration in response to various stimuli210, a similar mechanism to what is 
proposed in this study.  
 
While these data provide support for the proposed focal adhesion initiated, β-catenin 
mediate mechanism of substrate transduction further research is needed. FAK actively 
participates in numerous cellular pathways, making it difficult to determine if the 
observed changes are due strictly to β-catenin liberation from focal adhesion or due to 
changes in other proteins affected by FAK by these data alone192. For example, one 
downstream pathway directly affected by changes in FAK is the ak strain 
transforming/mammalian mechanistic target of rapamycin (AKT/mTORC) pathway. 
Upon phosphorylation, FAK stimulates the phosphorylation of AKT16,192. In addition, 
tension developed within the cytoskeleton during focal adhesion maturation can 
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increase mTORC2 activity which results in the phosphorylation of AKT and an 
upregulation in its activity192.  Significantly, AKT is a potent inactivator of GSK-3β, which 
phosphorylates β-catenin in the cytoplasm and leads to its eventual degradation, 
providing a potential mechanism by which changes in FAK activity can regulate β-
catenin activity210. Moreover, studies have determined that upon activation of mTORC2 
through increased cell tension, significant increases in β-catenin concentration in the 
cytoplasm occurs211. However, mTORC2 is predominately located in the endoplasmic 
reticulum1,40,41,68, suggesting it may not be responsible for the rapid changes we 
observed in response to pro-osteogenic substrates but may instead work at a distance 
well after adhesions have formed. Additionally, in various cancers, such as ovarian, 
colon, and intestinal cancer, where focal adhesions play a critical role in tumor 
metastasis, it has been observed that FAK directly influences the β-catenin 
activity201,212,213. It does so through phosphorylation of GSK-3β by upregulating AKT 
phosphorylation and proline rich-tyrosine kinase 2 (PYK2) activity, which directly inhibit 
GSK-3β212,213. Taken together, it is clear further studies that evaluate β-catenin bound 
directly at the focal adhesion are necessary to determine that the observed changes are 
not due to other contributing factors.  
 
The mechanism by which the transduction of substrate characteristics occurs is highly 
complex and it is challenging to segregate the numerous effects of proteins such as β-
catenin and FAK which may participate in cell transduction. The study presented here 
evaluated the effect of focal adhesion turnover on β-catenin localization, transcriptional 
activity and osteoblastic differentiation to evaluate a proposed focal adhesion initiated, 
β-catenin mediated mechanism of substate transduction. The evidence suggests that 
focal adhesion turnover and the observed changes in β-catenin translocation are 
related, however further study is needed to discern whether the β-catenin translocating 
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CONCLUSION 
 
This study examined how inhibition of focal adhesion turnover affects β-catenin 
translocation, β-catenin transcriptional activity, and the resulting osteoblastic 
differentiation to evaluate the proposed focal adhesion initiated, β-catenin mediated 
mechanism of substrate surface transduction. To evaluate if the previously observed 
translocation and increase in transcriptional activity was a result of focal adhesion 
turnover, inhibiting focal adhesion turnover was required. We found that introduction of 
PF-573228, an inhibitor of FAK that reduces focal adhesion turnover in vitro, to cells 
cultured on pro-osteogenic substrate significantly reduced osteogenic differentiation 
induced by the pro-osteogenic substrate compared to cells cultured on pro-osteogenic 
substrate in the absence of FAK inhibitor. In addition, the more rapid translocation of β-
catenin and increase in transcriptional activity observed in cells cultured in the absence 
of FAK inhibitor was abrogated when cells were cultured in the presence of FAK inhibitor, 
resulting in a translocation more similar to cells cultured on tissue culture polystyrene.  
 
This evidence provides support for the hypothesis that the observed changes in β-catenin 
translocation, transcriptional activity, and the resulting osteoblastic differentiation are 
directly related to the more rapid turnover in focal adhesions caused by the pro-
osteogenic substrate. Furthermore, the data presented here and previously by our group 
provides evidence for the support of our proposed mechanism of substrate surface 
transduction, in which focal adhesion turnover liberates β-catenin from the focal adhesion 
complex, allowing it to then translocate to the nucleus where it can participate in the 
transcriptional regulation of osteogenesis.  However, more study is needed to determine 
if the β-catenin we observe translocating is specifically released from the focal adhesion 
complex itself or is a result of changes in other cell pathways such as the AKT/mTORC 
which can be regulated by FAK as well.  
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CHAPTER 7. Conclusions and Future Perspectives 
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CONCLUSION 
 
The study presented here evaluated a novel aptamer-functionalized fibrin hydrogel and 
proposed and evaluated a focal adhesion initiated, β-catenin mediated, mechanism by 
which osteoblastic cells may transduce biomaterial substrate surfaces.  
 
We demonstrated successfully that our novel hydrogel functionalized with a VEGF-
specific aptamer significantly improved angiogenesis and osteogenesis in a critically 
sized cranial defect. The aptamer functionalized hydrogel release kinetics were 
significantly improved while maintaining the structural and mechanical properties of the 
native fibrin. The anti-VEGF DNA aptamer retained and released VEGF over the course 
of 15 days compared to 5 days in unfunctionalized fibrin hydrogels. The improved 
release kinetics resulted in a significant overall increase in angiogenesis, an increase in 
vessel density, and a decrease in separation of the blood vessels within the critically 
sized cranial defect. The aptamer functionalized hydrogel also elicited a significant, but 
limited improvement in osteogenesis. The limited healing of the bone tissue could be 
due to the time points examined during this study, but it could also be a consequence of 
poor interaction between the hydrogel and the cells themselves. Moreover, the hydrogel 
used in this study is only applicable to non-load bearing defects due to its mechanical 
incompetence. This is a significant limitation, as most bones within the body are load 
bearing and therefore necessitate a material or implant that can withstand the required 
mechanical loads. One way to overcome these limitations is to load the hydrogel with an 
osteoconductive material, such as hydroxyapatite.  
 
To address these limitations, we first had to synthesize and characterize hydroxyapatite 
particles. Using a nanoemulsion methodology and by controlling pH of the source 
solutions, we successfully synthesized carbonated hydroxyapatite particles of varying 
sizes. The hydroxyapatite synthesized was biologically similar, with a crystallinity of 
roughly 70%, a size of 200nm to 900nm, and a chemical composition that mimicked 
biological apatite. In addition, we also observed that the synthesized hydroxyapatite was 
non-cytotoxic and that 500nm particles induced significantly greater osteoblastic 
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differentiation of hFOB1.19 preosteoblastic cells. After successful synthesis of 
hydroxyapatite particles, we then sought to understand how preosteoblastic cells are 
interacting with these particles and the biomaterial substrate. Unfortunately, the 
mechanisms by which bone cells transduce substrate surfaces are not fully understood.  
This gap in understanding led us to propose a mechanism by which bone cells, 
specifically osteoblasts, transduce substrate surface characteristics and how these 
surface characteristics induce osteogenesis.  
 
The mechanism proposed in these studies is a focal adhesion initiated β-catenin 
mediated mechanism. To evaluate this mechanism, we developed a pro-osteogenic 
substrate composed of a PCL and the synthesized HAp at 30% wt/wt HAp/PCL. This 
substrate induced significantly greater osteoblastic differentiation in pre-osteoblastic 
cells compared to pre-osteoblastic cells grown on TCPS or other PCL/HAp substrates. 
In addition, this substrate induced significantly greater focal adhesion maturation, 
increased focal adhesion kinase phosphorylation, more rapid β-catenin translocation 
from the membrane to the nucleus, and significantly more β-catenin nuclear activity. 
Moreover, inhibition of β-catenin binding to TCF/LEF, upstream promoters of osteogenic 
genes, within the nucleus prevented the observed increase in osteoblastic differentiation 
and nuclear activity of β-catenin in cells grown on the pro-osteogenic substrate.  
 
Further, to evaluate the role of focal adhesions in this mechanism we inhibited focal 
adhesion kinase, with an PF-573228, which is shown to also inhibit focal adhesion 
turnover in vitro.  Inhibition of focal adhesion turnover caused a significant decrease in 
osteoblastic differentiation on the pro-osteogenic substrate. In addition, β-catenin 
translocation to the nucleus from the membrane and nuclear activity were both 
significantly downregulated. This suggests that focal adhesions play a critical role in the 
proposed mechanism of substrate surface transduction. Moreover, the data presented 
here provides evidence supporting the mechanism in which β-catenin is liberated from 
focal adhesions during turnover in response to pro-osteogenic substrates. After 
liberation β-catenin can actively translocate to the nucleus where, after binding to 
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TCF/LEF, it regulates osteogenic gene expression. This results in an overall increase in 




While the studies presented here provide evidence supporting the use of anti-VEGF 
aptamer functionalized hydrogel for critically sized cranial defects and a proposed focal 
adhesion initiated, β-catenin mediated mechanism of substrate surface transduction, 
many questions remain unanswered.  
 
The aptamer functionalized hydrogel, while successful, did not induce complete bone 
healing of the defect. While this is likely due, in part, to the time points examined, the 
possibility that the hydrogel may not be ideal for bone growth cannot be ignored. VEGF 
is known to increase mesenchymal recruitment and has been shown to play a synergistic 
role with BMP4 in inducing bone formation1. The high specificity of the aptamers used in 
this study would allow for multiple factors to be delivered at once or allow for a more 
osteogenic factor to be used. Continued efforts are needed to examine the effect of 
coupling VEGF delivery with other growth factors such as BMPs, PTH, and PRP has on 
bone healing in critical sized cranial defects. Interestingly, regulation of the Semaphorin-
3A (SEMA3A), which has been shown to regulate bone homeostasis, and VEGF are both 
regulated by Neuropilin-1 (NRP1), making it an attractive target for bone regeneration214. 
Specifically, NRP1 causes an upregulation of SEMA3A which has been observed to 
regulate bone homeostasis by inhibiting osteoclastic bone resorption and promoting 
osteoblastic bone formation through the Wnt/β-catenin signaling pathway. In addition, 
NRP1 upregulates VEGF receptor-2 (VEGFR2), promoting angiogenesis214. Continued 
study would allow evaluation of attractive proteins such as NRP1 or combinations of 
VEGF with other osteogenic agents to be evaluated.  
 
Further, focal adhesions and FAK play a significant role in the transduction of substrate 
surface characteristics and in inducing osteoblastic differentiation. For this reason, it 
would also be conducive to evaluate the introduction of aptamers tailored towards 
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proteins like FAK to which promote increased turnover and maturation of focal adhesions.  
Previous studies have shown the importance of integrin binding in the promotion of focal 
adhesion turnover and maturation. These studies have also highlighted that integrin 
response is highly dependent on the extracellular matrix and the proteins that are coating 
it, such as laminins, fibrinogen, and collagens11,54,215. Based on these observations, novel 
aptamers for proteins such as fibrinogen, which promote integrin binding, would be 
attractive targets to increase the overall osteogenic nature of the AFH.  
 
In addition, improving the mechanical properties of the hydrogel may also improve the 
osteogenic properties of the hydrogel overall. Numerous reviews summarize the ongoing 
research to develop combination biomaterials216. Attempts at integrating hydrogels and 
polymeric scaffolds have produced promising results. The polymers provide the 
mechanical stability and support required for bone applications while the hydrogels create 
a biomimetic environment that can be readily adapted to increase the overall 
osteoconductive properties of the material. Moreover, incorporation of osteoconductive 
materials themselves appears to be a promising avenue of study217.  
 
As we have demonstrated in this study, carbonated hydroxyapatite particles can induce 
significantly greater osteoblastic differentiation in vitro when incorporated in PCL. Carles-
Carner et al. reported similar observations67,218. They observed that incorporation of 
hydroxyapatite nanoparticles into polyethylene glycol (PEG) hydrogels, in vitro, 
upregulated osteoblastic differentiation roughly one-fold compared to non-hydroxyapatite 
loaded hydrogels67. Dhivya et al. also observed that incorporation of similar 
hydroxyapatite particles into a chitosan hydrogel, in vivo, yields a similar trend resulting 
in an overall increase in bone formation in a critically sized bone defect compared to non-
hydroxyapatite loaded hydrogel groups66,219. Incorporation of hydroxyapatite particles into 
a hydrogel scaffold also provides mechanical support, allowing for hydrogels to be 
synthesized with improved compressive strength59,173,220. Taken together, this information 
suggests that incorporation of hydroxyapatite particles into a VEGF specific aptamer-
functionalized hydrogel would significantly increase the overall osteogenic potential of the 
hydrogel itself. However, incorporation of osteoconductive particles may also cause 
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negative changes in hydrogel load efficiency, diffusion rate, and release kinetics and 
therefore warrants further study.  
 
Optimization of the hydrogel or biomaterial surface characteristics to promote 
osteogenesis would also be one avenue to pursue further. This approach is made 
possible by understanding how bone cells and their progenitors transduce surface 
characteristics and provides novel targets to increase osteogenesis. The study presented 
here provided evidence for a focal adhesion initiated, β-catenin mediated mechanism of 
substrate surface transduction. However, more evidence to support our proposed 
mechanism is still need and significant questions still need to be answered. One of the 
most important questions is whether β-catenin is bound at the focal adhesion complex. 
β-catenin most likely binds with ⍺-catenin at focal adhesion complexes, similar to what 
has been observed at adherens junctions. This is further supported by a recent study 
which observed that BCL9-2, mammalian relative of the Wnt signaling component, 
Legless, is integral for the function of activated β-catenin in the transcription of Wnt target 
genes during fly and fish development221. They observed that when BCL9-2 was 
overexpressed, focal adhesion formation was significantly downregulated221. They also 
noted that BCL9-2 directly overlaps the known binding site of β-catenin and ⍺-catenin221. 
This suggests that inhibition of ⍺-catenin binding to β-catenin significantly affects focal 
adhesion formation and a competitive interaction between ⍺-catenin and BCL9-2 may 
play a role in β-catenin’s ability to localize at the membrane or the nucleus. Unfortunately, 
co-immunoprecipitation of β-catenin with ⍺-catenin, paxillin, or vinculin would not provide 
the necessary evidence to determine if β-catenin is bound at focal adhesion complexes.  
Because these proteins are localized at both focal adhesions and adhesion junction’s co-
immunoprecipitation would not provide the necessary information to discriminate between 
β-catenin at a focal adhesion or an adhesion junction221. In addition, co-
immunoprecipitation would also not provide evidence for whether the bound β-catenin is 
translocating to the nucleus. To overcome this, we propose using both live cell imaging 
and a fluorescence resonance energy transfer (FRET). Labeling of FAK with a donor 
fluorophore would allow activation of β-catenin with an acceptor fluorophore to be 
activated when the two proteins are localized within the same vicinity221. This would 
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provide evidence of β-catenin localization to the focal adhesion complex. In addition, by 
fluorescently labeling FAK and β-catenin with a photo-switchable fluorophore, β-catenin 
that co-localizes with FAK could be switched and the labeled β-catenin tracked to 
determine if it then translocated to the nucleus. This would provide conclusive evidence 
of the mechanism proposed in this study.   
 
The completion of the proposed studies would provide further avenues of research, as it 
would provide a mechanism by which substrates are transduced by cells. Using this 
information as well as the information gained by evaluating how incorporation of 
osteoconductive materials and other biological factors into the AFH effects 
osteogenesis, more specific modifications could be made to the novel AFH further 
optimizing the osteogenic potential. 
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Supplemental Figure S1. Angiogenic evaluation of vessel density and spacing as a result of hydrogel 
treatment. (a,d) MicroCT analysis of vascular density (vessels/ micron) and vascular separation (micron) 
of the defect at 7 days post defect introduction for all intervention types (b,e) 14 days post defect 
introduction for all intervention types (c,f) 21 days post defect introduction for all intervention types. * p < 
0.05, ** p < 0.005, n ≥ 3 
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Supplemental Figure S2. Representative images of osteoblast cell morphology at 1, 3, and 7 days in 
response to various CHA particle sizes (200nm, 500nm, and 900nm) examined. No significant changes 
were observed in osteoblast morphology over time regardless of CHA particle size examined. With cells 
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5% HA/PCL Substrate 
 
 
Transduction of Substrate Surface Characteristics · Spring 2021 
Otto J. Juhl IV · Ph.D. Dissertation · Biomedical Engineering · Virginia Commonwealth University 165 
30% HA/PCL Substrate 
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50% HA/PCL Substrate 
 
Supplemental Figure S3. Fluorescent staining of focal adhesion complexes (Vinculin) and the nucleus 
(DAPI) in cells cultured on Glass, PCL, 5%, 30% or 50% substrates over 48 hours.  
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Supplemental Figure S4. Evaluation of the effect of PNU-74654, an inhibitor of β-catenin binding to 
TCF/LEF, on β-catenin nuclear activity in hFOB 1.19 cells 48 hours after the addition of the inhibitor. 
Inhibitor was evaluated at 10 µM, 25 µM, and 50µM with an untreated group (Control) and a group 
supplemented with an identical volume of DMSO (DMSO) serving as controls. Significance is considered 
p < 0.05, * = significantly different than all other groups. CT = cytotoxic concentration resulting in cell 




Supplemental Figure S5. Schematic illustration of the PCL and HAp substrate with 150nm thick PCL 
coating indicated at left and 500nm HA particles shown in red indicated at right.  
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Supplemental Figure S6. Evaluation of mineralization in hFOB 1.19 cells in hFOB1.19 cells cultured 
on TCPS, PCL, 5%, 30%, and 50% HAp/PCL substrates for 7, 10 and 14 days. Significance is 
considered p < 0.05, * = significantly different than all other groups. n=4 samples. 
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Supplemental Figure S7. Evaluation of the effect of PF-573228, an inhibitor of focal adhesion kinase, 
on normalized focal adhesion phosphorylation (phosphorylated/total) in hFOB 1.19 cells 48 hours after 
the addition of the inhibitor. Inhibitor was evaluated at 100nm, 150nm, and 200nM with an untreated 
group (Control) and a group supplemented with an identical volume of DMSO (DMSO) serving as 
controls. Significance is considered p < 0.05, * = significantly different than all other groups *. n=3 
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SUBSTRATE IN THE ABSENCE OF FAK INHIBITOR 
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SUBSTRATE IN THE PRESENCE OF FAK INHIBITOR 
 
Supplemental Figure S8. Fluorescent staining of focal adhesion complexes (vinculin) and the nucleus 
(DAPI) in cells cultured on pro-osteogenic substrate in the presence or absence of FAK inhibitor over 96 
hours.   
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Supplemental Figure S9. Evaluation of GTPases (a) Rac1, (b) Cd42, and (c) RhoA in hFOB1.19 cells 
cultured on POS after 4 hours, 12 hours, 24 hours, 48 hours and 72 hours in culture. Significance is 
considered p < 0.05. n=4 samples. 
 
